GT,Diagnosis 1
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Common symptoms include metabolic acidosis and decreased methylmalonyl-CoA mutase activity. However, death in infancy and childhood, although possible, are not guaranteed symptoms.

+2. Propionic Acidemia: This is a disorder that affects the breakdown of certain parts of proteins and lipids. Symptoms include metabolic acidosis and decreased methylmalonyl-CoA mutase activity. Death in infancy and childhood can occur in severe cases, but it's not a common symptom.

+3. Isovaleric Acidemia: This is a disorder characterized by a distinctive odor of sweaty feet and is caused by the accumulation of a particular acid (isovaleric acid) in the body. The common symptoms with the patient are metabolic acidosis and death in infancy or childhood. However, decreased methylmalonyl-CoA mutase activity is not a symptom of this disease.

+4. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to process certain protein building blocks. The common symptoms with the patient are metabolic acidosis and death in infancy or childhood. However, decreased methylmalonyl-CoA mutase activity is not a symptom of this disease.

+5. Glutaric Acidemia Type II: This is a disorder characterized by abnormalities in the breakdown of proteins and fats. The common symptoms with the patient are metabolic acidosis and death in infancy or childhood. However, decreased methylmalonyl-CoA mutase activity is not a symptom of this disease."
['Succinic semialdehyde dehydrogenase deficiency'],"+1. Spinal Muscular Atrophy (SMA): This is a genetic disorder characterized by weakness and wasting (atrophy) of the voluntary muscles in the arms and legs of infants and children. The symptoms in common with the patient are 'Motor delay' and 'Generalized hypotonia'. The symptoms not in common are 'Death in infancy', 'Pneumonia', and 'Elevated urinary carboxylic acid'.

+2. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. The symptoms in common with the patient are 'Motor delay', 'Generalized hypotonia', 'Death in infancy', and 'Pneumonia'. The symptom not in common is 'Elevated urinary carboxylic acid'.

+3. Propionic Acidemia: This is a disorder that causes an accumulation of certain acids and toxins in the body that can damage the brain and other organs. The symptoms in common with the patient are 'Motor delay', 'Generalized hypotonia', 'Death in infancy', and 'Elevated urinary carboxylic acid'. The symptom not in common is 'Pneumonia'.

+4. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells (neurons) in the brain to send and receive messages. The symptoms in common with the patient are 'Motor delay' and 'Generalized hypotonia'. The symptoms not in common are 'Death in infancy', 'Pneumonia', and 'Elevated urinary carboxylic acid'.

+5. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. The symptoms in common with the patient are 'Motor delay', 'Generalized hypotonia', 'Death in infancy', and 'Elevated urinary carboxylic acid'. The symptom not in common is 'Pneumonia'."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. Symptoms not in common with the patient include 'Liver and kidney disease', 'Intellectual disability', and 'Failure to thrive'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. Symptoms not in common with the patient include 'Intellectual disability', 'Delayed development', and 'Behavioral, emotional, and social problems'.

+3. Prenatal and Infantile Hyperphenylalaninemia: This is a condition that affects how the body processes the amino acid phenylalanine. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. Symptoms not in common with the patient include 'Intellectual disability', 'Delayed development', and 'Seizures'.

+4. Neonatal Death Syndrome: This is a term used to describe the death of a newborn within the first 28 days of life. Symptoms in common with the patient include 'Neonatal death' and 'Death in infancy'. Symptoms not in common with the patient include 'Stillbirth', 'Premature birth', and 'Low birth weight'.

+5. Congenital Abnormality Syndrome: This is a broad term that includes any structural or functional anomalies that occur during intrauterine life and can be identified prenatally, at birth, or sometimes may only be detected later in infancy. Symptoms in common with the patient include 'Abnormality of prenatal development or birth'. Symptoms not in common with the patient include 'Physical deformities', 'Intellectual disability', and 'Growth retardation'."
['PMM2-CDG'],"+1. Congenital Diaphragmatic Hernia: This is a birth defect where there is an opening in the diaphragm, allowing organs in the abdomen to move into the chest. Symptoms in common: 'Congenital diaphragmatic hernia'. Symptoms not in common: 'Respiratory distress', 'Cyanosis'.

+2. Cerebellar Atrophy: This is a condition where the cerebellum (part of the brain) shrinks, leading to a variety of neurological symptoms. Symptoms in common: 'Cerebellar atrophy', 'Motor delay'. Symptoms not in common: 'Difficulty with coordination and balance', 'Slurred speech'.

+3. Failure to Thrive: This is a term used in pediatric, adult as well as veterinary medicine, to indicate insufficient weight gain or inappropriate weight loss. Symptoms in common: 'Failure to thrive'. Symptoms not in common: 'Poor weight gain', 'Delayed development'.

+4. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common: 'Death in infancy'. Symptoms not in common: 'Sleeping on the stomach', 'Exposure to tobacco smoke'.

+5. Hiatus Hernia: This is a condition in which part of the stomach pushes up through the diaphragm muscle. Symptoms in common: 'Hiatus hernia'. Symptoms not in common: 'Heartburn', 'Difficulty swallowing'.

+6. Lipodystrophy: This is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. Symptoms in common: 'Lipodystrophy'. Symptoms not in common: 'Insulin resistance', 'Hepatomegaly'.

+7. Cerebellar Agenesis: This is a rare condition in which a person is born without one or both parts of the cerebellum, the part of the brain that controls voluntary muscle movements. Symptoms in common: 'Cerebellar agenesis', 'Motor delay'. Symptoms not in common: 'Difficulty with coordination and balance', 'Involuntary eye movements'.

+8. Muscular Dystrophy: This is a group of diseases that cause progressive weakness and loss of muscle mass. Symptoms in common: 'Abnormal muscle physiology', 'Motor delay'. Symptoms not in common: 'Muscle weakness', 'Difficulty walking'."
['Maple syrup urine disease'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common include 'Generalized hypotonia', 'Feeding difficulties', 'Motor delay', 'Intellectual disability', 'Death in infancy', 'Death in childhood', and 'Death in adolescence'. Symptoms not in common include 'Hydronephrosis', 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Fever', 'Opisthotonus', 'Athetosis', 'Kyphoscoliosis', 'Neonatal death', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', and 'Elevated urinary carboxylic acid'.

+2. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to process certain parts of proteins. Symptoms in common include 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Feeding difficulties', 'Hypervalinemia', 'Hyperleucinemia', and 'Hyperisoleucinemia'. Symptoms not in common include 'Hydronephrosis', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Fever', 'Opisthotonus', 'Athetosis', 'Kyphoscoliosis', 'Neonatal death', 'Death in childhood', 'Death in adolescence', and 'Elevated urinary carboxylic acid'.

+3. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common include 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Fever', 'Opisthotonus', 'Athetosis', and 'Feeding difficulties'. Symptoms not in common include 'Hydronephrosis', 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Kyphoscoliosis', 'Neonatal death', 'Death in childhood', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Death in adolescence', and 'Elevated urinary carboxylic acid'.

+4. Pantothenate Kinase-Associated Neurodegeneration: This is a type of neurodegeneration with brain iron accumulation. Symptoms in common include 'Generalized hypotonia', 'Opisthotonus', 'Athetosis', and 'Kyphoscoliosis'. Symptoms not in common include 'Hydronephrosis', 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Motor delay', 'Death in infancy', 'Fever', 'Neonatal death', 'Death in childhood', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Death in adolescence', 'Feeding difficulties', and 'Elevated urinary carboxylic acid'."
['Phenylketonuria'],"+1. Celiac Disease: This is an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. Symptoms in common with the patient include 'Skin rash', 'Diarrhea', 'Gastrointestinal inflammation'. Symptoms not in common include 'Malnutrition', 'Fatigue', 'Bone loss'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Intellectual disability', 'Delayed development', 'Musty odor in breath, skin, or urine'.

+3. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Hypertyrosinemia', 'Neonatal death', 'Death in infancy'. Symptoms not in common include 'Liver and kidney disease', 'Problems affecting the nervous system'.

+4. Herpes Simplex Virus (HSV): This is a common viral infection that causes sores on your mouth or genitals. Symptoms in common with the patient include 'Skin rash', 'Recurrent viral infections', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'. Symptoms not in common include 'Fever', 'Tiredness', 'Muscle aches'.

+5. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common with the patient include 'Obesity', 'Hernia'. Symptoms not in common include 'Poor muscle tone', 'Distinctive facial features', 'Short stature'.

+6. Necrotizing Enterocolitis (NEC): This is a medical condition where a portion of the bowel dies. Symptoms in common with the patient include 'Neonatal death', 'Death in infancy', 'Gastrointestinal inflammation', 'Diarrhea'. Symptoms not in common include 'Bloody stool', 'Abdominal distension', 'Lethargy'."
['Biotinidase deficiency'],"+1. Eczema: This is a condition that makes your skin red and itchy. It's common in children but can occur at any age. Eczema is long lasting and tends to flare up periodically. It may be accompanied by asthma or hay fever. Symptoms in common with the patient: 'Obsolete Eczematoid dermatitis', 'Skin rash'. Symptoms not in common with the patient: 'Asthma', 'Hay fever'.

+2. Alopecia Areata: This is a condition that causes hair to fall out in small patches, which can be unnoticeable. These patches may connect, however, and then become noticeable. The condition develops when the immune system attacks the hair follicles, resulting in hair loss. Symptoms in common with the patient: 'Alopecia'. Symptoms not in common with the patient: 'Nail pitting', 'White patches on the skin'.

+3. Lactic Acidosis: This is a high level of lactic acid in the blood, which can be caused by chronic alcohol use, heart failure, cancer, seizures, liver failure, prolonged lack of oxygen, or low blood sugar. Symptoms in common with the patient: 'Increased circulating lactate concentration'. Symptoms not in common with the patient: 'Nausea', 'Vomiting', 'Abdominal pain', 'Rapid breathing'.

+4. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Symptoms in common with the patient: 'Death in infancy', 'Increased CSF lactate'. Symptoms not in common with the patient: 'Psychomotor regression', 'Respiratory failure'. 

+5. Dermatitis Herpetiformis: This is a skin condition that causes intensely itchy, typically blistering skin rash. The rash is characterized by eruptions of clusters of small blisters or vesicles and usually appears on the elbows, knees, back, and buttocks. Symptoms in common with the patient: 'Obsolete Eczematoid dermatitis', 'Skin rash'. Symptoms not in common with the patient: 'Blisters on the skin', 'Rash on elbows, knees, back, and buttocks'."
['PMM2-CDG'],"+1. Alström Syndrome: This is a rare genetic disorder characterized by cone-rod dystrophy, intellectual disability, and abnormal facial shape. However, the patient does not show symptoms of lipodystrophy, cerebellar atrophy, and cerebellar agenesis which are also associated with this disease.

+2. Joubert Syndrome: This is a rare genetic disorder that may cause cerebellar atrophy and abnormal facial shape. However, the patient does not show symptoms of cerebellar agenesis, which is also associated with this disease.

+3. Zellweger Syndrome: This is a rare genetic disorder that may cause intellectual disability, abnormal facial shape, and cerebellar agenesis. However, the patient does not show symptoms of acute hepatitis and chronic hepatitis, which are also associated with this disease.

+4. Hepatitis: This could be either acute or chronic inflammation of the liver. The patient shows symptoms of acute hepatitis and chronic hepatitis. However, the patient does not show symptoms of thromboembolism and death in infancy, which can also occur in severe cases.

+5. Cerebellar Atrophy: This is a condition where the cerebellum shrinks or wastes away. The patient shows symptoms of cerebellar atrophy. However, the patient does not show symptoms of abnormal calvaria morphology and lipodystrophy, which can also occur in some cases.

+6. Lipodystrophy: This is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. The patient shows symptoms of lipodystrophy. However, the patient does not show symptoms of thromboembolism and death in infancy, which can also occur in some cases.

+7. Thromboembolism: This is a condition where a blood clot forms in a blood vessel and blocks it. The patient shows symptoms of thromboembolism. However, the patient does not show symptoms of cerebellar agenesis and acute hepatitis, which can also occur in some cases. 

+8. Infant Death Syndrome: This is a diagnosis given when an infant dies unexpectedly and the cause of death remains unexplained after a thorough investigation. The patient shows symptoms of death in infancy. However, the patient does not show symptoms of chronic hepatitis and abnormal calvaria morphology, which can also occur in some cases."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Acidemia Type 1: This is a genetic disorder that affects the body's ability to process certain proteins. Symptoms include macrocephaly, generalized hypotonia, dystonia, lethargy, and glutaric aciduria. The patient has all these symptoms. However, the patient does not have neonatal death, which is also a symptom of this disease.

+2. Carnitine Deficiency: This is a condition that prevents the body from using fats for energy, particularly during periods without food. Symptoms include decreased plasma free carnitine, lethargy, and vomiting. The patient has these symptoms. However, the patient does not have muscle weakness and confusion, which are also symptoms of this disease.

+3. MELAS Syndrome: This is a rare genetic disorder that can affect many of the body's systems, particularly the brain and nervous system (encephalo-) and muscles (myopathy). Symptoms include generalized hypotonia, dystonia, and vomiting. The patient has these symptoms. However, the patient does not have seizures and stroke-like episodes, which are also symptoms of this disease.

+4. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms include generalized hypotonia, dystonia, and lethargy. The patient has these symptoms. However, the patient does not have poor sucking ability and loss of previously acquired motor skills, which are also symptoms of this disease.

+5. Cystic Hygroma: This is a fluid-filled sac that results from a blockage in the lymphatic system. Symptoms include cystic hygroma. The patient has this symptom. However, the patient does not have a soft bulge on the side of the neck, which is also a symptom of this disease.

+6. Gastroenteritis: This is an inflammation of the lining of the intestines caused by a virus, bacteria or parasites. Symptoms include diarrhea, vomiting, and fever. The patient has these symptoms. However, the patient does not have abdominal pain, which is also a symptom of this disease. 

+7. Sleep Apnea: This is a potentially serious sleep disorder in which breathing repeatedly stops and starts. Symptoms include sleep abnormality and drowsiness. The patient has these symptoms. However, the patient does not have loud snoring, which is also a symptom of this disease."
['Isovaleric acidemia'],"+1. Neonatal Hyperammonemia: This is a condition characterized by high levels of ammonia in the blood. Symptoms in common with the patient include 'Hyperammonemia', 'Lethargy', 'Drowsiness', 'Death in infancy', 'Neonatal death', and 'Feeding difficulties'. Symptoms not in common include 'Abnormal circulating glycine concentration' and 'Abnormal circulating carnitine concentration'.

+2. Glycine Encephalopathy: This is a metabolic disorder characterized by abnormally high levels of glycine in the body. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Lethargy', 'Death in infancy', 'Drowsiness', 'Sleep abnormality', 'Neonatal death', 'Death in childhood', 'Abnormal circulating glycine concentration', and 'Feeding difficulties'. Symptoms not in common include 'Hyperammonemia' and 'Abnormal circulating carnitine concentration'.

+3. Carnitine Deficiency: This is a condition characterized by low levels of carnitine in the body. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Lethargy', 'Death in infancy', 'Drowsiness', 'Sleep abnormality', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration', and 'Feeding difficulties'. Symptoms not in common include 'Hyperammonemia' and 'Abnormal circulating glycine concentration'.

+4. Sudden Infant Death Syndrome (SIDS): This is a condition where an infant dies suddenly and unexpectedly. Symptoms in common with the patient include 'Death in infancy', 'Neonatal death', 'Death in childhood', and 'Sleep abnormality'. Symptoms not in common include 'Hyperammonemia', 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration', 'Abnormality of prenatal development or birth', 'Lethargy', 'Drowsiness', and 'Feeding difficulties'. 

+5. Hypoxic-Ischemic Encephalopathy (HIE): This is a condition caused by a lack of oxygen to the brain. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Lethargy', 'Death in infancy', 'Drowsiness', 'Sleep abnormality', 'Neonatal death', 'Death in childhood', and 'Feeding difficulties'. Symptoms not in common include 'Hyperammonemia', 'Abnormal circulating glycine concentration', and 'Abnormal circulating carnitine concentration'."
['PMM2-CDG'],"+1. Congenital Cerebellar Ataxia: This is a condition characterized by lack of voluntary coordination of muscle movements. Symptoms in common with the patient include Ataxia, Cerebellar atrophy, Hyporeflexia, Motor delay, and Intellectual disability. Symptoms not in common include Seizures and Dysarthria.

+2. Joubert Syndrome: This is a rare genetic disorder that affects the area of the brain that controls balance and coordination. Symptoms in common with the patient include Ataxia, Hypotonia, Nystagmus, and Intellectual disability. Symptoms not in common include Breathing abnormalities and Kidney abnormalities.

+3. Dandy-Walker Syndrome: This is a congenital brain malformation involving the cerebellum and the fluid filled spaces around it. Symptoms in common with the patient include Ataxia, Hypotonia, and Cerebellar agenesis. Symptoms not in common include Hydrocephalus and Cranial nerve paralysis.

+4. Pontocerebellar Hypoplasia: This is a group of related conditions that affect the development of the brain. Symptoms in common with the patient include Microcephaly, Strabismus, Nystagmus, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia, and Encephalopathy. Symptoms not in common include Muscle weakness and Respiratory insufficiency.

+5. Porencephaly: This is an extremely rare condition of the central nervous system involving a cyst or cavity in a cerebral hemisphere of the brain. Symptoms in common with the patient include Microcephaly, Strabismus, Nystagmus, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, and Encephalopathy. Symptoms not in common include Seizures and Hemiplegia.

+6. Cerebellar Hypoplasia: This is a neurological condition in which the cerebellum is smaller than usual or not completely developed. Symptoms in common with the patient include Microcephaly, Strabismus, Nystagmus, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia, and Encephalopathy. Symptoms not in common include Seizures and Dysarthria."
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1. Leber's Hereditary Optic Neuropathy: This is a condition characterized by vision loss, particularly in young adults. Symptoms in common with the patient include Strabismus, Nystagmus, and Optic atrophy. However, the patient does not show other symptoms such as sudden painless central vision loss.

+2. Congenital Heart Disease: This is a problem with the heart's structure and function that is present at birth. Symptoms in common with the patient include Ventricular septal defect. However, the patient does not show other symptoms such as cyanosis (bluish tint to the skin, lips, and fingernails), rapid breathing, and fatigue.

+3. Urea Cycle Disorder: This is a genetic disorder caused by a mutation that results in a deficiency of one of the six enzymes in the urea cycle. Symptoms in common with the patient include Hyperammonemia, Hyperalaninemia, and Neonatal death. However, the patient does not show other symptoms such as irritability, refusal to eat, and vomiting.

+4. Homocystinuria: This is a disorder of the metabolism of the amino acid methionine. Symptoms in common with the patient include Hyperhomocystinemia, Motor delay, and Generalized hypotonia. However, the patient does not show other symptoms such as tall stature, osteoporosis, and intellectual disability.

+5. Methylmalonic Acidemia: This is a disorder in which the body cannot break down certain proteins and fats. Symptoms in common with the patient include Methylmalonic aciduria, Elevated urinary carboxylic acid, and Abnormal circulating carnitine concentration. However, the patient does not show other symptoms such as lethargy, failure to thrive, and recurrent vomiting.

+6. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include Death in infancy and Death in childhood. However, the patient does not show other symptoms as SIDS usually has no symptoms or warning signs. 

+7. Prenatal and Birth Complications: These are problems that occur during pregnancy or birth. Symptoms in common with the patient include Abnormality of prenatal development or birth. However, the patient does not show other symptoms such as low birth weight, premature birth, and maternal health problems."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine-acylcarnitine translocase deficiency: This is a rare metabolic condition that prevents the body from converting certain fats into energy. Symptoms in common include 'Hypoglycemia', 'Vomiting', 'Diarrhea', 'Elevated circulating hepatic transaminase concentration', 'Abnormal circulating carnitine concentration'. However, 'Death in infancy' is not a common symptom.

+2. Medium-chain acyl-CoA dehydrogenase deficiency (MCADD): This is a disorder that prevents the body from converting certain fats into energy. Symptoms in common include 'Hypoglycemia', 'Vomiting', 'Diarrhea'. However, 'Elevated circulating hepatic transaminase concentration', 'Abnormal circulating carnitine concentration', and 'Death in infancy' are not common symptoms.

+3. Glycogen storage disease type I: This is a genetic disorder that affects the body's ability to regulate and break down glycogen. Symptoms in common include 'Hypoglycemia', 'Vomiting', 'Diarrhea', 'Elevated circulating hepatic transaminase concentration'. However, 'Abnormal circulating carnitine concentration' and 'Death in infancy' are not common symptoms.

+4. Reye's syndrome: This is a rare but serious condition that causes swelling in the liver and brain. Symptoms in common include 'Vomiting', 'Diarrhea', 'Elevated circulating hepatic transaminase concentration'. However, 'Hypoglycemia', 'Abnormal circulating carnitine concentration', and 'Death in infancy' are not common symptoms.

+5. Carnitine palmitoyltransferase II deficiency: This is a condition that prevents the body from using certain fats for energy. Symptoms in common include 'Hypoglycemia', 'Vomiting', 'Diarrhea', 'Elevated circulating hepatic transaminase concentration', 'Abnormal circulating carnitine concentration'. However, 'Death in infancy' is not a common symptom."
['Succinic semialdehyde dehydrogenase deficiency'],"+1. Addison's Disease: This is a disorder that occurs when your body produces insufficient amounts of certain hormones produced by your adrenal glands. Symptoms in common with the patient include Hyponatremia and Hyperkalemia. Symptoms not in common include fatigue, weight loss, and skin darkening.

+2. Congenital Adrenal Hyperplasia: This is a group of inherited genetic disorders that affect the adrenal glands. Symptoms in common with the patient include Hyponatremia and Hyperkalemia. Symptoms not in common include early puberty in boys, excessive body hair in girls, and severe acne.

+3. Adrenal Insufficiency: This occurs when the adrenal glands don't produce enough of certain hormones. Symptoms in common with the patient include Hyponatremia and Hyperkalemia. Symptoms not in common include chronic fatigue, muscle weakness, and loss of appetite.

+4. Cushing's Syndrome: This is a condition caused by prolonged exposure to high levels of cortisol. Symptoms in common with the patient include Hyponatremia. Symptoms not in common include weight gain, fatty tissue deposits, and purple or pink stretch marks.

+5. Hyperaldosteronism: This is a condition in which the adrenal gland releases too much of the hormone aldosterone. Symptoms in common with the patient include Hyperkalemia. Symptoms not in common include high blood pressure, muscle weakness, and frequent urination.

+6. Methylmalonic Acidemia: This is a disorder in which the body cannot break down certain proteins and fats properly. Symptoms in common with the patient include Elevated urinary carboxylic acid, Coma, and Neonatal death. Symptoms not in common include vomiting, lethargy, and developmental delay.

+7. Propionic Acidemia: This is a disorder that prevents the body from processing certain parts of proteins and lipids properly. Symptoms in common with the patient include Elevated urinary carboxylic acid, Coma, and Neonatal death. Symptoms not in common include poor feeding, weak muscle tone, and intellectual disability. 

+8. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include Death in infancy. Symptoms not in common include no signs of suffering and usually occurs during sleep. 

+9. Respiratory Acidosis: This is a condition that occurs when the lungs can't remove enough of the carbon dioxide produced by the body. Symptoms in common with the patient include Respiratory acidosis. Symptoms not in common include confusion, fatigue, and shortness of breath."
['Classic homocystinuria'],"+1. Marfan Syndrome: This is a genetic disorder that affects the body's connective tissue. Common symptoms include long limbs and fingers, tall and thin body type, curved spine, chest sinks in or sticks out, flexible joints, flat feet, crowded teeth, and heart problems. Symptoms in common with the patient: Ptosis, Ectopia lentis, Large hands, Long foot. Symptoms not in common with the patient: Curved spine, Chest sinks in or sticks out, Flexible joints, Flat feet, Crowded teeth, Heart problems.

+2. Homocystinuria: This is a rare inherited disorder where the body is unable to process certain building blocks of proteins properly. Common symptoms include nearsightedness, dislocation of the lens in the eye, abnormally long limbs, intellectual disability, and a tendency to form blood clots. Symptoms in common with the patient: Ectopia lentis, Intellectual disability, Large hands, Long foot, Hyperhomocystinemia. Symptoms not in common with the patient: Nearsightedness, Tendency to form blood clots.

+3. Down Syndrome: This is a genetic disorder caused when abnormal cell division results in an extra full or partial copy of chromosome 21. Common symptoms include intellectual disability, delayed motor skills, large hands, and fatigue. Symptoms in common with the patient: Intellectual disability, Large hands, Motor delay, Fatigue. Symptoms not in common with the patient: None.

+4. Methionine Adenosyltransferase Deficiency: This is a rare metabolic disorder characterized by persistent hypermethioninemia. Common symptoms include intellectual disability, motor delay, and hypermethioninemia. Symptoms in common with the patient: Intellectual disability, Motor delay, Hypermethioninemia. Symptoms not in common with the patient: None.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Common symptoms include motor delay, intellectual disability, and fatigue. Symptoms in common with the patient: Intellectual disability, Motor delay, Fatigue. Symptoms not in common with the patient: None. 

+6. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Common symptoms include death in childhood. Symptoms in common with the patient: Death in childhood. Symptoms not in common with the patient: None. 

+7. Adolescent Suicide: This refers to the act of a teenager, typically between the ages of 13 and 19, intentionally taking their own life. Common symptoms include death in adolescence. Symptoms in common with the patient: Death in adolescence. Symptoms not in common with the patient: None."
[],"+1. Diabetes Mellitus: This is a chronic disease that affects the body's ability to use sugar for energy. Symptoms in common with the patient include 'Hyperinsulinemia' and 'Hypoglycemia'. Symptoms not in common include 'Frequent urination', 'Increased thirst', and 'Unexplained weight loss'.

+2. Epilepsy: This is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain. The symptom in common with the patient is 'Seizure'. Symptoms not in common include 'Temporary confusion', 'Staring spells', and 'Uncontrollable jerking movements of the arms and legs'.

+3. Sjogren's Syndrome: This is an autoimmune disease characterized by dryness of the mouth and eyes. The symptom in common with the patient is 'Carious teeth'. Symptoms not in common include 'Dry eyes', 'Joint pain, swelling and stiffness', and 'Swollen salivary glands'.

+4. Hypohidrotic Ectodermal Dysplasia: This is a genetic disorder characterized by a reduced ability to sweat, sparse hair, and abnormal teeth. Symptoms in common with the patient include 'Sparse hair' and 'Carious teeth'. Symptoms not in common include 'Reduced sweating', 'Fever during hot weather', and 'Thin, brittle nails'.

+5. Hemoglobinopathy: This is a group of disorders passed down through families (inherited) that affect the body's hemoglobin, the protein that carries oxygen in the blood. The symptom in common with the patient is 'Abnormal hemoglobin'. Symptoms not in common include 'Anemia', 'Delayed growth and development', and 'Overgrowth of bone, especially in the face and skull'.

+6. Neonatal Death: This refers to the death of a baby within the first 28 days of life. Symptoms in common with the patient include 'Neonatal death', 'Death in infancy', and 'Death in childhood'. This is not a disease but a condition that can be caused by various diseases or complications.

+7. Feeding Difficulties: This is a condition where infants and children have problems eating or drinking. The symptom in common with the patient is 'Feeding difficulties'. This is not a disease but a symptom that can be caused by various diseases or conditions."
['Propionic acidemia'],"+1. Nonketotic Hyperglycinemia: This is a metabolic disorder characterized by abnormally high levels of glycine in the body. Symptoms in common with the patient include intellectual disability, seizure, motor delay, neonatal death, death in infancy, and hyperglycinemia. Symptoms not in common with the patient are hypotonia, lethargy, and apnea.

+2. Propionic Acidemia: This is a disorder that affects the breakdown of proteins and fats in the body. Symptoms in common with the patient include intellectual disability, seizure, motor delay, death in infancy, and hepatomegaly. Symptoms not in common with the patient are vomiting, poor feeding, and lethargy.

+3. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare metabolic disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include abnormality of prenatal development or birth, intellectual disability, seizure, motor delay, death in infancy, neonatal death, death in childhood, and abnormal circulating carnitine concentration. Symptoms not in common with the patient are muscle weakness and heart problems.

+4. Citrullinemia Type II: This is a disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms in common with the patient include intellectual disability, seizure, motor delay, death in infancy, hyperammonemia, and hepatomegaly. Symptoms not in common with the patient are confusion, poor memory, and loss of consciousness.

+5. Diamond-Blackfan Anemia: This is a disorder that primarily affects the bone marrow, causing a decreased ability to produce red blood cells. Symptoms in common with the patient include abnormality of prenatal development or birth, intellectual disability, anemia, and death in childhood. Symptoms not in common with the patient are short stature, heart defects, and kidney abnormalities. 

+6. Glycogen Storage Disease Type IV: This is a disorder caused by the buildup of a complex sugar called glycogen in the body's cells. Symptoms in common with the patient include abnormality of prenatal development or birth, intellectual disability, motor delay, death in infancy, hepatomegaly, and neonatal death. Symptoms not in common with the patient are muscle weakness, heart disease, and respiratory failure."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common with the patient include generalized hypotonia, metabolic acidosis, apnea, decreased methylmalonyl-CoA mutase activity, feeding difficulties, methylmalonic aciduria, and abnormal nervous system physiology. However, the patient does not show symptoms of death in infancy, thrombocytopenia, leukopenia, and neonatal death.

+2. Neonatal Isovaleric Acidemia: This is a metabolic disorder characterized by an inability of the body to process certain proteins. The common symptoms with the patient are generalized hypotonia, metabolic acidosis, apnea, feeding difficulties, and abnormal nervous system physiology. The patient does not have symptoms of death in infancy, thrombocytopenia, leukopenia, decreased methylmalonyl-CoA mutase activity, neonatal death, and methylmalonic aciduria.

+3. Propionic Acidemia: This is a disorder that affects the breakdown of certain parts of proteins and lipids. The common symptoms with the patient are generalized hypotonia, metabolic acidosis, apnea, feeding difficulties, and abnormal nervous system physiology. The patient does not have symptoms of death in infancy, thrombocytopenia, leukopenia, decreased methylmalonyl-CoA mutase activity, neonatal death, and methylmalonic aciduria.

+4. Severe Combined Immunodeficiency (SCID): This is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. The patient's symptoms of generalized hypotonia, leukopenia, and feeding difficulties are common with this disease. However, the patient does not show symptoms of death in infancy, thrombocytopenia, metabolic acidosis, apnea, decreased methylmalonyl-CoA mutase activity, neonatal death, and methylmalonic aciduria.

+5. Wiskott-Aldrich Syndrome: This is a condition that affects blood cells and cells of the immune system. The patient's symptoms of thrombocytopenia and leukopenia are common with this disease. However, the patient does not show symptoms of generalized hypotonia, death in infancy, metabolic acidosis, apnea, decreased methylmalonyl-CoA mutase activity, neonatal death, feeding difficulties, and methylmalonic aciduria."
['Systemic primary carnitine deficiency'],"+1. Medium-chain acyl-CoA dehydrogenase deficiency:
This is a condition that prevents the body from converting certain fats to energy, particularly during periods without food. Symptoms in common with the patient include hypoglycemia, vomiting, and sudden death. Symptoms not in common include muscle weakness, lethargy, and seizures.

+2. Reye's syndrome:
This is a rare but serious condition that causes swelling in the liver and brain. Symptoms in common with the patient include coma, vomiting, and hypoglycemia. Symptoms not in common include confusion, seizures, and loss of consciousness.

+3. Carnitine palmitoyltransferase II deficiency:
This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include hypoglycemia, sudden death, and decreased plasma free carnitine. Symptoms not in common include muscle pain, weakness, and fatigue.

+4. Hypophosphatasia:
This is a rare genetic disorder characterized by the abnormal development of bones and teeth. Symptoms in common with the patient include elevated circulating alkaline phosphatase concentration. Symptoms not in common include premature loss of teeth, bone pain, and fractures.

+5. Maple syrup urine disease:
This is a metabolic disorder in which the body is unable to process certain protein building blocks (amino acids) properly. Symptoms in common with the patient include abnormal circulating aspartate family amino acid concentration and abnormal circulating alanine concentration. Symptoms not in common include poor feeding, developmental delay, and maple syrup odor in the earwax, sweat, and urine.

+6. Lactic acidosis:
This is a high level of lactic acid, a waste product produced by cells, in the bloodstream. Symptoms in common with the patient include increased circulating lactate dehydrogenase concentration. Symptoms not in common include rapid breathing, abdominal pain, and fatigue."
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1. Tay-Sachs Disease: This is a rare, inherited disorder that progressively destroys nerve cells in the brain and spinal cord. Symptoms in common include 'Lethargy', 'Death in infancy', 'Clumsiness', 'Drowsiness', 'Sleep abnormality', 'Poor coordination', 'Neonatal death', 'Death in childhood'. Symptoms not in common include 'Decreased plasma free carnitine', 'Feeding difficulties'.

+2. Leigh Syndrome: A severe neurological disorder that typically arises in the first year of life. Symptoms in common include 'Lethargy', 'Death in infancy', 'Drowsiness', 'Sleep abnormality', 'Neonatal death', 'Death in childhood', 'Feeding difficulties'. Symptoms not in common include 'Clumsiness', 'Poor coordination', 'Decreased plasma free carnitine'.

+3. Carnitine Deficiency: A condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common include 'Lethargy', 'Drowsiness', 'Sleep abnormality', 'Decreased plasma free carnitine', 'Feeding difficulties'. Symptoms not in common include 'Death in infancy', 'Clumsiness', 'Poor coordination', 'Neonatal death', 'Death in childhood'.

+4. Ataxia Telangiectasia: A rare, neurodegenerative, autosomal recessive disease causing severe disability. Symptoms in common include 'Lethargy', 'Clumsiness', 'Drowsiness', 'Sleep abnormality', 'Poor coordination'. Symptoms not in common include 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Decreased plasma free carnitine', 'Feeding difficulties'.

+5. Narcolepsy: A chronic sleep disorder that causes overwhelming daytime drowsiness. Symptoms in common include 'Lethargy', 'Drowsiness', 'Sleep abnormality'. Symptoms not in common include 'Death in infancy', 'Clumsiness', 'Poor coordination', 'Neonatal death', 'Death in childhood', 'Decreased plasma free carnitine', 'Feeding difficulties'."
[],"+1. Hypothyroidism: This is a condition in which the thyroid gland does not produce enough thyroid hormones. Symptoms in common with the patient include 'Hypothyroidism'. Symptoms not in common include 'Weight gain', 'Fatigue', 'Depression', 'Sensitivity to cold', 'Muscle weakness', 'Elevated blood cholesterol level', 'Pain, stiffness or swelling in your joints'.

+2. Dysarthria: This is a motor speech disorder resulting from neurological injury. Symptoms in common with the patient include 'Dysarthria'. Symptoms not in common include 'Slurred or slow speech', 'Difficulty articulating words', 'Difficulty moving the tongue or facial muscles', 'Changes in voice quality'.

+3. Spastic Diplegia: This is a form of cerebral palsy primarily affecting the lower body. Symptoms in common with the patient include 'Spastic diplegia'. Symptoms not in common include 'Muscle stiffness', 'Walking on toes', 'Crossed knees', 'Narrow base of walk'.

+4. Encephalopathy: This is a general term describing a disease that affects the function or structure of your brain. Symptoms in common with the patient include 'Encephalopathy'. Symptoms not in common include 'Memory loss', 'Confusion', 'Personality changes', 'Involuntary twitching'.

+5. Hyperreflexia: This is a condition in which your muscles respond unusually strongly to stimuli. Symptoms in common with the patient include 'Hyperreflexia'. Symptoms not in common include 'Anxiety', 'Tremors', 'High blood pressure', 'Rapid heartbeat'.

+6. Spastic Tetraplegia: This is the most severe form of cerebral palsy and involves the loss of use of the whole body. Symptoms in common with the patient include 'Spastic tetraplegia'. Symptoms not in common include 'Intellectual disability', 'Seizures', 'Difficulty with vision and hearing'.

+7. Ethylmalonic Encephalopathy: This is a rare inherited disorder characterized by the buildup of substances in the blood and urine. Symptoms in common with the patient include 'Ethylmalonic aciduria'. Symptoms not in common include 'Chronic diarrhea', 'Orthostatic acrocyanosis', 'Petechiae'.

+8. Cytochrome C Oxidase Deficiency: This is a condition that can affect several parts of the body, including the muscles used for movement (skeletal muscles), the heart, the brain, or the liver. Symptoms in common with the patient include 'Cytochrome C oxidase-negative muscle fibers'. Symptoms not in common include 'Lactic acidosis', 'Hepatomegaly', 'Cardiomyopathy'.

+9. Glycine Encephalopathy: This is a genetic metabolic disorder characterized by abnormally high levels of an amino acid called glycine. Symptoms in common with the patient include 'Abnormal circulating glycine concentration'. Symptoms not in common include 'Intellectual disability', 'Seizures', 'Breathing difficulties'.

+10. Viral Infection: This is a disease that can be caused by different kinds of viruses, of which the common cold is the most known. Symptoms in common with the patient include 'Recurrent viral infections'. Symptoms not in common include 'Fever', 'Cough', 'Sore throat', 'Runny or stuffy nose'."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine Deficiency, Systemic Primary:
This is a metabolic disorder that prevents the body from using certain fats for energy, particularly during periods without food. Common symptoms include muscle weakness, confusion, and decreased alertness. In severe cases, it can lead to heart failure and sudden death. 
- Common Symptoms: 'Abnormal circulating carnitine concentration'
- Uncommon Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death'

+2. Carnitine Palmitoyltransferase II Deficiency:
This is a condition that prevents the body from using certain fats for energy, particularly during periods of fasting. Symptoms include muscle pain and weakness, and more severe cases can lead to breathing problems, seizures, coma, and sudden death.
- Common Symptoms: 'Abnormal circulating carnitine concentration'
- Uncommon Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death'

+3. Carnitine-Acylcarnitine Translocase Deficiency:
This is a severe disorder that prevents the body from using certain fats for energy. Symptoms include feeding difficulties, lethargy, hypoglycemia, hepatomegaly, cardiac arrhythmias, and sudden death.
- Common Symptoms: 'Abnormal circulating carnitine concentration', 'Death in infancy', 'Neonatal death'
- Uncommon Symptoms: 'Abnormality of prenatal development or birth'

+4. Medium-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a disorder that prevents the body from converting certain fats to energy, particularly during periods of fasting. Symptoms include vomiting, lethargy, hypoglycemia, and sudden death.
- Common Symptoms: 'Abnormal circulating carnitine concentration'
- Uncommon Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death'

+5. Zellweger Syndrome:
This is a rare, congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms include abnormalities in prenatal development, neonatal death, and abnormalities in the levels of very long-chain fatty acids.
- Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death'
- Uncommon Symptoms: 'Abnormal circulating carnitine concentration'"
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Acidemia Type 1: This is a genetic disorder that affects the body's ability to process certain proteins. Symptoms include macrocephaly, generalized hypotonia, dystonia, metabolic acidosis, glutaric aciduria, elevated circulating glutaric acid concentration, and decreased plasma free carnitine. The patient does not show symptoms of cystic hygroma, hyperhidrosis, lethargy, death in infancy, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, neonatal death, death in childhood, and dyskinesia.

+2. Malignant Hyperthermia: This is a reaction to certain medications used during general anesthesia. Symptoms include hyperhidrosis, fever, and dystonia. The patient does not show symptoms of macrocephaly, cystic hygroma, lethargy, generalized hypotonia, death in infancy, metabolic acidosis, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia.

+3. Cystic Hygroma: This is a fluid-filled sac that results from a blockage in the lymphatic system. Symptoms include cystic hygroma. The patient does not show symptoms of macrocephaly, hyperhidrosis, lethargy, generalized hypotonia, dystonia, death in infancy, metabolic acidosis, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia.

+4. Hypotonia-Cystinuria Syndrome: This is a genetic disorder characterized by reduced muscle tone (hypotonia) and the presence of cystine in the urine (cystinuria). Symptoms include generalized hypotonia. The patient does not show symptoms of macrocephaly, cystic hygroma, hyperhidrosis, lethargy, dystonia, death in infancy, metabolic acidosis, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia.

+5. Dystonia: This is a movement disorder in which a person's muscles contract uncontrollably. Symptoms include dystonia. The patient does not show symptoms of macrocephaly, cystic hygroma, hyperhidrosis, lethargy, generalized hypotonia, death in infancy, metabolic acidosis, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia' and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Liver cirrhosis', 'Renal tubular dysfunction', and 'Rickets'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia' and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Intellectual disability', 'Delayed speech', and 'Behavioral disorders'.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy', 'Neonatal death', and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Apnea' and 'Low birth weight'.

+4. Tay-Sachs Disease: This is a rare, inherited disorder that progressively destroys nerve cells in the brain and spinal cord. Symptoms in common with the patient include 'Death in infancy', 'Death in childhood', and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Cherry-red spot of the macula', 'Progressive neurologic deterioration', and 'Seizures'.

+5. Juvenile Huntington's Disease: This is a rare form of Huntington's disease that begins in childhood or adolescence. Symptoms in common with the patient include 'Death in adolescence' and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Movement abnormalities', 'Cognitive decline', and 'Psychiatric symptoms'."
['L-2-hydroxyglutaric aciduria'],"+1. Cerebral Palsy: This is a group of disorders that affect movement and muscle tone or posture. It's caused by damage that occurs to the immature brain as it develops, most often before birth. Symptoms in common include 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Difficulty walking', 'Difficulty climbing stairs', 'Difficulty running'. Symptoms not in common include 'Death in infancy', 'Abnormal cerebral white matter morphology', 'Death in childhood'.

+2. Rett Syndrome: This is a rare genetic disorder that affects brain development, resulting in severe mental and physical disability. It is estimated to affect about 1 in 12,000 girls born each year and is only rarely seen in boys. Symptoms in common include 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia'. Symptoms not in common include 'Death in infancy', 'Difficulty walking', 'Abnormal cerebral white matter morphology', 'Difficulty climbing stairs', 'Death in childhood', 'Difficulty running'.

+3. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells (neurons) in the brain to send and receive messages. This disease is one of a group of genetic disorders called leukodystrophies. Symptoms in common include 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Death in infancy', 'Abnormal cerebral white matter morphology', 'Difficulty walking'. Symptoms not in common include 'Difficulty climbing stairs', 'Death in childhood', 'Difficulty running'.

+4. Tay-Sachs Disease: This is a rare, inherited disorder that destroys nerve cells in the brain and spinal cord. The most common form of Tay-Sachs, known as Infantile Tay-Sachs disease, becomes apparent around 3 to 6 months of age. Symptoms in common include 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Death in infancy', 'Difficulty walking'. Symptoms not in common include 'Abnormal cerebral white matter morphology', 'Difficulty climbing stairs', 'Death in childhood', 'Difficulty running'.

+5. Krabbe Disease: This is a rare and often fatal disorder of the nervous system. It is characterized by progressive damage to the white matter of the brain (leukodystrophy). Symptoms in common include 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Death in infancy', 'Abnormal cerebral white matter morphology', 'Difficulty walking', 'Difficulty climbing stairs'. Symptoms not in common include 'Death in childhood', 'Difficulty running'."
['Maple syrup urine disease'],"+1. Prader-Willi Syndrome: This is a genetic disorder that causes obesity, intellectual disability, and shortness in height. Symptoms in common with the patient include obesity and generalized hypotonia. Symptoms not in common include intellectual disability and shortness in height.

+2. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include generalized hypotonia, death in infancy, and neonatal death. Symptoms not in common include lactic acidosis and progressive neurological deterioration.

+3. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to process certain protein building blocks. Symptoms in common with the patient include hypoglycemia, hypervalinemia, hyperleucinemia, and hyperisoleucinemia. Symptoms not in common include maple syrup odor in the earwax, sweat, and urine.

+4. Hypoglycemia, Leucine-Induced: This is a condition in which consuming the amino acid leucine causes episodes of low blood sugar (hypoglycemia). Symptoms in common with the patient include hypoglycemia, hyperleucinemia, and hyperisoleucinemia. Symptoms not in common include seizures and confusion.

+5. Spastic Paraplegia: This is a group of hereditary diseases characterized by progressive stiffness and contraction (spasticity) in the lower limbs. Symptoms in common with the patient include spasticity. Symptoms not in common include difficulty walking and muscle weakness.

+6. Major Depressive Disorder: This is a common and serious medical illness that negatively affects how you feel, the way you think and how you act. Symptoms in common with the patient include apathy. Symptoms not in common include persistent sadness, loss of interest or pleasure in activities, and difficulty sleeping or sleeping too much. 

+7. Early Adult Death Syndrome: This is a hypothetical disease characterized by death in early adulthood. Symptoms in common with the patient include death in early adulthood. Symptoms not in common are not applicable as this is a hypothetical disease."
['Classic galactosemia'],"+1. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. Some symptoms in common with the patient include 'Delayed speech and language development' and 'Obesity'. However, the patient does not show 'Feeding difficulties' and 'Poor growth'.

+2. Galactosemia: This is a disorder that affects how the body processes a simple sugar called galactose. A small amount of galactose is present in many foods. It is primarily part of a larger sugar called lactose, which is found in all dairy products and many baby formulas. The classic form of galactosemia, which is the most common and most severe form of the condition, can cause life-threatening complications starting in the newborn period. Symptoms in common with the patient include 'Abnormality of galactoside metabolism', 'Hypergalactosemia', and 'Death in infancy'. The patient does not show 'Vomiting' and 'Diarrhea'.

+3. Tyrosinemia: This is an inherited disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Abnormal circulating tyrosine concentration', 'Hyperalaninemia', and 'Aminoaciduria'. The patient does not show 'Liver and kidney disease' and 'Intellectual disability'.

+4. Maple Syrup Urine Disease (MSUD): This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. Symptoms in common with the patient include 'Abnormal circulating aspartate family amino acid concentration', 'Hyperalaninemia', and 'Aminoaciduria'. The patient does not show 'Sweet odor in urine and earwax' and 'Feeding difficulties'.

+5. Gilbert's Syndrome: This is a mild liver disorder in which the liver does not properly process bilirubin. Symptoms in common with the patient include 'Increased total bilirubin'. The patient does not show 'Jaundice' and 'Fatigue'."
['3-hydroxy-3-methylglutaric aciduria'],"+1. Propionic Acidemia: This is a metabolic disorder characterized by the accumulation of propionic acid in the blood. Common symptoms include metabolic acidosis, hyperammonemia, vomiting, and death in infancy. However, the patient does not show symptoms of abnormal circulating glycine concentration and elevated urinary carboxylic acid.

+2. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms include vomiting, metabolic acidosis, hyperammonemia, and death in infancy. The patient does not have 3-Methylglutaric aciduria and dicarboxylic aciduria, which are common in this disease.

+3. Isovaleric Acidemia: This is a genetic disorder in which the body is unable to process certain proteins properly. Symptoms include vomiting, metabolic acidosis, and death in infancy. The patient does not have elevated urinary carboxylic acid and abnormal circulating glycine concentration, which are common in this disease.

+4. Multiple Carboxylase Deficiency: This is a disorder characterized by metabolic acidosis, vomiting, and hyperammonemia. However, the patient does not show symptoms of dicarboxylic aciduria and 3-Methylglutaric aciduria, which are common in this disease.

+5. Glutaric Acidemia Type II: This is a disorder characterized by metabolic acidosis, vomiting, fever, and death in infancy. However, the patient does not show symptoms of elevated urinary carboxylic acid and abnormal circulating glycine concentration, which are common in this disease. 

+6. 3-Methylglutaconic Aciduria: This is a disorder characterized by 3-Methylglutaric aciduria, vomiting, and metabolic acidosis. However, the patient does not show symptoms of hyperammonemia and elevated urinary carboxylic acid, which are common in this disease."
['Classic homocystinuria'],"+1. Hemolytic Anemia: This condition is characterized by the destruction of red blood cells leading to anemia. Common symptoms include jaundice and anemia, which the patient has. However, the patient does not show signs of fatigue, shortness of breath, and rapid heart rate, which are also common in this disease.

+2. Gilbert's Syndrome: This is a mild liver disorder that causes an increased level of bilirubin in the blood, leading to jaundice. The patient's symptom of jaundice aligns with this disease, but the patient does not have abdominal pain or fatigue, which are also associated with Gilbert's Syndrome.

+3. Homocystinuria: This is a genetic disorder that affects the metabolism of the amino acid methionine. Symptoms include generalized hypotonia, hyperhomocystinemia, and progressive neurologic deterioration, which the patient has. However, the patient does not have other symptoms like intellectual disability and nearsightedness.

+4. Methionine Adenosyltransferase Deficiency: This is a rare metabolic disorder characterized by persistent hypermethioninemia. The patient's symptoms of hypomethioninemia and abnormality of folate metabolism align with this disease, but the patient does not have other symptoms like intellectual disability and liver disease.

+5. Porphyrin Metabolism Disorder: This is a group of rare genetic disorders that affect the body's ability to produce heme. The patient's symptom of abnormal circulating porphyrin concentration aligns with this disease, but the patient does not have other symptoms like skin sensitivity to sunlight and abdominal pain.

+6. Severe Combined Immunodeficiency (SCID): This is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells, leading to severe impairment of the immune system. The patient's symptom of recurrent viral infections aligns with this disease, but the patient does not have other symptoms like diarrhea and failure to thrive.

+7. Tay-Sachs Disease: This is a rare and fatal genetic disorder that progressively destroys nerve cells in the brain and spinal cord. The patient's symptoms of progressive neurologic deterioration and death in childhood align with this disease, but the patient does not have other symptoms like seizures and loss of motor skills."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in adolescence', and 'Death in early adulthood'. Symptoms not in common with the patient are 'Liver and kidney disease', 'Rickets', and 'Failure to thrive'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in adolescence', and 'Death in early adulthood'. Symptoms not in common with the patient are 'Intellectual disability', 'Delayed development', and 'Behavioral problems'.

+3. Congenital Obstructive Pulmonary Disease: This is a type of lung disease that prevents proper airflow from the lungs. Symptoms in common with the patient include 'Upper airway obstruction', 'Chronic pulmonary obstruction', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in adolescence', and 'Death in early adulthood'. Symptoms not in common with the patient are 'Shortness of breath', 'Wheezing', and 'Chest tightness'.

+4. Birth Defects: These are health problems or physical abnormalities that are present at birth. They can range from mild to severe, and some can even be life-threatening. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in adolescence', and 'Death in early adulthood'. Symptoms not in common with the patient are 'Physical deformities', 'Intellectual disability', and 'Developmental delay'."
['Biotinidase deficiency'],"+1. Alzheimer's Disease: This is a progressive disease that destroys memory and other important mental functions. Common symptoms include apathy and fatigue. However, the patient's symptoms of seizure, spasticity, death in infancy, alopecia, dyspnea, and elevated urinary carboxylic acid are not typically associated with this disease.

+2. Epilepsy: This is a central nervous system (neurological) disorder in which brain activity becomes abnormal, causing seizures. The patient's symptom of seizure aligns with this disease. However, apathy, spasticity, death in infancy, alopecia, dyspnea, fatigue, and elevated urinary carboxylic acid are not common symptoms of epilepsy.

+3. Spastic Paraplegia: This is a group of hereditary disorders characterized by progressive spasticity and weakness of the leg and hip muscles. The patient's symptom of spasticity aligns with this disease. However, apathy, seizure, death in infancy, alopecia, dyspnea, fatigue, and elevated urinary carboxylic acid are not common symptoms of spastic paraplegia.

+4. Alopecia Areata: This is a condition that causes hair to fall out in small patches. The patient's symptom of alopecia aligns with this disease. However, apathy, seizure, spasticity, death in infancy, dyspnea, fatigue, and elevated urinary carboxylic acid are not common symptoms of alopecia areata.

+5. Chronic Obstructive Pulmonary Disease (COPD): This is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. The patient's symptom of dyspnea aligns with this disease. However, apathy, seizure, spasticity, death in infancy, alopecia, fatigue, and elevated urinary carboxylic acid are not common symptoms of COPD.

+6. Chronic Fatigue Syndrome (CFS): This is a complicated disorder characterized by extreme fatigue that can't be explained by any underlying medical condition. The patient's symptom of fatigue aligns with this disease. However, apathy, seizure, spasticity, death in infancy, alopecia, dyspnea, and elevated urinary carboxylic acid are not common symptoms of CFS.

+7. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. The patient's symptom of elevated urinary carboxylic acid aligns with this disease. However, apathy, seizure, spasticity, death in infancy, alopecia, dyspnea, and fatigue are not common symptoms of Methylmalonic Acidemia."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Common symptoms include vomiting, diarrhea, and failure to gain weight and grow at the expected rate (failure to thrive). The patient has 'Hypertyrosinemia' and 'Vomiting' in common with this disease, but does not have 'Failure to thrive'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include intellectual disability, seizures, behavioral problems, and mental disorders. The patient has 'Hyperphenylalaninemia' in common with this disease, but does not have 'Intellectual disability', 'Seizures', 'Behavioral problems', and 'Mental disorders'.

+3. Gastroenteritis: This is an inflammation of the lining of the intestines caused by a virus, bacteria or parasites. Symptoms include diarrhea, abdominal pain, vomiting, headache, fever and chills. The patient has 'Vomiting', 'Fever', and 'Gastrointestinal inflammation' in common with this disease, but does not have 'Diarrhea', 'Abdominal pain', 'Headache', and 'Chills'.

+4. Obesity: This is a complex disease involving an excessive amount of body fat. Obesity isn't just a cosmetic concern. It can increase your risk of diseases and health problems, such as heart disease, diabetes and high blood pressure. The patient has 'Obesity' in common with this disease.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. SIDS is sometimes known as crib death because the infants often die in their cribs. The patient has 'Death in infancy' and 'Neonatal death' in common with this disease, but does not have 'Unexplained death during sleep'.

+6. Childhood Cancer: This is a cancer that occurs in children. The most common cancers in children are leukemia, brain and spinal cord tumors, neuroblastoma, Wilms tumor, and lymphoma. The patient has 'Death in childhood' in common with this disease, but does not have 'Leukemia', 'Brain and spinal cord tumors', 'Neuroblastoma', 'Wilms tumor', and 'Lymphoma'.

+7. Adolescent Suicide: This is a serious public health problem that can have lasting harmful effects on individuals, families, and communities. The patient has 'Death in adolescence' in common with this disease, but does not have 'Suicidal thoughts' and 'Depression'."
['Biotinidase deficiency'],"+1. Nonketotic Hyperglycinemia: This is a metabolic disorder characterized by abnormally high levels of the amino acid glycine in bodily fluids and tissues. Symptoms in common with the patient include 'Aminoaciduria', 'Abnormal circulating glycine concentration', and 'Metabolic acidosis'. Symptoms not in common include 'Hypertonia', 'Seizures', and 'Intellectual disability'.

+2. Propionic Acidemia: This is a disorder that affects the breakdown of certain proteins and lipids. Symptoms in common with the patient include 'Metabolic acidosis', 'Aminoaciduria', and 'Increased CSF lactate'. Symptoms not in common include 'Poor appetite', 'Vomiting', and 'Weak muscle tone'.

+3. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common with the patient include 'Metabolic acidosis', 'Increased CSF lactate', and 'Aminoaciduria'. Symptoms not in common include 'Fatigue', 'Weakness', and 'Rapid breathing'.

+4. Glycogen Storage Disease Type I: This is a genetic disorder that affects the body's ability to regulate and break down glycogen. Symptoms in common with the patient include 'Metabolic acidosis' and 'Increased CSF lactate'. Symptoms not in common include 'Hypoglycemia', 'Short stature', and 'Growth delay'.

+5. Pyruvate Dehydrogenase Deficiency: This is a genetic disorder that affects the metabolism of carbohydrates. Symptoms in common with the patient include 'Metabolic acidosis', 'Increased CSF lactate', and 'Aminoaciduria'. Symptoms not in common include 'Poor feeding', 'Developmental delay', and 'Weak muscle tone'.

+6. Psoriasis: This is a skin condition that speeds up the life cycle of skin cells. Symptoms in common with the patient include 'Skin rash', 'Erythematous plaque', 'Erythematous macule', and 'Erythematous papule'. Symptoms not in common include 'Itching', 'Burning', and 'Soreness'.

+7. Dermatomyositis: This is an inflammatory disease marked by muscle weakness and a distinctive skin rash. Symptoms in common with the patient include 'Skin rash', 'Alopecia', 'Erythematous plaque', 'Erythematous macule', and 'Erythematous papule'. Symptoms not in common include 'Muscle weakness', 'Difficulty swallowing', and 'Lung problems'.

+8. Lactic Acidosis: This is a high level of lactic acid, usually caused by excessive physical activity, or certain diseases. Symptoms in common with the patient include 'Metabolic acidosis' and 'Increased CSF lactate'. Symptoms not in common include 'Nausea', 'Vomiting', and 'Rapid breathing'."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common include 'Decreased methylmalonyl-CoA mutase activity', 'Feeding difficulties', 'Dehydration', 'Neonatal death', and 'Death in infancy'. 

+2. Neonatal Adrenoleukodystrophy: This is a disorder that affects the adrenal glands, nervous system, and testes. Symptoms in common include 'Neonatal death' and 'Feeding difficulties'. Symptoms not in common include adrenal insufficiency, seizures, and hearing loss.

+3. Bartter syndrome: This is a group of rare conditions that affect the kidneys. The common symptom with the patient is 'Dehydration'. Symptoms not in common include excessive thirst, excessive urination, and growth delay.

+4. Cystic Fibrosis: This is a hereditary disease that affects the lungs and digestive system. The common symptom with the patient is 'Feeding difficulties'. Symptoms not in common include persistent cough, frequent lung infections, and salty-tasting skin.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The common symptom with the patient is 'Death in infancy'. Symptoms not in common include brain abnormalities, low birth weight, and respiratory infection."
['Biotinidase deficiency'],"+1. Pyruvate Carboxylase Deficiency: This is a rare genetic disorder characterized by a deficiency of the enzyme pyruvate carboxylase. Symptoms include lethargy, generalized hypotonia, death in infancy, metabolic acidosis, increased circulating lactate concentration, drowsiness, sleep abnormality, and decreased pyruvate carboxylase activity. The patient has all these symptoms.

+2. Propionic Acidemia: This is a rare metabolic disorder characterized by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms include lethargy, generalized hypotonia, death in infancy, metabolic acidosis, and propionyl-CoA carboxylase deficiency. The patient has all these symptoms.

+3. Glycine Encephalopathy: This is a rare genetic disorder characterized by an abnormal increase in the amino acid glycine. Symptoms include lethargy, drowsiness, sleep abnormality, and abnormal circulating glycine concentration. The patient has all these symptoms.

+4. Methylmalonic Acidemia: This is a rare genetic disorder characterized by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms include lethargy, generalized hypotonia, death in infancy, metabolic acidosis, and elevated urinary carboxylic acid. The patient has all these symptoms.

+5. Chronic Fatigue Syndrome: This is a complex disorder characterized by extreme fatigue that can't be explained by any underlying medical condition. Symptoms include lethargy, drowsiness, sleep abnormality, and fatigue. The patient has all these symptoms.

+6. Stomatitis: This is a condition that causes painful swelling and sores inside the mouth. The symptom is stomatitis. The patient has this symptom.

+7. Stridor: This is a high-pitched, wheezing sound caused by disrupted airflow. The symptom is stridor. The patient has this symptom.

+8. Gangrene: This is a serious and potentially life-threatening condition that arises when a considerable mass of body tissue dies (necrosis). The symptom is gangrene. The patient has this symptom.

+9. Aminoaciduria: This is a condition characterized by the excretion of amino acids in the urine. The symptom is aminoaciduria. The patient has this symptom.

+10. Fever: This is a temporary increase in body temperature, often due to an illness. The symptom is fever. The patient has this symptom."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia' and 'Neonatal death'. However, 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this condition.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. The patient's symptom of 'Hyperphenylalaninemia' is a key indicator of this disease. However, 'Death in infancy', 'Neonatal death', and 'Death in childhood' are not common symptoms unless the disease is left untreated.

+3. Maple Syrup Urine Disease: This is a metabolic disorder in which the body cannot break down certain parts of proteins. Symptoms can be severe and may lead to 'Death in infancy' and 'Neonatal death'. However, the patient's symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not typically associated with this condition.

+4. Alkaptonuria: This is a rare genetic disorder that affects the body's ability to process certain amino acids, causing a buildup of homogentisic acid which can darken the urine. The patient's symptoms do not align with this disease as 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', and 'Hyperphenylalaninemia' are not common symptoms.

+5. Citrullinemia: This is a condition that causes ammonia and other toxic substances to accumulate in the blood. Two types of this condition are known; type 1 and type 2. Both types can lead to 'Neonatal death'. However, the patient's symptoms of 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', and 'Hyperphenylalaninemia' are not typically associated with this condition."
['3-hydroxy-3-methylglutaric aciduria'],"+1. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): This is a metabolic disorder that affects the body's ability to break down certain fats and proteins. Symptoms in common with the patient include 'Dicarboxylic aciduria' and 'Elevated urinary carboxylic acid'. However, 'Death in infancy' and '3-Methylglutaric aciduria' are not typically associated with this condition.

+2. Glutaric Acidemia Type I: This is a rare genetic disorder characterized by deficiency of an enzyme that helps break down certain amino acids. Symptoms in common with the patient include '3-Methylglutaric aciduria' and 'Elevated urinary carboxylic acid'. However, 'Death in infancy' and 'Dicarboxylic aciduria' are not typically associated with this condition.

+3. 3-Methylglutaconic Aciduria: This is a group of autosomal recessive disorders which cause a type of organic aciduria. The patient's symptoms '3-Methylglutaric aciduria' and 'Elevated urinary carboxylic acid' are associated with this disease. However, 'Death in infancy' and 'Dicarboxylic aciduria' are not common symptoms.

+4. Ethylmalonic Encephalopathy: This is a rare inherited disorder that affects several parts of the body, including the nervous system. The patient's symptom 'Dicarboxylic aciduria' is common in this disease. However, 'Death in infancy', '3-Methylglutaric aciduria', and 'Elevated urinary carboxylic acid' are not typically associated with this condition.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The patient's symptom 'Death in infancy' is associated with this condition. However, 'Dicarboxylic aciduria', '3-Methylglutaric aciduria', and 'Elevated urinary carboxylic acid' are not symptoms of this disease."
['Wilson disease'],"+1. Dental Caries: This is a condition characterized by tooth decay caused by bacterial infection. The patient's symptom of 'Carious teeth' aligns with this disease. However, other common symptoms such as toothache, tooth sensitivity, and visible holes in the teeth are not mentioned.

+2. Obesity: This is a complex disease involving an excessive amount of body fat. The patient's symptom of 'Obesity' aligns with this disease. However, other common symptoms such as shortness of breath, increased sweating, and fatigue are not mentioned.

+3. Hepatitis: This is an inflammation of the liver, often caused by a viral infection. The patient's symptom of 'Elevated circulating hepatic transaminase concentration' aligns with this disease. However, other common symptoms such as jaundice, abdominal pain, and loss of appetite are not mentioned.

+4. Some Genetic Disorders: Certain genetic disorders can lead to 'Death in childhood', but other symptoms such as developmental delays, intellectual disability, or physical abnormalities are not mentioned.

+5. Porphyria: This is a group of rare genetic disorders that affect the nervous system or skin. The patient's symptom of 'Abnormal circulating porphyrin concentration' aligns with this disease. However, other common symptoms such as abdominal pain, light sensitivity, and neurological complications are not mentioned.

+6. Wilson's Disease: This is a rare inherited disorder that causes copper to accumulate in your liver, brain and other vital organs. The patient's symptoms of 'Decreased circulating ceruloplasmin concentration', 'Increased urinary copper concentration', and 'Decreased circulating copper concentration' aligns with this disease. However, other common symptoms such as jaundice, fatigue, and tremors are not mentioned.

+7. Iron Deficiency Anemia: This is a common type of anemia characterized by a decrease in the number of red blood cells caused by a lack of iron. The patient's symptom of 'Decreased serum iron' aligns with this disease. However, other common symptoms such as fatigue, weakness, and pale skin are not mentioned.

+8. Amino Acid Metabolism Disorder: This refers to a group of metabolic disorders due to the disruption of the normal metabolism of amino acids. The patient's symptoms of 'Abnormal circulating aspartate family amino acid concentration' and 'Abnormal circulating alanine concentration' aligns with this disease. However, other common symptoms such as failure to thrive, developmental delay, and seizures are not mentioned."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine Deficiency, Systemic Primary:
This is a metabolic disorder that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include 'Abnormal circulating carnitine concentration'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this disease.

+2. Carnitine Palmitoyltransferase II Deficiency:
This is a condition that prevents the body from using certain fats for energy, particularly during periods of fasting. The patient's symptom of 'Abnormal circulating carnitine concentration' is common in this disease. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this disease.

+3. Carnitine-Acylcarnitine Translocase Deficiency:
This is a rare metabolic condition that prevents the body from converting certain fats into energy. The patient's symptom of 'Abnormal circulating carnitine concentration' is common in this disease. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this disease.

+4. Trifunctional Protein Deficiency:
This is a condition that prevents the body from converting certain fats into energy. The patient's symptom of 'Abnormal circulating carnitine concentration' is common in this disease. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this disease.

+5. Carnitine Cycle Disorders:
These are a group of metabolic disorders that prevent the body from using certain fats for energy. The patient's symptom of 'Abnormal circulating carnitine concentration' is common in these diseases. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with these diseases."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. However, 'Death in infancy', 'Death in childhood', and 'Recurrent viral infections' are not typically associated with this condition.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. The common symptom with the patient is 'Hyperphenylalaninemia'. However, 'Death in infancy', 'Death in childhood', 'Recurrent viral infections', and 'Hypertyrosinemia' are not typically associated with this condition.

+3. Severe Combined Immunodeficiency (SCID): This is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. A common symptom with the patient is 'Recurrent viral infections'. However, 'Death in infancy', 'Death in childhood', 'Hypertyrosinemia', and 'Hyperphenylalaninemia' are not typically associated with this condition.

+4. Infantile Neuroaxonal Dystrophy (INAD): This is a rare inherited neurological disorder. It affects the nerve axons (which are responsible for conducting messages) in the brain and other parts of the body, leading to a loss of physical and mental skills. The common symptoms with the patient are 'Death in infancy' and 'Death in childhood'. However, 'Recurrent viral infections', 'Hypertyrosinemia', and 'Hyperphenylalaninemia' are not typically associated with this condition. 

Please note that these are potential diagnoses based on the given symptoms. Further tests and examinations are needed to confirm the diagnosis."
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1. Primary Hyperoxaluria: This is a rare genetic disorder characterized by the overproduction of a substance called oxalate. Symptoms in common with the patient include Aminoaciduria and Elevated urinary carboxylic acid. Symptoms not in common include kidney stones and progressive renal failure.

+2. Glycine Encephalopathy: Also known as non-ketotic hyperglycinemia, this is a genetic disorder characterized by abnormally high levels of glycine. Symptoms in common with the patient include Abnormal circulating glycine concentration. Symptoms not in common include seizures, intellectual disability, and breathing difficulties.

+3. Carnitine Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include Abnormal circulating carnitine concentration. Symptoms not in common include muscle weakness, confusion, and vomiting.

+4. Organic Acidemia: This is a group of metabolic disorders which can lead to abnormal levels of organic acids in the body. Symptoms in common with the patient include Elevated urinary carboxylic acid and Aminoaciduria. Symptoms not in common include poor feeding, developmental delay, and lethargy.

+5. Hyperglycinemia: This is a condition characterized by an excess of glycine in the body. Symptoms in common with the patient include Abnormal circulating glycine concentration. Symptoms not in common include seizures, low muscle tone, and developmental delay."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1. Pompe Disease: This is a genetic disorder characterized by muscle weakness and trouble breathing. Symptoms in common with the patient include 'Generalized hypotonia', 'Hepatomegaly', and 'Feeding difficulties'. However, '3-Methylglutaconic aciduria' is not a common symptom of this disease.

+2. Leigh Syndrome: This is a severe neurological disorder that typically becomes apparent in the first year of life. Symptoms in common with the patient include 'Generalized hypotonia', 'Death in infancy', 'Tachypnea', and 'Feeding difficulties'. '3-Methylglutaconic aciduria' and 'Hepatomegaly' are not typically associated with this condition.

+3. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy. Symptoms in common with the patient include 'Generalized hypotonia', 'Neonatal death', 'Hepatomegaly', and 'Feeding difficulties'. '3-Methylglutaconic aciduria' and 'Tachypnea' are not typically associated with this condition.

+4. Zellweger Syndrome: This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include 'Generalized hypotonia', 'Neonatal death', 'Hepatomegaly', and 'Feeding difficulties'. '3-Methylglutaconic aciduria' is not a common symptom of this disease.

+5. 3-Methylglutaconic Aciduria: This is a group of autosomal recessive disorders characterized by an increased excretion of 3-methylglutaconic acid. Symptoms in common with the patient include 'Generalized hypotonia', '3-Methylglutaconic aciduria', 'Neonatal death', and 'Feeding difficulties'. 'Hepatomegaly' and 'Tachypnea' are not typically associated with this condition."
['Citrullinemia type I'],"+1. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common include 'Delayed speech and language development', 'Hyperhidrosis', 'Obesity', 'Sleep abnormality'. Symptoms not in common include 'Pustule', 'Acute hepatitis', 'Chronic hepatitis'.

+2. Congenital Hypothyroidism: This is a condition that affects the production of thyroid hormones, which are necessary for normal growth and development. Symptoms in common include 'Delayed speech and language development', 'Lethargy', 'Motor delay', 'Hypothermia'. Symptoms not in common include 'Hyperammonemia', 'Respiratory alkalosis', 'Oroticaciduria', 'Elevated plasma citrulline'.

+3. Hyper IgM Syndrome: This is a rare primary immunodeficiency disorder that affects the immune system. Symptoms in common include 'Hyperhidrosis', 'Pustule', 'Acute hepatitis', 'Chronic hepatitis'. Symptoms not in common include 'Obesity', 'Death in infancy', 'Hypoglycemia', 'Respiratory alkalosis'.

+4. Urea Cycle Disorder: These are genetic disorders that result in a deficiency of one of the six enzymes in the urea cycle. Symptoms in common include 'Hyperammonemia', 'Oroticaciduria', 'Elevated plasma citrulline', 'Drowsiness'. Symptoms not in common include 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Lethargy', 'Motor delay'.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common include 'Death in infancy', 'Neonatal death', 'Death in childhood'. Symptoms not in common include 'Hyperhidrosis', 'Obesity', 'Hypoglycemia', 'Respiratory alkalosis'.

+6. Hypoglycemia: This is a condition caused by a very low level of blood sugar (glucose), your body's main energy source. Symptoms in common include 'Hypoglycemia', 'Lethargy', 'Drowsiness', 'Sleep abnormality'. Symptoms not in common include 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Motor delay', 'Obesity'. 

+7. Chronic Hepatitis: This is a long-term inflammation of the liver. Symptoms in common include 'Acute hepatitis', 'Chronic hepatitis'. Symptoms not in common include 'Delayed speech and language development', 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Lethargy'."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Acidemia Type 1: This is a genetic disorder that affects the body's ability to process certain proteins. Symptoms in common with the patient include Macrocephaly, Seizure, Generalized hypotonia, Death in infancy, Athetosis, Glutaric aciduria, and Neonatal death. The patient does not have Abnormality of visual evoked potentials and Irritability which are not typically associated with this disease.

+2. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Symptoms in common with the patient include Macrocephaly, Irritability, Seizure, Generalized hypotonia, and Death in infancy. The patient does not have Abnormality of visual evoked potentials, Athetosis, Glutaric aciduria, and Neonatal death which are not typically associated with this disease.

+3. Alexander Disease: This is a rare genetic disorder that primarily affects the nervous system. Symptoms in common with the patient include Macrocephaly, Seizure, Generalized hypotonia, and Irritability. The patient does not have Abnormality of visual evoked potentials, Death in infancy, Athetosis, Glutaric aciduria, and Neonatal death which are not typically associated with this disease.

+4. Zellweger Syndrome: This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include Seizure, Generalized hypotonia, and Neonatal death. The patient does not have Macrocephaly, Abnormality of visual evoked potentials, Irritability, Death in infancy, Athetosis, and Glutaric aciduria which are not typically associated with this disease.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include Seizure, Generalized hypotonia, and Death in infancy. The patient does not have Macrocephaly, Abnormality of visual evoked potentials, Irritability, Athetosis, Glutaric aciduria, and Neonatal death which are not typically associated with this disease."
['Tyrosinemia type 1'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', '4-Hydroxyphenylpyruvic aciduria', and 'Elevated urinary delta-aminolevulinic acid'. Symptoms not in common include 'Liver cirrhosis' and 'Renal tubular dysfunction'.

+2. Phenylketonuria (PKU): This is a rare genetic condition that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Delayed speech and language development' and 'Abnormal circulating phenylalanine concentration'. Symptoms not in common include 'Intellectual disability' and 'Musty body odor'.

+3. Alkaptonuria: This is a rare inherited genetic disorder in which the body cannot process the amino acids phenylalanine and tyrosine, which are found in protein. Symptoms in common with the patient include '4-Hydroxyphenylpyruvic aciduria'. Symptoms not in common include 'Dark urine' and 'Arthritis-like symptoms'.

+4. Acute Intermittent Porphyria: This is a rare metabolic disorder affecting the production of heme, the oxygen-binding component of hemoglobin. Symptoms in common with the patient include 'Elevated urinary delta-aminolevulinic acid'. Symptoms not in common include 'Abdominal pain' and 'Neuropathy'.

+5. Childhood Disintegrative Disorder: This is a condition in which children develop normally and then, usually between the ages of 2 and 10, lose many of the skills they had developed. Symptoms in common with the patient include 'Delayed speech and language development' and 'Death in childhood'. Symptoms not in common include 'Loss of social skills' and 'Loss of bowel and bladder control'."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Hyperphenylalaninemia'. Symptoms not in common with the patient include 'Intellectual disability', 'Delayed development', and 'Fair skin and blue eyes'.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', and 'Death in childhood'. Symptoms not in common with the patient include 'Liver and kidney disease', 'Problems affecting the nervous system', and 'Cabbage-like odor'.

+3. Propionic Acidemia: This is a disorder that causes harmful amounts of organic acids to build up in the body. Symptoms in common with the patient include 'Elevated urinary carboxylic acid', 'Death in infancy', 'Neonatal death', and 'Death in childhood'. Symptoms not in common with the patient include 'Weak muscle tone (hypotonia)', 'Poor feeding', and 'Developmental delay'.

+4. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common with the patient include 'Obesity'. Symptoms not in common with the patient include 'Intellectual impairment', 'Short stature', and 'Hypogonadism'.

+5. Congenital Anomalies: These are structural or functional anomalies that occur during intrauterine life and can be identified prenatally, at birth, or sometimes may only be detected later in infancy. Symptoms in common with the patient include 'Abnormality of prenatal development or birth'. Symptoms not in common with the patient include 'Congenital heart defects', 'Neural tube defects', and 'Cleft lip or palate'."
['Phenylketonuria'],"+1. Attention Deficit Hyperactivity Disorder (ADHD): This is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. The patient's symptoms of hyperactivity align with this diagnosis. However, the patient does not exhibit the typical inattention and impulsivity associated with ADHD.

+2. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms include intellectual disability, seizures, and hyperphenylalaninemia, which align with the patient's symptoms. However, the patient does not exhibit the typical musty odor in breath, skin, or urine associated with PKU.

+3. Tyrosinemia: This is a genetic disorder characterized by elevated levels of the amino acid tyrosine, a condition known as hypertyrosinemia. The patient's symptoms align with this diagnosis. However, the patient does not exhibit the typical liver and kidney problems associated with Tyrosinemia.

+4. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms include intellectual disability, seizures, severe short stature, and obesity, which align with the patient's symptoms. However, the patient does not exhibit the typical food craving and skin picking associated with Prader-Willi Syndrome.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms include intellectual disability, seizures, and death in childhood, which align with the patient's symptoms. However, the patient does not exhibit the typical loss of appetite and vomiting associated with Leigh Syndrome.

+6. Organic Acidemia: This is a group of metabolic disorders which can lead to a buildup of toxic substances in the body. Symptoms include elevated urinary carboxylic acid, which aligns with the patient's symptoms. However, the patient does not exhibit the typical metabolic acidosis and lethargy associated with Organic Acidemia."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common with the patient include 'Seizure', 'Generalized hypotonia', 'Death in infancy', 'Metabolic acidosis', 'Vomiting', 'Methylmalonic acidemia', 'Neonatal death', 'Methylmalonic aciduria'. Symptoms not in common are 'Thrombocytopenia' and 'Leukopenia'.

+2. Propionic Acidemia: This is a rare genetic disorder that affects the ability of the body to process proteins and lipids. Symptoms in common with the patient include 'Seizure', 'Generalized hypotonia', 'Death in infancy', 'Metabolic acidosis', 'Vomiting', 'Neonatal death'. Symptoms not in common are 'Thrombocytopenia', 'Leukopenia', 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Hyperammonemia'.

+3. Urea Cycle Disorder: This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. Symptoms in common with the patient include 'Seizure', 'Generalized hypotonia', 'Death in infancy', 'Hyperammonemia', 'Vomiting', 'Neonatal death'. Symptoms not in common are 'Thrombocytopenia', 'Leukopenia', 'Metabolic acidosis', 'Methylmalonic acidemia', 'Methylmalonic aciduria'.

+4. Neonatal Sepsis: This is a type of neonatal infection and can be caused by bacteria, viruses, or fungi. Symptoms in common with the patient include 'Seizure', 'Generalized hypotonia', 'Death in infancy', 'Vomiting', 'Neonatal death'. Symptoms not in common are 'Thrombocytopenia', 'Leukopenia', 'Metabolic acidosis', 'Hyperammonemia', 'Methylmalonic acidemia', 'Methylmalonic aciduria'.

+5. Thrombocytopenia-Absent Radius Syndrome: This is a rare genetic disorder that primarily affects the development of the bones and blood cells. Symptoms in common with the patient include 'Thrombocytopenia', 'Generalized hypotonia', 'Death in infancy'. Symptoms not in common are 'Seizure', 'Leukopenia', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting', 'Methylmalonic acidemia', 'Neonatal death', 'Methylmalonic aciduria'."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine Deficiency, Systemic Primary:
This is a metabolic disorder that prevents the body from using certain fats for energy. Symptoms in common with the patient include 'Abnormal circulating carnitine concentration'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this disease.

+2. Carnitine Palmitoyltransferase II Deficiency:
This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include 'Neonatal death' and 'Abnormal circulating carnitine concentration'. The symptoms 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this disease.

+3. Carnitine-Acylcarnitine Translocase Deficiency:
This is a rare metabolic condition that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Neonatal death' and 'Abnormal circulating carnitine concentration'. The symptoms 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this disease.

+4. Medium-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Neonatal death' and 'Abnormal circulating carnitine concentration'. The symptoms 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this disease.

+5. Trifunctional Protein Deficiency:
This is a disorder that prevents the body from breaking down certain fats to produce energy. Symptoms in common with the patient include 'Neonatal death' and 'Abnormal circulating carnitine concentration'. The symptoms 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this disease."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common with the patient include 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting', 'Methylmalonic aciduria', and 'Death in infancy'. 

+2. Propionic Acidemia: This is a disorder that affects the breakdown of certain parts of proteins and lipids. Symptoms in common with the patient include 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting', and 'Death in infancy'. The patient does not have 'Methylmalonic aciduria', which is not a common symptom of this disease.

+3. Isovaleric Acidemia: This is a disorder characterized by a distinctive odor of sweaty feet and is caused by the buildup of organic acids in the body. Symptoms in common with the patient include 'Metabolic acidosis', 'Hyperammonemia', and 'Vomiting'. The patient does not have 'Methylmalonic aciduria' and 'Death in infancy' is not a common symptom of this disease.

+4. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to process certain protein building blocks. Symptoms in common with the patient include 'Metabolic acidosis', 'Hyperammonemia', and 'Vomiting'. The patient does not have 'Methylmalonic aciduria' and 'Death in infancy' is not a common symptom of this disease.

+5. Urea Cycle Disorder: This is a genetic disorder caused by a mutation that results in a deficiency of one of the six enzymes in the urea cycle. Symptoms in common with the patient include 'Hyperammonemia', 'Vomiting', and 'Metabolic acidosis'. The patient does not have 'Methylmalonic aciduria' and 'Death in infancy' is not a common symptom of this disease."
['Ornithine transcarbamylase deficiency'],"+1. Orotic Aciduria:
This is a rare metabolic disorder characterized by a deficiency of certain enzymes in the pathway for the synthesis of pyrimidines. Common symptoms include oroticaciduria, which the patient has. However, seizures, death in infancy, hyperammonemia, cerebral edema, and neonatal death, which are not typically associated with this condition, are also present in the patient.

+2. Urea Cycle Disorder:
This is a genetic disorder caused by a mutation that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. The patient's symptoms of hyperammonemia, cerebral edema, and neonatal death are common in this disorder. However, the patient also has seizures, death in infancy, and oroticaciduria, which are not typically associated with this condition.

+3. Neonatal Seizures:
These are seizures that occur in a child under one month of age. The patient's symptom of seizures is common in this condition. However, the patient also has death in infancy, hyperammonemia, cerebral edema, oroticaciduria, and neonatal death, which are not typically associated with this condition.

+4. Hyperammonemia:
This is a metabolic disturbance characterized by an excess of ammonia in the blood. It is a dangerous condition as it can lead to encephalopathy and death. The patient's symptoms of hyperammonemia, seizures, cerebral edema, and neonatal death are common in this disorder. However, the patient also has death in infancy and oroticaciduria, which are not typically associated with this condition.

+5. Cerebral Edema:
This is a condition where there is excess accumulation of fluid in the intracellular or extracellular spaces of the brain. The patient's symptoms of cerebral edema, seizures, and neonatal death are common in this disorder. However, the patient also has death in infancy, hyperammonemia, and oroticaciduria, which are not typically associated with this condition. 

+6. Sudden Infant Death Syndrome (SIDS):
This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The patient's symptoms of death in infancy and neonatal death are common in this disorder. However, the patient also has seizures, hyperammonemia, cerebral edema, and oroticaciduria, which are not typically associated with this condition."
['Biotinidase deficiency'],"+1. Epilepsy: This condition is characterized by recurrent seizures. The patient's symptom of 'Seizure' aligns with this disease. However, 'Generalized hypotonia', 'Growth delay', 'Death in infancy', 'Alopecia', 'Fasciculations', 'Elevated urinary carboxylic acid' are not typically associated with Epilepsy.

+2. Hypotonic cerebral palsy: This is a form of cerebral palsy characterized by decreased muscle tone. The patient's symptoms of 'Generalized hypotonia' and 'Growth delay' are common in this condition. However, 'Seizure', 'Death in infancy', 'Alopecia', 'Fasciculations', 'Elevated urinary carboxylic acid' are not typically associated with Hypotonic cerebral palsy.

+3. Infantile neuroaxonal dystrophy: This is a rare neurodegenerative disorder characterized by a progressive loss of vision and physical and mental skills. The patient's symptoms of 'Seizure', 'Generalized hypotonia', 'Growth delay', 'Death in infancy', 'Fasciculations' align with this disease. However, 'Alopecia' and 'Elevated urinary carboxylic acid' are not typically associated with Infantile neuroaxonal dystrophy.

+4. Alopecia universalis: This is a condition characterized by the complete loss of hair on the scalp and body. The patient's symptom of 'Alopecia' aligns with this disease. However, 'Seizure', 'Generalized hypotonia', 'Growth delay', 'Death in infancy', 'Fasciculations', 'Elevated urinary carboxylic acid' are not typically associated with Alopecia universalis.

+5. Methylmalonic acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. The patient's symptoms of 'Growth delay', 'Death in infancy', 'Elevated urinary carboxylic acid' align with this disease. However, 'Seizure', 'Generalized hypotonia', 'Alopecia', 'Fasciculations' are not typically associated with Methylmalonic acidemia."
['Phenylketonuria'],"+1. Metabolic Syndrome: This is a cluster of conditions that occur together, increasing your risk of heart disease, stroke, and type 2 diabetes. These conditions include increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels. The patient's symptoms of obesity and hypercholesterolemia are common with this disease. However, hypertyrosinemia, hyperphenylalaninemia, and death in early adulthood are not typically associated with metabolic syndrome.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. PKU is caused by a defect in the gene that helps create the enzyme needed to break down phenylalanine. Symptoms include hyperphenylalaninemia and, if untreated, can lead to intellectual disabilities, seizures, behavioral problems, and mental disorders. The patient's symptom of hyperphenylalaninemia is common with this disease, but obesity, hypercholesterolemia, hypertyrosinemia, and death in early adulthood are not typically associated with PKU.

+3. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. If untreated, tyrosinemia can lead to liver and kidney failure, neurological crises, and an increased risk of liver cancer. The patient's symptom of hypertyrosinemia is common with this disease, but obesity, hypercholesterolemia, hyperphenylalaninemia, and death in early adulthood are not typically associated with tyrosinemia.

+4. Familial Hypercholesterolemia: This is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein (LDL, or ""bad cholesterol""), in the blood and early cardiovascular disease. The patient's symptom of hypercholesterolemia is common with this disease, but obesity, hypertyrosinemia, hyperphenylalaninemia, and death in early adulthood are not typically associated with familial hypercholesterolemia.

+5. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. The patient's symptom of obesity is common with this disease, but hypercholesterolemia, hypertyrosinemia, hyperphenylalaninemia, and death in early adulthood are not typically associated with Prader-Willi syndrome."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia' and 'Hyperphenylalaninemia'. Symptoms not in common with the patient are 'Liver and kidney disease', 'Intellectual disability', and 'Nervous system problems'.

+2. Smith-Lemli-Opitz Syndrome: This is a developmental disorder that causes multiple malformations and intellectual disability. Symptoms in common with the patient include 'Hypospadias', 'Premature birth', and 'Severe short stature'. Symptoms not in common with the patient are 'Microcephaly', 'Cleft palate', and '2-3 toe syndactyly'.

+3. Pena-Shokeir Syndrome: This is a rare disorder characterized by contractures of the joints, facial anomalies, underdeveloped lungs, and growth retardation. Symptoms in common with the patient include 'Neonatal death', 'Premature birth', and 'Severe short stature'. Symptoms not in common with the patient are 'Facial anomalies', 'Underdeveloped lungs', and 'Joint contractures'.

+4. Phenylketonuria: This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. Symptoms not in common with the patient are 'Intellectual disability', 'Delayed development', and 'Behavioral, emotional and social problems'.

+5. Omphalocele: This is a birth defect of the abdominal (belly) wall. The infant’s intestines, liver, or other organs stick outside of the belly through the belly button. Symptoms in common with the patient include 'Hernia'. Symptoms not in common with the patient are 'Abdominal organs outside of the belly', 'Visible sac-like covering', and 'Failure to thrive'. 

+6. Meckel Syndrome: This is a severe disorder characterized by multiple malformations and death in infancy. Symptoms in common with the patient include 'Death in infancy', 'Severe short stature', and 'Hernia'. Symptoms not in common with the patient are 'Encephalocele', 'Polydactyly', and 'Cystic kidneys'."
['Smith-Lemli-Opitz syndrome'],"+1. Smith-Lemli-Opitz Syndrome: This is a developmental disorder characterized by intellectual disability, small head size (microcephaly), low-set ears, and distinctive facial features including a wide nasal bridge. Other symptoms include syndactyly, motor delay, and elevated levels of 7-dehydrocholesterol and 8-dehydrocholesterol. However, the patient does not show symptoms of death in infancy, neonatal death, or death in childhood.

+2. Down Syndrome: This genetic disorder is often associated with physical growth delays, characteristic facial features, and mild to moderate intellectual disability. Common symptoms include low-set ears, wide nasal bridge, and delayed speech and language development. However, the patient does not show symptoms of strabismus, severe short stature, or severe hearing impairment.

+3. Rubinstein-Taybi Syndrome: This condition is characterized by intellectual disability, broad thumbs and first toes, and distinctive facial features including a wide nasal bridge and low-set ears. Other symptoms include difficulty walking and delayed speech and language development. However, the patient does not show symptoms of death in infancy, neonatal death, or death in childhood.

+4. Patau Syndrome: This is a severe genetic disorder causing numerous physical abnormalities and a high rate of death in infancy and childhood. Symptoms include microcephaly, low-set ears, and severe intellectual disability. However, the patient does not show symptoms of syndactyly, difficulty climbing stairs, or elevated circulating 7-dehydrocholesterol concentration.

+5. Duchenne Muscular Dystrophy: This is a severe type of muscular dystrophy. The symptom of difficulty walking, running, and climbing stairs are common in this disease. However, the patient does not show symptoms of death in infancy, neonatal death, or death in childhood. Also, the patient does not have elevated 8-dehydrocholesterol or severe hearing impairment."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Acidemia Type 1: This is a genetic disorder characterized by deficiency of an enzyme that helps break down certain amino acids. Symptoms in common include Ataxia, Dehydration, Diarrhea, Progressive neurologic deterioration, Glutaric aciduria, Elevated circulating glutaric acid concentration, and Decreased plasma free carnitine. Symptoms not in common are Death in infancy, Fever, Opisthotonus, Athetosis, and Death in childhood.

+2. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare metabolic condition where the body is unable to use certain fats for energy. Symptoms in common include Dehydration, Fever, Diarrhea, and Decreased plasma free carnitine. Symptoms not in common are Ataxia, Death in infancy, Opisthotonus, Athetosis, Progressive neurologic deterioration, Glutaric aciduria, Elevated circulating glutaric acid concentration, and Death in childhood.

+3. Glutaric Acidemia Type 2: This is a metabolic disorder that prevents the body from properly processing certain proteins and fats. Symptoms in common include Ataxia, Dehydration, Diarrhea, Progressive neurologic deterioration, Glutaric aciduria, Elevated circulating glutaric acid concentration, and Decreased plasma free carnitine. Symptoms not in common are Death in infancy, Fever, Opisthotonus, Athetosis, and Death in childhood.

+4. Infantile Neuroaxonal Dystrophy: This is a rare inherited neurological disorder that primarily affects the nervous system. Symptoms in common include Ataxia, Death in infancy, Progressive neurologic deterioration, and Death in childhood. Symptoms not in common are Dehydration, Fever, Diarrhea, Opisthotonus, Athetosis, Glutaric aciduria, Elevated circulating glutaric acid concentration, and Decreased plasma free carnitine.

+5. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common include Dehydration, Fever, Diarrhea, and Decreased plasma free carnitine. Symptoms not in common are Ataxia, Death in infancy, Opisthotonus, Athetosis, Progressive neurologic deterioration, Glutaric aciduria, Elevated circulating glutaric acid concentration, and Death in childhood."
['Phenylketonuria'],"+1. Down Syndrome: This is a genetic disorder that results in some level of learning disability and certain physical characteristics. Common symptoms include motor delay and generalized hypotonia. However, the symptoms of hip dysplasia, death in infancy, hypertyrosinemia, neonatal death, and hyperphenylalaninemia are not typically associated with Down Syndrome.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that affects a person's ability to metabolize the amino acid phenylalanine. Symptoms include hyperphenylalaninemia and motor delay. However, the symptoms of abnormality of prenatal development or birth, generalized hypotonia, hip dysplasia, death in infancy, hypertyrosinemia, and neonatal death are not typically associated with PKU.

+3. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. Symptoms include hypertyrosinemia. However, the symptoms of abnormality of prenatal development or birth, motor delay, generalized hypotonia, hip dysplasia, death in infancy, and neonatal death are not typically associated with Tyrosinemia.

+4. Developmental Hip Dysplasia: This is a condition where the 'ball and socket' joint of the hip does not properly form in babies and young children. Symptoms include hip dysplasia. However, the symptoms of abnormality of prenatal development or birth, motor delay, generalized hypotonia, death in infancy, hypertyrosinemia, neonatal death, and hyperphenylalaninemia are not typically associated with Developmental Hip Dysplasia.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms include death in infancy and neonatal death. However, the symptoms of abnormality of prenatal development or birth, motor delay, generalized hypotonia, hip dysplasia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with SIDS."
['Phenylketonuria'],"+1. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Common symptoms include weak muscle tone (hypotonia), poor growth, and delayed development. While the patient does exhibit generalized hypotonia, they do not show signs of poor growth or delayed development.

+2. Ondine's Curse (Congenital Central Hypoventilation Syndrome): This is a rare disorder characterized by abnormal control of breathing. While the patient does show signs of apnea, they do not exhibit other common symptoms such as shallow breathing or breathing pauses during sleep.

+3. Phenylketonuria: This is a rare genetic disorder that prevents the body from breaking down an amino acid called phenylalanine. The patient does exhibit hyperphenylalaninemia, a common symptom of this disease. However, they do not show signs of other common symptoms such as intellectual disability or fair skin and hair.

+4. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. The patient does exhibit hypertyrosinemia, a common symptom of this disease. However, they do not show signs of other common symptoms such as liver and kidney disturbances or problems affecting the nervous system.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The patient does exhibit neonatal death and death in infancy, common symptoms of this disease. However, they do not show signs of other common symptoms such as being found on their stomach or side.

+6. Pierre Robin Sequence: This is a condition present at birth, in which the infant has a smaller than normal lower jaw (retrognathia), a tongue that falls back in the throat, and difficulty breathing. The patient does exhibit retrognathia, a common symptom of this disease. However, they do not show signs of other common symptoms such as cleft palate or glossoptosis. 

+7. Epilepsy: This is a central nervous system (neurological) disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness. The patient does exhibit seizures, a common symptom of this disease. However, they do not show signs of other common symptoms such as temporary confusion or staring spells."
['Tyrosinemia type 1'],"+1. Autism Spectrum Disorder: This is a developmental disorder that affects communication and behavior. Symptoms in common with the patient include 'Autistic behavior', 'Hyperactivity', 'Intellectual disability', and 'Motor delay'. Symptoms not in common include 'Social impairment' and 'Repetitive behaviors'.

+2. Lesch-Nyhan Syndrome: This is a genetic disorder characterized by neurological and behavioral abnormalities and the overproduction of uric acid. Symptoms in common with the patient include 'Self-mutilation', 'Hyperactivity', 'Intellectual disability', and 'Motor delay'. Symptoms not in common include 'Gout', 'Kidney stones', and 'Blood in urine'.

+3. Epilepsy: This is a central nervous system disorder in which brain activity becomes abnormal, causing seizures. Symptoms in common with the patient include 'Seizure'. Symptoms not in common include 'Temporary confusion', 'Staring spell', and 'Uncontrollable jerking movements of the arms and legs'.

+4. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common with the patient include 'Hyperactivity', 'Intellectual disability', 'Motor delay', and 'Obesity'. Symptoms not in common include 'Short stature', 'Small hands and feet', and 'Almond-shaped eyes'.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy' and 'Neonatal death'. Symptoms not in common include 'Sleeping on the stomach' and 'Exposure to tobacco smoke'.

+6. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Elevated circulating alkaline phosphatase concentration', 'Hypertyrosinemia', and 'Abnormal circulating alanine concentration'. Symptoms not in common include 'Liver and kidney disease', 'Growth failure', and 'Rickets'.

+7. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia' and 'Intellectual disability'. Symptoms not in common include 'Musty odor' and 'Skin rashes'.

+8. Hepatocellular Carcinoma: This is a type of liver cancer that often occurs in people with chronic liver diseases. Symptoms in common with the patient include 'Elevated circulating alpha-fetoprotein concentration'. Symptoms not in common include 'Abdominal pain', 'Loss of appetite', and 'Yellowing of the skin and eyes (jaundice)'.

+9. Iron Deficiency Anemia: This is a common type of anemia that occurs when your blood lacks enough healthy red blood cells or hemoglobin. Symptoms in common with the patient include 'Decreased serum iron'. Symptoms not in common include 'Fatigue', 'Pale skin', and 'Shortness of breath'."
['Classic galactosemia'],"+1. Galactosemia: This is a disorder that affects the body's ability to process a simple sugar called galactose. Symptoms that match with the patient include 'Hypergalactosemia', 'Vomiting', 'Neonatal death', and 'Death in infancy'. The symptom 'Increased total bilirubin' is not typically associated with this disease.

+2. Crigler-Najjar Syndrome: This is a severe condition characterized by high levels of a toxic substance called bilirubin in the blood (hyperbilirubinemia). Symptoms that match with the patient include 'Increased total bilirubin', 'Neonatal death', and 'Death in infancy'. The symptoms 'Vomiting' and 'Hypergalactosemia' are not typically associated with this disease.

+3. Gilbert's Syndrome: This is a mild liver disorder in which the liver does not properly process bilirubin. Symptoms that match with the patient include 'Increased total bilirubin'. The symptoms 'Vomiting', 'Hypergalactosemia', 'Neonatal death', and 'Death in infancy' are not typically associated with this disease.

+4. Neonatal Hemochromatosis: This is a rare liver disease characterized by the accumulation of iron in the liver and other tissues. Symptoms that match with the patient include 'Neonatal death' and 'Death in infancy'. The symptoms 'Vomiting', 'Increased total bilirubin', and 'Hypergalactosemia' are not typically associated with this disease.

+5. Biliary Atresia: This is a rare disease of the liver and bile ducts that occurs in infants. Symptoms that match with the patient include 'Increased total bilirubin', 'Neonatal death', and 'Death in infancy'. The symptoms 'Vomiting' and 'Hypergalactosemia' are not typically associated with this disease."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Hyperphenylalaninemia' and 'Abnormal circulating tyrosine concentration'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this condition.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Abnormal circulating tyrosine concentration'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', and 'Hyperphenylalaninemia' are not typically associated with this condition.

+3. Maternal Phenylketonuria: This is a condition in pregnant women who have previously diagnosed phenylketonuria (PKU). Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', and 'Abnormality of prenatal development or birth'. However, 'Death in infancy' and 'Neonatal death' are not typically associated with this condition.

+4. Neonatal Death Syndrome: This is a condition where a newborn dies within the first 28 days of life. Symptoms in common with the patient include 'Neonatal death' and 'Death in infancy'. However, 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', and 'Abnormality of prenatal development or birth' are not typically associated with this condition.

+5. Inborn Errors of Metabolism: These are genetic disorders that result from a defect in the enzymes involved in the breakdown of food components. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'."
['Biotinidase deficiency'],"+1. Carnitine Palmitoyltransferase II Deficiency: This is a metabolic condition that prevents the body from converting certain fats into energy. Common symptoms include muscle weakness and pain, fatigue, and low blood sugar. The patient's symptoms of 'Obesity' and 'Abnormal circulating carnitine concentration' are in line with this disease. However, 'Death in childhood' and 'Death in adolescence' are not typically associated with this condition.

+2. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone, feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. The patient's symptom of 'Obesity' matches this disease, but 'Death in childhood', 'Death in adolescence', and 'Abnormal circulating carnitine concentration' are not common symptoms.

+3. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare metabolic condition that prevents the body from converting certain fats into energy. Symptoms include hypoglycemia, lethargy, muscle weakness, and cardiomyopathy. The patient's symptom of 'Abnormal circulating carnitine concentration' aligns with this disease, but 'Obesity', 'Death in childhood', and 'Death in adolescence' are not typically associated with this condition.

+4. Alpers' Disease: This is a progressive neurologic disorder that begins during childhood. Symptoms include seizures, dementia, spasticity, and optic atrophy. The patient's symptoms of 'Death in childhood' and 'Death in adolescence' are consistent with this disease. However, 'Obesity' and 'Abnormal circulating carnitine concentration' are not common symptoms.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. The patient's symptoms of 'Death in childhood' and 'Death in adolescence' align with this disease, but 'Obesity' and 'Abnormal circulating carnitine concentration' are not typically associated with this condition."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Intellectual disability', 'Hyperphenylalaninemia'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in adolescence' are not typically associated with this condition.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death'. However, 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Hyperphenylalaninemia', 'Death in adolescence' are not typically associated with this condition.

+3. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder in which the body is unable to break down certain amino acids. Symptoms in common with the patient include 'Intellectual disability', 'Death in infancy', 'Neonatal death'. However, 'Abnormality of prenatal development or birth', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in adolescence' are not typically associated with this condition.

+4. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy', 'Neonatal death'. However, 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in adolescence' are not typically associated with this condition.

+5. Trisomy 18 (Edwards Syndrome): This is a genetic disorder caused by the presence of all or part of an extra 18th chromosome. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Death in infancy', 'Neonatal death', 'Death in adolescence'. However, 'Hypertyrosinemia', 'Hyperphenylalaninemia' are not typically associated with this condition."
['Smith-Lemli-Opitz syndrome'],"+1. Smith-Lemli-Opitz Syndrome: This is a genetic disorder characterized by distinctive facial features, small head size (microcephaly), intellectual disability, and multiple malformations. Symptoms in common with the patient include microcephaly, intellectual disability, low-set ears, and skin rash. Symptoms not in common include polydactyly, cleft palate, and heart defects.

+2. CHARGE Syndrome: This is a disorder that affects many areas of the body. CHARGE is an abbreviation for several of the features common in the disorder: coloboma, heart defect, atresia choanae, growth retardation, genital abnormalities, and ear abnormalities. Symptoms in common with the patient include low-set ears, intellectual disability, and strabismus. Symptoms not in common include coloboma, heart defects, and growth retardation.

+3. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common with the patient include intellectual disability, motor delay, and feeding difficulties. Symptoms not in common include short stature, almond-shaped eyes, and obesity.

+4. Sotos Syndrome: This is a disorder characterized by a distinctive facial appearance, overgrowth in childhood, and learning disabilities or delayed development of mental and movement abilities. Symptoms in common with the patient include intellectual disability, motor delay, and strabismus. Symptoms not in common include overgrowth and advanced bone age.

+5. Cornelia de Lange Syndrome: This is a developmental disorder that affects many parts of the body. Symptoms in common with the patient include low-set ears, intellectual disability, and feeding difficulties. Symptoms not in common include distinctive facial features, hirsutism, and limb abnormalities.

+6. Smith-Magenis Syndrome: This is a developmental disorder that affects many parts of the body. Symptoms in common with the patient include intellectual disability, sleep abnormalities, and self-injurious behavior. Symptoms not in common include distinctive facial features, short stature, and obesity. 

+7. Rett Syndrome: This is a rare genetic disorder that affects brain development, resulting in severe mental and physical disability. Symptoms in common with the patient include intellectual disability, motor delay, and hand-wringing. Symptoms not in common include loss of purposeful hand skills, loss of social engagement, and severely impaired language development. 

+8. Fragile X Syndrome: This is a genetic condition that causes a range of developmental problems including learning disabilities and cognitive impairment. Symptoms in common with the patient include intellectual disability, strabismus, and low-set ears. Symptoms not in common include long face, large ears, and macroorchidism. 

+9. Angelman Syndrome: This is a genetic disorder that primarily affects the nervous system. Symptoms in common with the patient include intellectual disability, motor delay, and strabismus. Symptoms not in common include ataxia, seizures, and inappropriate happy demeanor. 

+10. Down Syndrome: This is a genetic disorder caused when abnormal cell division results in an extra full or partial copy of chromosome 21. Symptoms in common with the patient include intellectual disability, low-set ears, and strabismus. Symptoms not in common include distinctive facial features, short stature, and congenital heart disease."
['Canavan disease'],"+1. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. Some symptoms in common with the patient are 'Generalized hypotonia', 'Obesity', and 'Strabismus'. However, 'Death in infancy', 'Fever', 'Cerebral atrophy', 'Abnormal circulating aspartate family amino acid concentration' and 'Hyporeflexia' are not typically associated with this condition.

+2. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Symptoms in common with the patient are 'Generalized hypotonia', 'Strabismus', 'Death in infancy', and 'Cerebral atrophy'. However, 'Obesity', 'Fever', 'Abnormal circulating aspartate family amino acid concentration' and 'Hyporeflexia' are not typically associated with this condition.

+3. Maple Syrup Urine Disease: This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. Symptoms in common with the patient are 'Generalized hypotonia', 'Abnormal circulating aspartate family amino acid concentration'. However, 'Strabismus', 'Obesity', 'Death in infancy', 'Fever', 'Cerebral atrophy', and 'Hyporeflexia' are not typically associated with this condition.

+4. Infantile Neuroaxonal Dystrophy: This is a rare neurodegenerative disorder characterized by a progressive loss of vision, and physical and mental skills. Symptoms in common with the patient are 'Generalized hypotonia', 'Strabismus', 'Death in infancy', 'Cerebral atrophy'. However, 'Obesity', 'Fever', 'Abnormal circulating aspartate family amino acid concentration' and 'Hyporeflexia' are not typically associated with this condition.

+5. Hypothyroidism: This is a condition in which the thyroid gland does not produce enough thyroid hormone. Symptoms in common with the patient are 'Generalized hypotonia', 'Obesity'. However, 'Strabismus', 'Death in infancy', 'Fever', 'Cerebral atrophy', 'Abnormal circulating aspartate family amino acid concentration' and 'Hyporeflexia' are not typically associated with this condition."
['Phenylketonuria'],"+1. Obesity: This is a complex disease involving an excessive amount of body fat. Obesity isn't just a cosmetic concern. It can increase your risk of diseases and health problems, such as heart disease, diabetes and high blood pressure. The patient has this symptom.

+2. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. SIDS is sometimes known as crib death because the infants often die in their cribs. The patient has the symptom of 'Death in infancy'.

+3. Coarctation of the Aorta: This is a narrowing of the aorta, the large blood vessel that branches off your heart and delivers oxygen-rich blood to your body. When this occurs, your heart must pump harder to force blood through the narrowed part of your aorta. The patient has this symptom.

+4. Fever: Fever is a temporary increase in your body temperature, often due to an illness. Having a fever is a sign that something out of the ordinary is going on in your body. The patient has this symptom.

+5. Pneumonia: This is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus, causing cough with phlegm or pus, fever, chills, and difficulty breathing. The patient has this symptom.

+6. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. The patient has the symptom of 'Hypertyrosinemia'.

+7. Neonatal Death: This refers to the death of a baby within the first 28 days of life. This could be due to a variety of reasons including birth defects, preterm birth, complications during pregnancy, or infections. The patient has this symptom.

+8. Childhood Diseases: These are diseases that occur during childhood. The patient has the symptom of 'Death in childhood'.

+9. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. PKU is caused by a defect in the gene that helps create the enzyme needed to break down phenylalanine. The patient has the symptom of 'Hyperphenylalaninemia'.

+10. Adolescent Diseases: These are diseases that occur during adolescence. The patient has the symptom of 'Death in adolescence'.

+11. Early Adult Death: This refers to death occurring in early adulthood, often due to diseases or accidents. The patient has the symptom of 'Death in early adulthood'."
['Classic homocystinuria'],"+1. Homocystinuria: This is a disorder that can cause eye problems, skeletal abnormalities, and cognitive issues. The patient's symptoms of 'Hyperhomocystinemia', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', and 'Death in childhood' are common with this disease. However, the patient does not have symptoms of eye problems, skeletal abnormalities, and cognitive issues which are also associated with this disease.

+2. Methionine Adenosyltransferase Deficiency: This is a rare metabolic disorder characterized by persistent hypermethioninemia. The patient's symptom of 'Hypermethioninemia' is common with this disease. However, the patient does not have symptoms of persistent vomiting, failure to thrive, and liver disease which are also associated with this disease.

+3. Cystathionine Beta-Synthase Deficiency: This is a genetic disorder characterized by an increased level of homocysteine in the blood. The patient's symptoms of 'Hyperhomocystinemia', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', and 'Death in childhood' are common with this disease. However, the patient does not have symptoms of dislocation of the optical lens, osteoporosis, and learning problems which are also associated with this disease.

+4. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. The patient's symptom of 'Aminoaciduria' is common with this disease. However, the patient does not have symptoms of liver and kidney disturbances, neurological crises, and skin and eye abnormalities which are also associated with this disease.

+5. Nonketotic Hyperglycinemia: This is a genetic disorder characterized by abnormally high levels of a molecule called glycine. The patient's symptoms of 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', and 'Death in childhood' are common with this disease. However, the patient does not have symptoms of seizures, breathing difficulties, and developmental delay which are also associated with this disease."
[],"+1. Ataxia-Telangiectasia:
This is a rare, neurodegenerative, autosomal recessive disease causing severe disability. Symptoms in common with the patient include Ataxia and Generalized hypotonia. However, the patient does not show signs of Telangiectasia, which is a common symptom of this disease.

+2. Leigh Syndrome:
This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within a couple of years, usually due to respiratory failure. Symptoms in common with the patient include Generalized hypotonia and Death in childhood. However, the patient does not show signs of Lactic acidosis and Optic atrophy, which are common symptoms of this disease.

+3. Pyrimidine Metabolic Disorder:
This is a group of disorders characterized by an abnormal accumulation of pyrimidines in the body. Symptoms in common with the patient include Abnormal circulating pyrimidine concentration and Uraciluria. However, the patient does not show signs of Anemia and Intellectual disability, which are common symptoms of this disease.

+4. Orotic Aciduria:
This is a disorder that occurs when the body can't break down orotic acid, leading to its accumulation in the body. Symptoms in common with the patient include Abnormal circulating pyrimidine concentration and Uraciluria. However, the patient does not show signs of Megaloblastic anemia and Failure to thrive, which are common symptoms of this disease.

+5. Spinocerebellar Ataxia:
This is a progressive, degenerative, genetic disease with multiple types, each of which could be considered a disease in its own right. Symptoms in common with the patient include Ataxia and Generalized hypotonia. However, the patient does not show signs of Dysarthria and Nystagmus, which are common symptoms of this disease."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. However, 'Hyperphenylalaninemia' and 'Death in early adulthood' are not typically associated with this condition.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. However, 'Hypertyrosinemia' and 'Death in early adulthood' are not typically associated with this condition.

+3. Alkaptonuria: This is a rare genetic disorder that causes homogentisic acid to build up in the body. Symptoms in common with the patient include 'Death in early adulthood'. However, 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not typically associated with this condition.

+4. Tyrosinemia Type II: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine. Symptoms in common with the patient include 'Hypertyrosinemia'. However, 'Hyperphenylalaninemia' and 'Death in early adulthood' are not typically associated with this condition.

+5. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder in which the body cannot break down certain parts of proteins. Symptoms in common with the patient include 'Death in early adulthood'. However, 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not typically associated with this condition."
[],"+1. Orotic Aciduria:
This is a rare metabolic disorder characterized by excessive amounts of orotic acid in the urine. Symptoms in common with the patient include 'Abnormal circulating pyrimidine concentration' and 'Uraciluria'. However, 'Death in infancy', 'Respiratory insufficiency', and 'Neonatal death' are not typically associated with this condition.

+2. Mitochondrial DNA Depletion Syndrome:
This is a group of disorders characterized by a significant drop in mitochondrial DNA. The symptoms that match with the patient are 'Death in infancy', 'Respiratory insufficiency', and 'Neonatal death'. The symptoms 'Abnormal circulating pyrimidine concentration' and 'Uraciluria' are not usually associated with this disease.

+3. Pyrimidine Metabolism Disorder:
This is a group of disorders that affect the body's ability to break down certain proteins. The symptoms that match with the patient are 'Abnormal circulating pyrimidine concentration' and 'Uraciluria'. However, 'Death in infancy', 'Respiratory insufficiency', and 'Neonatal death' are not typically associated with this condition.

+4. Leigh Syndrome:
This is a severe neurological disorder that typically becomes apparent in the first year of life. The symptoms that match with the patient are 'Death in infancy', 'Respiratory insufficiency', and 'Neonatal death'. The symptoms 'Abnormal circulating pyrimidine concentration' and 'Uraciluria' are not usually associated with this disease.

+5. Alpers Syndrome:
This is a progressive neurological disorder that begins during childhood. The symptoms that match with the patient are 'Death in infancy', 'Respiratory insufficiency', and 'Neonatal death'. The symptoms 'Abnormal circulating pyrimidine concentration' and 'Uraciluria' are not typically associated with this condition."
['Tyrosinemia type 1'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Aminoaciduria', 'Elevated circulating alpha-fetoprotein concentration'. Symptoms not in common include 'Cabbage-like odor', 'Renal tubular dysfunction', and 'Hepatocellular carcinoma'.

+2. Wilson's Disease: This is a rare inherited disorder that causes copper to accumulate in your liver, brain and other vital organs. Symptoms in common with the patient include 'Hepatomegaly', 'Ascites', 'Anemia'. Symptoms not in common include 'Kayser-Fleischer ring', 'Neurological symptoms', and 'Psychiatric disturbance'.

+3. Hereditary Spherocytosis: This is a condition that affects red blood cells. Symptoms in common with the patient include 'Pallor', 'Anemia', 'Death in infancy'. Symptoms not in common include 'Jaundice', 'Splenomegaly', and 'Gallstones'.

+4. Hypoalbuminemia: This is a medical sign in which the level of albumin in the blood is low. Symptoms in common with the patient include 'Hypoalbuminemia', 'Ascites', 'Hypoproteinemia'. Symptoms not in common include 'Edema', 'Fatigue', and 'Muscle weakness'.

+5. Porphyria: This is a group of rare genetic disorders that affect the nervous system or skin. Symptoms in common with the patient include 'Abnormal circulating porphyrin concentration', 'Pallor', 'Anemia'. Symptoms not in common include 'Photosensitivity', 'Neuropathy', and 'Abdominal pain'.

+6. Thrombocytosis: This is a disorder in which your body produces too many platelets. Symptoms in common with the patient include 'Thrombocytosis'. Symptoms not in common include 'Headache', 'Dizziness', and 'Chest pain'.

+7. Hernia: This is a condition in which part of an organ is displaced and protrudes through the wall of the cavity containing it. Symptoms in common with the patient include 'Hernia'. Symptoms not in common include 'Bulging of the affected area', 'Pain', and 'Discomfort'."
['Canavan disease'],"+1. Epilepsy: This is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain. The patient's symptom of 'Seizure' matches with this disease. However, 'Motor delay', 'Death in infancy', and 'Abnormal circulating aspartate family amino acid concentration' are not typically associated with this condition.

+2. Cerebral Palsy: This is a group of disorders that affect a person's ability to move and maintain balance and posture. It is due to abnormal brain development or damage to the developing brain that affects a person's ability to control his or her muscles. The patient's symptom of 'Motor delay' matches with this disease. However, 'Seizure', 'Death in infancy', and 'Abnormal circulating aspartate family amino acid concentration' are not typically associated with this condition.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The patient's symptom of 'Death in infancy' matches with this disease. However, 'Seizure', 'Motor delay', and 'Abnormal circulating aspartate family amino acid concentration' are not typically associated with this condition.

+4. Amino Acid Metabolism Disorder: These are a group of metabolic disorders due to the malfunction of the enzymes to digest different amino acids. The patient's symptom of 'Abnormal circulating aspartate family amino acid concentration' matches with this disease. However, 'Seizure', 'Motor delay', and 'Death in infancy' are not typically associated with this condition.

+5. Infantile Neuroaxonal Dystrophy: This is a rare inherited neurological disorder. It affects the nerve axons that conduct messages in the brain and other parts of the body, leading to a progressive loss of vision and of physical and mental skills. The patient's symptoms of 'Seizure', 'Motor delay', and 'Death in infancy' match with this disease. However, 'Abnormal circulating aspartate family amino acid concentration' is not typically associated with this condition."
['Isovaleric acidemia'],"+1. Sudden Infant Death Syndrome (SIDS): This is a sudden, unexplained death of an infant less than one year of age. Symptoms in common: 'Death in infancy', 'Neonatal death'. Symptoms not in common: 'Fever', 'Vomiting', 'Diarrhea', 'Abdominal pain', 'Death in childhood', 'Gastrointestinal inflammation', 'Recurrent viral infections', 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Body odor'.

+2. Gastroenteritis: This is an inflammation of the gastrointestinal tract, involving both the stomach and the small intestine. Symptoms in common: 'Fever', 'Vomiting', 'Diarrhea', 'Abdominal pain', 'Gastrointestinal inflammation'. Symptoms not in common: 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Recurrent viral infections', 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Body odor'.

+3. Carnitine Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common: 'Abnormal circulating carnitine concentration'. Symptoms not in common: 'Death in infancy', 'Fever', 'Vomiting', 'Diarrhea', 'Abdominal pain', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Recurrent viral infections', 'Abnormal circulating glycine concentration', 'Death in adolescence', 'Body odor'.

+4. Glycine Encephalopathy: This is a metabolic disorder characterized by abnormally high levels of a molecule called glycine. Symptoms in common: 'Abnormal circulating glycine concentration'. Symptoms not in common: 'Death in infancy', 'Fever', 'Vomiting', 'Diarrhea', 'Abdominal pain', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Recurrent viral infections', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Body odor'.

+5. Trimethylaminuria: This is a disorder in which the body is unable to break down trimethylamine, a compound derived from the diet that has a strong odor of rotting fish. Symptoms in common: 'Body odor'. Symptoms not in common: 'Death in infancy', 'Fever', 'Vomiting', 'Diarrhea', 'Abdominal pain', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Recurrent viral infections', 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence'."
['Phenylketonuria'],"+1. Hypertension: This is a condition where the force of the blood against the artery walls is too high. Symptoms in common: Hypertension. Symptoms not in common: None.

+2. Intellectual Disability: This is a disorder marked by below average intellectual function and a lack of skills necessary for day-to-day living. Symptoms in common: Intellectual disability. Symptoms not in common: None.

+3. Obesity: This is a complex disease involving an excessive amount of body fat. Obesity isn't just a cosmetic concern. It can increase your risk of diseases and health problems. Symptoms in common: Obesity. Symptoms not in common: None.

+4. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. Symptoms in common: Hypertyrosinemia. Symptoms not in common: None.

+5. Phenylketonuria: This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common: Hyperphenylalaninemia. Symptoms not in common: None.

+6. Sudden Cardiac Death: This is the sudden, unexpected death caused by loss of heart function (sudden cardiac arrest). Symptoms in common: Death in adolescence, Death in early adulthood. Symptoms not in common: None.

+7. Organic Acidemia: This is a group of metabolic disorders which can lead to abnormal accumulations of organic acids in the body. Symptoms in common: Elevated urinary carboxylic acid. Symptoms not in common: None."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare genetic disorder characterized by metabolic abnormalities, particularly affecting the ability to convert certain fats into energy. Common symptoms include abnormal prenatal development, small for gestational age, neonatal death, and abnormal circulating carnitine concentration. However, the patient does not exhibit hyperalaninemia and severe hearing impairment, which are not typically associated with this condition.

+2. Propionic Acidemia: This is a metabolic disorder in which the body is unable to process certain parts of proteins and lipids properly. It is associated with symptoms such as abnormal prenatal development, small for gestational age, and death in infancy. However, the patient does not exhibit hyperalaninemia and severe hearing impairment, which are not typically associated with this condition.

+3. Nonketotic Hyperglycinemia: This is a rare genetic disorder characterized by an excess of glycine on the body's tissues and fluids. It is associated with symptoms such as abnormal prenatal development, small for gestational age, neonatal death, and death in infancy. However, the patient does not exhibit abnormal circulating carnitine concentration and severe hearing impairment, which are not typically associated with this condition.

+4. Pyruvate Dehydrogenase Deficiency: This is a rare genetic disorder that affects the enzyme pyruvate dehydrogenase, which is important for breaking down carbohydrates in cells to produce energy. It is associated with symptoms such as abnormal prenatal development, small for gestational age, and death in infancy. However, the patient does not exhibit hyperalaninemia, abnormal circulating carnitine concentration, and severe hearing impairment, which are not typically associated with this condition.

+5. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to break down certain amino acids. It is associated with symptoms such as abnormal prenatal development, small for gestational age, and death in infancy. However, the patient does not exhibit hyperalaninemia, abnormal circulating carnitine concentration, and severe hearing impairment, which are not typically associated with this condition."
['Ornithine transcarbamylase deficiency'],"+1. Ornithine Transcarbamylase Deficiency: This is a genetic disorder that results in the accumulation of ammonia in the blood. Symptoms in common with the patient include 'Lethargy', 'Death in infancy', 'Drowsiness', 'Sleep abnormality', and 'Abnormal circulating ornithine concentration'. The patient does not have 'Oroticaciduria' which is not typically associated with this disease.

+2. Orotic Aciduria: This is a rare metabolic disorder characterized by an excess of orotic acid in the urine. The patient's symptom 'Oroticaciduria' is in common with this disease. However, 'Lethargy', 'Death in infancy', 'Drowsiness', 'Sleep abnormality', and 'Abnormal circulating ornithine concentration' are not typically associated with this disease.

+3. Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome: This is a rare metabolic disorder characterized by an excess of ornithine in the blood. Symptoms in common with the patient include 'Lethargy', 'Drowsiness', 'Sleep abnormality', and 'Abnormal circulating ornithine concentration'. 'Death in infancy' and 'Oroticaciduria' are not typically associated with this disease.

+4. Narcolepsy: This is a neurological disorder that affects the control of sleep and wakefulness. Symptoms in common with the patient include 'Lethargy', 'Drowsiness', and 'Sleep abnormality'. 'Death in infancy', 'Oroticaciduria', and 'Abnormal circulating ornithine concentration' are not typically associated with this disease.

+5. Hypersomnia: This is a neurological disorder characterized by excessive daytime sleepiness. Symptoms in common with the patient include 'Lethargy', 'Drowsiness', and 'Sleep abnormality'. 'Death in infancy', 'Oroticaciduria', and 'Abnormal circulating ornithine concentration' are not typically associated with this disease."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Acidemia Type 1: This is a genetic disorder characterized by deficiency of an enzyme that helps break down certain amino acids. Symptoms in common with the patient include Ataxia, Dystonia, Abnormal cerebral morphology, Glutaric aciduria, Death in childhood, Decreased plasma free carnitine, and Abnormal myelination.

+2. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. Symptoms in common with the patient include Ataxia, Dystonia, and Abnormal cerebral morphology. However, the patient does not show symptoms of Lactic acidosis and Progressive neurologic deterioration, which are common in Leigh Syndrome.

+3. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Symptoms in common with the patient include Ataxia, Dystonia, and Abnormal cerebral morphology. However, the patient does not show symptoms of Macrocephaly and Optic atrophy, which are common in Canavan Disease.

+4. Wilson's Disease: This is a rare inherited disorder that causes copper to accumulate in your liver, brain and other vital organs. Symptoms in common with the patient include Ataxia and Dystonia. However, the patient does not show symptoms of Kayser-Fleischer ring and Hepatolenticular degeneration, which are common in Wilson's Disease.

+5. Friedreich's Ataxia: This is a genetic disease that causes progressive damage to the nervous system. Symptoms in common with the patient include Ataxia and Abnormal cerebral morphology. However, the patient does not show symptoms of Scoliosis and Diabetes mellitus, which are common in Friedreich's Ataxia. 

+6. Metachromatic Leukodystrophy: This is a rare genetic disorder characterized by the accumulation of fats called sulfatides in cells. Symptoms in common with the patient include Ataxia, Dystonia, and Abnormal myelination. However, the patient does not show symptoms of Peripheral demyelination and Progressive motor deterioration, which are common in Metachromatic Leukodystrophy."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Phenylalanine is a building block of proteins that is obtained through the diet. It is found in all proteins and in some artificial sweeteners. If PKU is not treated, phenylalanine can build up to harmful levels in the body, causing intellectual disability and other serious health problems. The symptoms the patient has in common with this disease are 'Hyperphenylalaninemia'. The symptoms the patient does not have in common are 'Death in infancy' and 'Neonatal death'.

+2. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder in which the body cannot break down certain parts of proteins. The urine of people with this condition can smell like maple syrup. If untreated, MSUD can lead to significant physical and intellectual disabilities and death. The symptoms the patient does not have in common with this disease are 'Death in infancy', 'Neonatal death', and 'Hyperphenylalaninemia'.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. SIDS is sometimes known as crib death because the infants often die in their cribs. The symptoms the patient has in common with this disease are 'Death in infancy' and 'Neonatal death'. The symptom the patient does not have in common is 'Hyperphenylalaninemia'. 

+4. Neonatal Infections: These are infections of the neonate (newborn) acquired during prenatal development or in the first four weeks of life. Neonatal infections may be contracted by mother to child transmission, in the birth canal during childbirth, or contracted postnatally from the hospital environment. The symptoms the patient has in common with this disease are 'Death in infancy' and 'Neonatal death'. The symptom the patient does not have in common is 'Hyperphenylalaninemia'."
['Systemic primary carnitine deficiency'],"+1. Acute Intermittent Porphyria: This is a genetic disorder affecting the production of heme, a component of hemoglobin. Symptoms in common: 'Irritability', 'Coma', 'Encephalopathy', 'Vomiting', 'Abnormal circulating porphyrin concentration'. Symptoms not in common: 'Skin rash', 'Pain in the abdomen', 'Urinary problems'.

+2. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common: 'Generalized hypotonia', 'Cardiomyopathy', 'Hypoglycemia', 'Vomiting', 'Hepatomegaly', 'Death in childhood', 'Decreased plasma free carnitine'. Symptoms not in common: 'Muscle weakness', 'Respiratory failure'.

+3. Hepatic Encephalopathy: This is a decline in brain function that occurs as a result of severe liver disease. Symptoms in common: 'Irritability', 'Coma', 'Encephalopathy', 'Hepatomegaly', 'Elevated circulating hepatic transaminase concentration'. Symptoms not in common: 'Confusion', 'Slurred speech', 'Sleep disturbances'.

+4. Glycogen Storage Disease Type I: This is a genetic disorder that affects the processing of glycogen, a form of sugar that is converted into glucose for energy. Symptoms in common: 'Hypoglycemia', 'Vomiting', 'Hepatomegaly', 'Elevated circulating hepatic transaminase concentration'. Symptoms not in common: 'Growth delay', 'Osteoporosis', 'Kidney stones'.

+5. Hemolytic Anemia: This is a condition in which red blood cells are destroyed and removed from the bloodstream before their normal lifespan is over. Symptoms in common: 'Irritability', 'Anemia', 'Hypoglycemia', 'Vomiting'. Symptoms not in common: 'Jaundice', 'Dark urine', 'Rapid heart rate'.

+6. Maple Syrup Urine Disease: This is a metabolic disorder in which the body cannot break down certain parts of proteins. Symptoms in common: 'Irritability', 'Coma', 'Generalized hypotonia', 'Encephalopathy', 'Vomiting', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration'. Symptoms not in common: 'Poor feeding', 'Sweet-smelling urine', 'Seizures'."
['PMM2-CDG'],"+1. Joubert Syndrome: This is a rare genetic disorder that affects the area of the brain that controls balance and coordination. Common symptoms include 'Ataxia', 'Hyporeflexia', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', 'Growth delay', and 'Encephalopathy'. However, 'Strabismus', 'Nystagmus', 'Death in infancy', and 'Cerebellar agenesis' are not typically associated with this condition.

+2. Dandy-Walker Syndrome: This is a congenital brain malformation involving the cerebellum and the fluid filled spaces around it. Symptoms often associated with this condition include 'Ataxia', 'Hyporeflexia', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', and 'Growth delay'. However, 'Strabismus', 'Nystagmus', 'Encephalopathy', 'Death in infancy', and 'Cerebellar agenesis' are not typically associated with this condition.

+3. Pontocerebellar Hypoplasia: This is a group of related conditions that affect the development of the brain. Symptoms that match include 'Ataxia', 'Hyporeflexia', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', 'Encephalopathy', 'Growth delay', and 'Death in infancy'. However, 'Strabismus', 'Nystagmus', and 'Cerebellar agenesis' are not typically associated with this condition.

+4. Congenital Cerebellar Ataxia: This is a disorder that occurs when the cerebellum is damaged or does not develop properly. Symptoms that match include 'Ataxia', 'Hyporeflexia', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', and 'Growth delay'. However, 'Strabismus', 'Nystagmus', 'Encephalopathy', 'Death in infancy', and 'Cerebellar agenesis' are not typically associated with this condition.

+5. Cerebellar Agenesis: This is a rare condition in which a person is born without one or both parts of the cerebellum. Symptoms that match include 'Ataxia', 'Hyporeflexia', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', 'Encephalopathy', 'Growth delay', 'Death in infancy', and 'Cerebellar agenesis'. However, 'Strabismus' and 'Nystagmus' are not typically associated with this condition."
['Classic homocystinuria'],"+1. Marfan Syndrome: This is a genetic disorder that affects the body's connective tissue. Common symptoms include myopia and ectopia lentis. However, the patient does not show signs of delayed speech and language development, intellectual disability, death in infancy, hyperhomocystinemia, hypermethioninemia, aminoaciduria, death in childhood, abnormal circulating alanine concentration, or dyskinesia.

+2. Homocystinuria: This is a rare inherited disorder where the body is unable to process certain building blocks of proteins properly. Symptoms include myopia, ectopia lentis, intellectual disability, hyperhomocystinemia, and death in infancy. However, the patient does not show signs of delayed speech and language development, hypermethioninemia, aminoaciduria, death in childhood, abnormal circulating alanine concentration, or dyskinesia.

+3. Methionine Adenosyltransferase Deficiency: This is a rare metabolic disorder characterized by persistent hypermethioninemia. Symptoms include hypermethioninemia and intellectual disability. However, the patient does not show signs of myopia, delayed speech and language development, ectopia lentis, death in infancy, hyperhomocystinemia, aminoaciduria, death in childhood, abnormal circulating alanine concentration, or dyskinesia.

+4. Hyperalaninemia: This is a condition characterized by elevated levels of the amino acid alanine in the blood. Symptoms include abnormal circulating alanine concentration. However, the patient does not show signs of myopia, delayed speech and language development, ectopia lentis, intellectual disability, death in infancy, hyperhomocystinemia, hypermethioninemia, aminoaciduria, death in childhood, or dyskinesia.

+5. Dyskinesia: This is a disorder that results in involuntary movements. The patient shows signs of dyskinesia. However, the patient does not show signs of myopia, delayed speech and language development, ectopia lentis, intellectual disability, death in infancy, hyperhomocystinemia, hypermethioninemia, aminoaciduria, death in childhood, or abnormal circulating alanine concentration."
['Ornithine transcarbamylase deficiency'],"+1. Epilepsy: This condition is characterized by recurrent seizures. Symptoms in common with the patient include 'Seizure', 'Ataxia', 'Lethargy', 'Hyperreflexia', 'Drowsiness', and 'Sleep abnormality'. Symptoms not in common include 'Metabolic acidosis', 'Fever', 'Hyperammonemia', 'Diarrhea', 'Fasciculations', 'Oroticaciduria', 'Death in childhood', and 'Death in adolescence'.

+2. Urea Cycle Disorder: This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. Symptoms in common with the patient include 'Seizure', 'Ataxia', 'Lethargy', 'Hyperammonemia', 'Drowsiness', and 'Oroticaciduria'. Symptoms not in common include 'Hyperreflexia', 'Metabolic acidosis', 'Fever', 'Diarrhea', 'Sleep abnormality', 'Fasciculations', 'Death in childhood', and 'Death in adolescence'.

+3. Meningitis: This is an inflammation of the meninges caused by viral or bacterial infection. Symptoms in common with the patient include 'Seizure', 'Fever', 'Lethargy', 'Drowsiness', and 'Sleep abnormality'. Symptoms not in common include 'Ataxia', 'Hyperreflexia', 'Metabolic acidosis', 'Hyperammonemia', 'Diarrhea', 'Fasciculations', 'Oroticaciduria', 'Death in childhood', and 'Death in adolescence'.

+4. Metabolic Acidosis: This is a condition that occurs when the body produces too much acid or when the kidneys are not removing enough acid from the body. Symptoms in common with the patient include 'Metabolic acidosis', 'Lethargy', 'Drowsiness', and 'Hyperammonemia'. Symptoms not in common include 'Seizure', 'Ataxia', 'Hyperreflexia', 'Fever', 'Diarrhea', 'Sleep abnormality', 'Fasciculations', 'Oroticaciduria', 'Death in childhood', and 'Death in adolescence'.

+5. Neurodegenerative Disorders: These are hereditary and sporadic conditions characterized by progressive nervous system dysfunction. Symptoms in common with the patient include 'Seizure', 'Ataxia', 'Lethargy', 'Hyperreflexia', 'Drowsiness', 'Sleep abnormality', and 'Fasciculations'. Symptoms not in common include 'Metabolic acidosis', 'Fever', 'Hyperammonemia', 'Diarrhea', 'Oroticaciduria', 'Death in childhood', and 'Death in adolescence'."
['Smith-Lemli-Opitz syndrome'],"+1. Smith-Lemli-Opitz Syndrome: This is a genetic disorder characterized by distinctive facial features, small head size (microcephaly), intellectual disability, and multiple congenital malformations. Symptoms in common with the patient include microcephaly, intellectual disability, failure to thrive, death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, death in childhood, elevated circulating 7-dehydrocholesterol concentration, and feeding difficulties. Symptoms not in common include pointed chin, short chin, strabismus, ptosis, hyperactivity, syndactyly, ataxia, generalized hypotonia, hyperreflexia, and fatigue.

+2. Cornelia de Lange Syndrome: This is a developmental disorder that affects many parts of the body. The symptoms in common with the patient include microcephaly, intellectual disability, failure to thrive, feeding difficulties, and hyperactivity. Symptoms not in common include pointed chin, short chin, strabismus, ptosis, syndactyly, ataxia, generalized hypotonia, hyperreflexia, death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, death in childhood, elevated circulating 7-dehydrocholesterol concentration, and fatigue.

+3. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common with the patient include intellectual disability, failure to thrive, feeding difficulties, and hyperactivity. Symptoms not in common include microcephaly, pointed chin, short chin, strabismus, ptosis, syndactyly, ataxia, generalized hypotonia, hyperreflexia, death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, death in childhood, elevated circulating 7-dehydrocholesterol concentration, and fatigue.

+4. Angelman Syndrome: This is a genetic disorder that primarily affects the nervous system. Symptoms in common with the patient include intellectual disability, ataxia, generalized hypotonia, hyperactivity, and feeding difficulties. Symptoms not in common include microcephaly, pointed chin, short chin, strabismus, ptosis, syndactyly, hyperreflexia, failure to thrive, death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, death in childhood, elevated circulating 7-dehydrocholesterol concentration, and fatigue."
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"+1. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Common symptoms include generalized hypotonia, increased circulating lactate concentration, and abnormal circulating aspartate family amino acid concentration. However, symptoms such as hypertriglyceridemia, hepatomegaly, and abnormal circulating creatine kinase concentration are not typically associated with this condition.

+2. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms include hepatomegaly, neonatal death, and increased circulating lactate dehydrogenase concentration. However, symptoms such as generalized hypotonia, death in infancy, and abnormal circulating alanine concentration are not typically associated with this condition.

+3. Reye Syndrome: This is a rare but serious condition that causes swelling in the liver and brain. Reye's syndrome most often affects children and teenagers recovering from a viral infection and can lead to death. Common symptoms include hepatomegaly and increased circulating lactate dehydrogenase concentration. However, symptoms such as generalized hypotonia, hypertriglyceridemia, and abnormal circulating creatine kinase concentration are not typically associated with this condition.

+4. Glycogen Storage Disease Type I: This is a genetic disorder that affects the metabolism of glucose, leading to an accumulation of glycogen in the liver and kidneys. Symptoms include hepatomegaly, hypertriglyceridemia, and abnormal circulating aspartate family amino acid concentration. However, symptoms such as generalized hypotonia, death in infancy, and increased circulating lactate dehydrogenase concentration are not typically associated with this condition.

+5. Mitochondrial Trifunctional Protein Deficiency: This is a condition that prevents the body from converting certain fats to energy, particularly during periods without food. Symptoms include generalized hypotonia, increased circulating lactate concentration, and neonatal death. However, symptoms such as hypertriglyceridemia, hepatomegaly, and abnormal circulating creatine kinase concentration are not typically associated with this condition."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Acidemia Type 1:
This is a genetic disorder that affects the body's ability to break down certain proteins. Symptoms in common with the patient include Microcephaly, Generalized hypotonia, Death in infancy, Cerebral cortical atrophy, Athetosis, Glutaric aciduria, Neonatal death, Decreased plasma free carnitine, Death in adolescence, and Abnormal circulating acylcarnitine concentration.

+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is a rare metabolic condition that prevents the body from converting certain fats into energy. Symptoms in common with the patient include Generalized hypotonia, Death in infancy, Neonatal death, Decreased plasma free carnitine, and Abnormal circulating acylcarnitine concentration. The patient does not have Microcephaly, Cerebral cortical atrophy, Athetosis, and Glutaric aciduria which are not typically associated with this disease.

+3. Canavan Disease:
This is a rare inherited disorder that causes progressive damage to nerve cells in the brain. Symptoms in common with the patient include Microcephaly, Generalized hypotonia, Death in infancy, Cerebral cortical atrophy, and Athetosis. The patient does not have Glutaric aciduria, Neonatal death, Decreased plasma free carnitine, Death in adolescence, and Abnormal circulating acylcarnitine concentration which are not typically associated with this disease.

+4. Zellweger Syndrome:
This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include Microcephaly, Generalized hypotonia, Death in infancy, and Cerebral cortical atrophy. The patient does not have Athetosis, Glutaric aciduria, Neonatal death, Decreased plasma free carnitine, Death in adolescence, and Abnormal circulating acylcarnitine concentration which are not typically associated with this disease."
['Propionic acidemia'],"+1. Nonketotic Hyperglycinemia: This is a metabolic disorder characterized by abnormally high levels of glycine in the body. Symptoms in common with the patient include 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Vomiting', 'Death in infancy', and 'Death in childhood'. Symptoms not in common include seizures, intellectual disability, and breathing difficulties.

+2. Propionic Acidemia: This is a disorder that affects the breakdown of proteins and fats in the body. Symptoms in common with the patient include 'Hyperammonemia', 'Vomiting', 'Death in infancy', and 'Elevated urinary carboxylic acid'. Symptoms not in common include poor feeding, weak muscle tone, and developmental delay.

+3. Carnitine-Acylcarnitine Translocase Deficiency: This is a disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Hyperammonemia', 'Vomiting', 'Death in infancy', 'Abnormal circulating carnitine concentration'. Symptoms not in common include low blood sugar, liver problems, and heart failure.

+4. Glutamine Synthetase Deficiency: This is a rare genetic disorder that affects the metabolism of the amino acid glutamine. Symptoms in common with the patient include 'Hyperammonemia', 'Abnormal circulating glutamine concentration'. Symptoms not in common include seizures, intellectual disability, and developmental delay.

+5. Sjögren-Larsson Syndrome: This is a genetic disorder that affects the skin and nervous system. Symptoms in common with the patient include 'Ichthyosis', 'Death in childhood'. Symptoms not in common include spasticity, intellectual disability, and delayed development."
['Succinic semialdehyde dehydrogenase deficiency'],"+1. Down Syndrome: This is a genetic disorder that causes lifelong intellectual disability and developmental delays. It is the most common genetic chromosomal disorder and cause of learning disabilities in children. Symptoms in common include 'Intellectual disability', 'Motor delay', and 'Abnormal facial shape'. However, 'Abnormal calvaria morphology', 'Death in childhood', 'Abnormal circulating monocarboxylic acid concentration', and 'Elevated urinary carboxylic acid' are not typically associated with Down Syndrome.

+2. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common include 'Intellectual disability', 'Motor delay', 'Death in childhood', 'Abnormal circulating monocarboxylic acid concentration', and 'Elevated urinary carboxylic acid'. However, 'Abnormal facial shape' and 'Abnormal calvaria morphology' are not typically associated with Methylmalonic Acidemia.

+3. Craniosynostosis: This is a birth defect in which one or more of the fibrous joints between the bones of a baby's skull close prematurely, before the baby's brain is fully formed. Symptoms in common include 'Abnormal facial shape' and 'Abnormal calvaria morphology'. However, 'Intellectual disability', 'Motor delay', 'Death in childhood', 'Abnormal circulating monocarboxylic acid concentration', and 'Elevated urinary carboxylic acid' are not typically associated with Craniosynostosis.

+4. Propionic Acidemia: This is a disorder that affects the breakdown of certain parts of proteins and lipids. Symptoms in common include 'Intellectual disability', 'Motor delay', 'Death in childhood', 'Abnormal circulating monocarboxylic acid concentration', and 'Elevated urinary carboxylic acid'. However, 'Abnormal facial shape' and 'Abnormal calvaria morphology' are not typically associated with Propionic Acidemia. 

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common include 'Intellectual disability', 'Motor delay', and 'Death in childhood'. However, 'Abnormal facial shape', 'Abnormal calvaria morphology', 'Abnormal circulating monocarboxylic acid concentration', and 'Elevated urinary carboxylic acid' are not typically associated with Leigh Syndrome."
['Classic galactosemia'],"+1. Galactosemia: This is a disorder that affects the body's ability to process a simple sugar called galactose. Symptoms in common with the patient include 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Hepatic failure', 'Death in infancy', 'Premature birth', 'Diarrhea', 'Increased total bilirubin', 'Prolonged partial thromboplastin time', 'Neonatal death', 'Death in childhood', 'Abnormality of galactoside metabolism', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Hypergalactosemia'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Delayed speech and language development', 'Intellectual disability', 'Motor delay'. Symptoms not in common include 'Musty odor', 'Skin conditions such as eczema', 'Light pigmentation'.

+3. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder in which the body cannot break down certain parts of proteins. Symptoms in common with the patient include 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Death in infancy', 'Neonatal death', 'Death in childhood'. Symptoms not in common include 'Urine that smells like maple syrup', 'Feeding difficulties', 'Lethargy'.

+4. Wilson's Disease: This is a rare inherited disorder that causes copper to accumulate in your liver, brain and other vital organs. Symptoms in common with the patient include 'Hepatic failure', 'Increased total bilirubin', 'Prolonged partial thromboplastin time'. Symptoms not in common include 'Kayser-Fleischer rings in the eyes', 'Tremors', 'Difficulty walking or swallowing'.

+5. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Hepatic failure', 'Death in infancy', 'Increased total bilirubin', 'Prolonged partial thromboplastin time', 'Neonatal death', 'Death in childhood'. Symptoms not in common include 'Cabbage-like odor', 'Pain in the legs and abdomen', 'Kidney problems'."
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1. Citrullinemia: This is a condition that causes ammonia and other toxic substances to accumulate in the blood. Symptoms include hyperammonemia and elevated plasma citrulline, which are present in the patient. However, the patient does not show other symptoms such as poor appetite and vomiting.

+2. Argininosuccinic Aciduria: This is a rare genetic disorder characterized by a deficiency of the enzyme that helps break down certain proteins. Symptoms include hyperammonemia and elevated plasma citrulline, which are present in the patient. The patient does not show other symptoms such as intellectual disability and liver damage.

+3. Hyperprolinemia: This is a condition characterized by an excess of the amino acid proline in the blood. The patient shows an abnormal circulating proline concentration, but does not show other symptoms such as seizures and intellectual disability.

+4. Urea Cycle Disorder: This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood. The patient's symptoms of hyperammonemia and elevated plasma citrulline are consistent with this disorder. However, the patient does not show other symptoms such as confusion and fatigue.

+5. Nonketotic Hyperglycinemia: This is a rare genetic disorder characterized by an excess of the amino acid glycine in the body. The patient does not show the typical symptoms such as hiccups and lethargy, but does show symptoms of neonatal death and death in infancy.

+6. Orotic Aciduria: This is a disorder that causes an excess of orotic acid in the body. The patient's symptoms of hyperammonemia and elevated plasma citrulline are consistent with this disorder. However, the patient does not show other symptoms such as failure to thrive and developmental delay."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. Symptoms not in common include 'Liver cirrhosis', 'Renal tubular dysfunction', and 'Cabbage-like odor'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. Symptoms not in common include 'Intellectual disability', 'Delayed speech', and 'Musty body odor'.

+3. Porphyrin Metabolism Disorders: These are a group of rare disorders that affect the body's ability to change molecules called porphyrins into heme, the substance that gives blood its red color. Symptoms in common with the patient include 'Abnormal circulating porphyrin concentration'. Symptoms not in common include 'Photosensitivity', 'Red or brown urine', and 'Abdominal pain'.

+4. Iron Deficiency Anemia: This is a common type of anemia — a condition in which blood lacks adequate healthy red blood cells. Symptoms in common with the patient include 'Decreased circulating ferritin concentration'. Symptoms not in common include 'Fatigue', 'Pale skin', and 'Shortness of breath'.

+5. Organic Acidemia: These are a group of metabolic disorders which disrupt normal amino acid metabolism, particularly branched-chain amino acids, causing a buildup of acids which are usually not present. Symptoms in common with the patient include 'Elevated urinary carboxylic acid'. Symptoms not in common include 'Poor feeding', 'Vomiting', and 'Lethargy'.

+6. Severe Combined Immunodeficiency (SCID): This is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in differing clinical presentations. Symptoms in common with the patient include 'Recurrent viral infections'. Symptoms not in common include 'Chronic diarrhea', 'Thrush in the mouth and throat', and 'Failure to thrive'.

+7. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy'. Symptoms not in common include 'Sleeping on the stomach', 'Exposure to tobacco smoke', and 'Premature birth'.

+8. Juvenile Huntington's disease: This is a less common, early-onset form of Huntington's disease that begins in childhood or adolescence. Symptoms in common with the patient include 'Death in childhood' and 'Death in adolescence'. Symptoms not in common include 'Behavioral changes', 'Uncontrolled movements', and 'Loss of previously learned academic or physical skills'. 

+9. Systemic Inflammatory Response Syndrome (SIRS): This is a systemic inflammatory response to a variety of severe clinical insults. Symptoms in common with the patient include 'Fever'. Symptoms not in common include 'Tachycardia', 'Tachypnea', and 'Leukocytosis'."
['Maple syrup urine disease'],"+1. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder that affects the body's ability to process certain amino acids. Symptoms in common with the patient include lethargy, generalized hypotonia, drowsiness, neonatal death, and abnormal circulating leucine concentration. Symptoms not in common include seizures, developmental delay, and feeding difficulties in infancy.

+2. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. Symptoms in common with the patient include lethargy, generalized hypotonia, tremor, death in infancy, and drowsiness. Symptoms not in common include loss of appetite, vomiting, and seizures.

+3. Phenylketonuria (PKU): This is a rare genetic disorder that affects a person's ability to metabolize the amino acid phenylalanine. Symptoms in common with the patient include generalized hypotonia, tremor, and body odor. Symptoms not in common include intellectual disability, seizures, and fair skin and hair.

+4. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include lethargy, generalized hypotonia, and body odor. Symptoms not in common include pain in the legs, diarrhea, and failure to gain weight and grow at the expected rate.

+5. Organic Acidemia: This is a group of metabolic disorders which can lead to abnormal accumulations of organic acids in the body. Symptoms in common with the patient include lethargy, generalized hypotonia, drowsiness, sleep abnormality, and elevated urinary carboxylic acid. Symptoms not in common include vomiting, metabolic acidosis, and failure to thrive."
['Phenylketonuria'],"+1. Neonatal Hemochromatosis: This is a rare liver disease that occurs in infants and can lead to death in infancy. Symptoms in common with the patient include 'Death in infancy', 'Premature birth', 'Anemia', 'Decreased circulating ferritin concentration', 'Decreased serum iron'. Symptoms not in common include 'Liver failure', 'Jaundice', 'Coagulation defects'.

+2. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Generalized hypotonia', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death'. Symptoms not in common include 'Liver and kidney failure', 'Rickets', 'Failure to thrive'.

+3. Phenylketonuria (PKU): This is a rare genetic condition that affects how the body processes the amino acid phenylalanine. Symptoms in common with the patient include 'Generalized hypotonia', 'Hyperphenylalaninemia'. Symptoms not in common include 'Intellectual disability', 'Delayed development', 'Musty odor in breath, skin, or urine'.

+4. Diamond-Blackfan Anemia: This is a rare blood disorder that affects the bone marrow's ability to produce red blood cells. Symptoms in common with the patient include 'Anemia', 'Death in infancy', 'Premature birth'. Symptoms not in common include 'Short stature', 'Abnormalities of the head, eyes, and neck', 'Increased risk of cancer'.

+5. Vitamin D Metabolism Disorder: This is a group of disorders characterized by an inability to properly metabolize vitamin D, leading to a variety of health issues. Symptoms in common with the patient include 'Abnormality of vitamin D metabolism', 'Anemia'. Symptoms not in common include 'Bone pain', 'Muscle weakness', 'Increased susceptibility to infections'. 

+6. Iron Deficiency Anemia: This is a common type of anemia that occurs when your blood lacks enough healthy red blood cells due to too little iron in your body. Symptoms in common with the patient include 'Anemia', 'Decreased circulating ferritin concentration', 'Decreased serum iron'. Symptoms not in common include 'Fatigue', 'Pale skin', 'Shortness of breath'."
['Smith-Lemli-Opitz syndrome'],"+1. Smith-Lemli-Opitz Syndrome: This is a developmental disorder characterized by intellectual disability, small head size, and multiple birth defects. Common symptoms include Hypertelorism, Anteverted nares, Syndactyly, Intellectual disability, and Abnormal foot morphology. The patient also has Hypocholesterolemia, Elevated 8-dehydrocholesterol, and Elevated circulating 7-dehydrocholesterol concentration which are common in this disease. However, the patient does not show Severe hearing impairment which is not a common symptom of this disease.

+2. Lesch-Nyhan Syndrome: This is a condition characterized by neurological and behavioral abnormalities and the overproduction of uric acid in the body. Common symptoms include Self-mutilation, Delayed speech and language development, Hyperactivity, and Intellectual disability. The patient also has Seizure and Motor delay which are common in this disease. However, the patient does not show Hypertelorism, Anteverted nares, and Syndactyly which are not common symptoms of this disease.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The patient has Death in infancy and Neonatal death which are common in this disease. However, the patient does not show Hypertelorism, Anteverted nares, Self-mutilation, Delayed speech and language development, Hyperactivity, Syndactyly, Intellectual disability, Seizure, Motor delay, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, and Elevated circulating 7-dehydrocholesterol concentration which are not common symptoms of this disease.

+4. Childhood Cancer: This is a term used to describe cancers that occur between birth and 14 years of age. The patient has Death in childhood which is common in this disease. However, the patient does not show Hypertelorism, Anteverted nares, Self-mutilation, Delayed speech and language development, Hyperactivity, Syndactyly, Intellectual disability, Seizure, Motor delay, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, and Elevated circulating 7-dehydrocholesterol concentration which are not common symptoms of this disease.

+5. Usher Syndrome: This is a condition characterized by partial or total hearing loss and vision loss that worsens over time. The patient has Severe hearing impairment which is common in this disease. However, the patient does not show Hypertelorism, Anteverted nares, Self-mutilation, Delayed speech and language development, Hyperactivity, Syndactyly, Intellectual disability, Seizure, Motor delay, Death in infancy, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, and Elevated circulating 7-dehydrocholesterol concentration which are not common symptoms of this disease."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common with the patient include 'Microcephaly', 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Failure to thrive', 'Small for gestational age', 'Metabolic acidosis', 'Hypoglycemia', 'Dehydration', 'Hyperammonemia', 'Hyperuricemia', 'Increased circulating lactate concentration', 'Hyperglycinemia', 'Hepatomegaly', 'Methylmalonic acidemia', 'Hyperglycinuria', 'Increased blood urea nitrogen', 'Elevated circulating alkaline phosphatase concentration', 'Decreased methylmalonyl-CoA mutase activity', 'Elevated circulating creatinine concentration', 'Severe short stature', 'Feeding difficulties', 'Methylmalonic aciduria', 'Chronic kidney disease', 'Elevated urinary carboxylic acid'. Symptoms not in common include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Splenomegaly', 'Anemia', 'Acute kidney injury', 'Fever', 'Hypothermia', 'Pneumonia', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating homocysteine concentration', 'Elevated circulating C-reactive protein concentration'.

+2. Propionic Acidemia: This is a disorder that affects the breakdown of certain parts of proteins and lipids. Symptoms in common with the patient include 'Microcephaly', 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Failure to thrive', 'Small for gestational age', 'Metabolic acidosis', 'Hypoglycemia', 'Dehydration', 'Hyperammonemia', 'Increased circulating lactate concentration', 'Hepatomegaly', 'Increased blood urea nitrogen', 'Elevated circulating alkaline phosphatase concentration', 'Elevated circulating creatinine concentration', 'Severe short stature', 'Feeding difficulties', 'Chronic kidney disease'. Symptoms not in common include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Splenomegaly', 'Anemia', 'Acute kidney injury', 'Fever', 'Hypothermia', 'Pneumonia', 'Hyperuricemia', 'Hyperglycinemia', 'Methylmalonic acidemia', 'Hyperglycinuria', 'Decreased methylmalonyl-CoA mutase activity', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating homocysteine concentration', 'Elevated circulating C-reactive protein concentration', 'Methylmalonic aciduria', 'Elevated urinary carboxylic acid'. 

+3. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to break down certain amino acids. Symptoms in common with the patient include 'Microcephaly', 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Failure to thrive', 'Small for gestational age', 'Metabolic acidosis', 'Hypoglycemia', 'Dehydration', 'Hyperammonemia', 'Increased circulating lactate concentration', 'Hyperglycinemia', 'Increased blood urea nitrogen', 'Elevated circulating alkaline phosphatase concentration', 'Elevated circulating creatinine concentration', 'Severe short stature', 'Feeding difficulties'. Symptoms not in common include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Splenomegaly', 'Anemia', 'Acute kidney injury', 'Fever', 'Hypothermia', 'Pneumonia', 'Hyperuricemia', 'Hepatomegaly', 'Methylmalonic acidemia', 'Hyperglycinuria', 'Decreased methylmalonyl-CoA mutase activity', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating homocysteine concentration', 'Elevated circulating C-reactive protein concentration', 'Methylmalonic aciduria', 'Chronic kidney disease', 'Elevated urinary carboxylic acid'."
[],"+1. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Common symptoms include generalized hypotonia, lethargy, and ataxia. However, the patient does not show symptoms of abnormal circulating pyrimidine concentration and uraciluria.

+2. Orotic Aciduria: This is a disorder that causes an excess of orotic acid in the body, leading to physical and developmental delays. Symptoms include abnormal circulating pyrimidine concentration and uraciluria. However, the patient does not show symptoms of death in infancy.

+3. Narcolepsy: This is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. Symptoms include drowsiness and sleep abnormality. However, the patient does not show symptoms of ataxia, generalized hypotonia, and death in infancy.

+4. Hypotonia-Cystinuria Syndrome: This is a condition characterized by reduced muscle tone (hypotonia), failure to thrive, growth retardation, and delayed development. Symptoms include generalized hypotonia and lethargy. However, the patient does not show symptoms of ataxia, death in infancy, drowsiness, sleep abnormality, abnormal circulating pyrimidine concentration, and uraciluria.

+5. Fatal Familial Insomnia: This is a rare genetic degenerative brain disorder. It is characterized by an inability to sleep (insomnia) that may be initially mild, but progressively worsens, leading to significant physical and mental deterioration. Symptoms include drowsiness and sleep abnormality. However, the patient does not show symptoms of ataxia, generalized hypotonia, death in infancy, abnormal circulating pyrimidine concentration, and uraciluria."
['Isovaleric acidemia'],"+1. Carnitine-Acylcarnitine Translocase Deficiency:
This is a rare genetic disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Hyperammonemia', 'Neonatal death', 'Death in infancy', 'Abnormal circulating carnitine concentration'. Symptoms not in common include 'Muscle weakness', 'Hypoglycemia'.

+2. Nonketotic Hyperglycinemia:
This is a rare genetic disorder characterized by abnormally high levels of a molecule called glycine in the body. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating glycine concentration'. Symptoms not in common include 'Intellectual disability', 'Seizures'.

+3. Urea Cycle Disorder:
This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. Symptoms in common with the patient include 'Hyperammonemia', 'Death in infancy', 'Neonatal death'. Symptoms not in common include 'Failure to thrive', 'Cognitive impairment'.

+4. Citrullinemia:
This is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms in common with the patient include 'Hyperammonemia', 'Death in infancy', 'Neonatal death'. Symptoms not in common include 'Failure to thrive', 'Cognitive impairment'.

+5. Propionic Acidemia:
This is a disorder that causes harmful amounts of certain acids to build up in the body. Symptoms in common with the patient include 'Hyperammonemia', 'Death in infancy', 'Neonatal death', 'Abnormal circulating glycine concentration'. Symptoms not in common include 'Intellectual disability', 'Seizures'."
['Biotinidase deficiency'],"+1. Infantile Neuroaxonal Dystrophy: This is a rare inherited neurological disorder characterized by a progressive loss of vision and physical and mental skills. Common symptoms include seizures and generalized hypotonia. However, death in infancy and elevated urinary carboxylic acid are not typically associated with this disease.

+2. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within a couple of years, usually due to respiratory failure. Seizures and generalized hypotonia are common symptoms, but elevated urinary carboxylic acid is not a typical symptom.

+3. Glutaric Aciduria Type 1: This is a rare genetic disorder characterized by deficiencies in certain enzymes that help break down proteins. Symptoms include seizures, generalized hypotonia, and elevated urinary carboxylic acid. However, death in infancy is not a common symptom.

+4. Menkes Disease: This is a disorder that affects copper levels in the body. It is characterized by seizures, generalized hypotonia, and death in infancy. However, elevated urinary carboxylic acid is not a typical symptom.

+5. Propionic Acidemia: This is a disorder that affects the breakdown of certain parts of proteins and lipids. Symptoms include seizures, generalized hypotonia, death in infancy, and elevated urinary carboxylic acid, making it a potential match for all the given symptoms."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare metabolic condition that prevents the body from converting certain fats into energy. Common symptoms include neonatal death and decreased plasma free carnitine, both of which are present in the patient. However, the patient does not exhibit other symptoms such as hypoglycemia, liver problems, or muscle weakness.

+2. 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: This is a rare condition that prevents the body from properly breaking down certain fats to produce energy. The patient's symptom of decreased 3-hydroxyacyl-CoA dehydrogenase level is a key indicator of this disease. However, the patient does not show other common symptoms such as hypoglycemia, liver problems, or muscle weakness.

+3. Prenatal and Infantile Hypophosphatasia: This is a rare genetic disorder characterized by the abnormal development of bones and teeth. The patient's symptoms of abnormality of prenatal development or birth, death in infancy, and neonatal death are common in this disease. However, the patient does not exhibit other symptoms such as bone pain or muscle weakness.

+4. Childhood Hypophosphatasia: This is a form of Hypophosphatasia that begins in childhood. It is characterized by the abnormal development of bones and teeth. The patient's symptoms of death in childhood and delayed speech and language development are common in this disease. However, the patient does not exhibit other symptoms such as bone pain or muscle weakness.

+5. Global Developmental Delay: This is a condition that occurs during the developmental period of a child. It is characterized by significant delay in two or more developmental domains such as cognitive, social, and physical development. The patient's symptom of delayed speech and language development is common in this disease. However, the patient does not exhibit other symptoms such as intellectual disability or behavioral problems."
['Maple syrup urine disease'],"+1. Epilepsy: This is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain. Symptoms in common with the patient: Seizure. Symptoms not in common with the patient: None.

+2. Cerebral Palsy: This is a group of disorders that affect a person's ability to move and maintain balance and posture. Symptoms in common with the patient: Spastic diplegia, Motor delay, Generalized hypotonia. Symptoms not in common with the patient: None.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient: Death in infancy, Apnea. Symptoms not in common with the patient: None.

+4. Metabolic Acidosis: This is a condition that occurs when the body produces excessive quantities of acid or when the kidneys are not removing enough acid from the body. Symptoms in common with the patient: Metabolic acidosis. Symptoms not in common with the patient: None.

+5. Chronic Obstructive Pulmonary Disease (COPD): This is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. Symptoms in common with the patient: Dyspnea. Symptoms not in common with the patient: None.

+6. Tetanus: This is a serious bacterial infection that causes stiffness in the muscles and spasms. Symptoms in common with the patient: Opisthotonus. Symptoms not in common with the patient: None.

+7. Maple Syrup Urine Disease (MSUD): This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. Symptoms in common with the patient: Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Body odor. Symptoms not in common with the patient: None.

+8. Neonatal Death: This is the death of a baby within the first 28 days of life. Symptoms in common with the patient: Neonatal death. Symptoms not in common with the patient: None.

+9. Feeding Difficulties: This is a condition where infants and children have problems eating or drinking. Symptoms in common with the patient: Feeding difficulties. Symptoms not in common with the patient: None."
['Propionic acidemia'],"+1. Schizophrenia: This is a mental disorder characterized by abnormal behavior, strange speech, and a decreased ability to understand reality. Common symptoms include false beliefs, unclear or confused thinking, and hearing voices. The patient's symptom of 'Psychosis' matches with this disease, but 'Osteoporosis', 'Intellectual disability', 'Anemia', 'Hyperammonemia', 'Cerebral atrophy', 'Hyperglycinemia', 'Kyphoscoliosis', 'Increased blood urea nitrogen', 'Elevated circulating creatinine concentration', 'Hyperalaninemia', 'Severe short stature', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Severe hearing impairment', 'Elevated urinary carboxylic acid', 'Death in early adulthood', 'Body odor' do not match.

+2. Osteoporosis: This is a disease where increased bone weakness increases the risk of a broken bone. The patient's symptom of 'Osteoporosis' matches with this disease, but 'Psychosis', 'Intellectual disability', 'Anemia', 'Hyperammonemia', 'Cerebral atrophy', 'Hyperglycinemia', 'Kyphoscoliosis', 'Increased blood urea nitrogen', 'Elevated circulating creatinine concentration', 'Hyperalaninemia', 'Severe short stature', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Severe hearing impairment', 'Elevated urinary carboxylic acid', 'Death in early adulthood', 'Body odor' do not match.

+3. Anemia: This is a decrease in the total amount of red blood cells or hemoglobin in the blood, or a lowered ability of the blood to carry oxygen. The patient's symptom of 'Anemia' matches with this disease, but 'Psychosis', 'Osteoporosis', 'Intellectual disability', 'Hyperammonemia', 'Cerebral atrophy', 'Hyperglycinemia', 'Kyphoscoliosis', 'Increased blood urea nitrogen', 'Elevated circulating creatinine concentration', 'Hyperalaninemia', 'Severe short stature', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Severe hearing impairment', 'Elevated urinary carboxylic acid', 'Death in early adulthood', 'Body odor' do not match.

+4. Hyperammonemia: This is a metabolic disturbance characterized by an excess of ammonia in the blood. The patient's symptom of 'Hyperammonemia' matches with this disease, but 'Psychosis', 'Osteoporosis', 'Intellectual disability', 'Anemia', 'Cerebral atrophy', 'Hyperglycinemia', 'Kyphoscoliosis', 'Increased blood urea nitrogen', 'Elevated circulating creatinine concentration', 'Hyperalaninemia', 'Severe short stature', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Severe hearing impairment', 'Elevated urinary carboxylic acid', 'Death in early adulthood', 'Body odor' do not match. 

+5. Cerebral Atrophy: This is a common feature of many of the diseases that affect the brain. Atrophy of any tissue means a decrement in the size of the cell, which can be due to progressive loss of cytoplasmic proteins. The patient's symptom of 'Cerebral atrophy' matches with this disease, but 'Psychosis', 'Osteoporosis', 'Intellectual disability', 'Anemia', 'Hyperammonemia', 'Hyperglycinemia', 'Kyphoscoliosis', 'Increased blood urea nitrogen', 'Elevated circulating creatinine concentration', 'Hyperalaninemia', 'Severe short stature', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Severe hearing impairment', 'Elevated urinary carboxylic acid', 'Death in early adulthood', 'Body odor' do not match."
['L-2-hydroxyglutaric aciduria'],"+1. L-2-Hydroxyglutaric Aciduria:
This is a rare inherited metabolic disorder characterized by the buildup of a certain acid (L-2-hydroxyglutaric acid) in the body. Symptoms include intellectual disability, seizures, ataxia, tremor, and early death. The patient has all the symptoms in common with this disease.

+2. Cerebral Palsy:
This is a group of disorders that affect a person's ability to move and maintain balance and posture. Symptoms can include seizures, intellectual disability, and tremor. However, the patient does not have symptoms such as muscle stiffness, impaired movement, and abnormal reflexes, which are common in cerebral palsy.

+3. Epilepsy:
This is a central nervous system disorder in which brain activity becomes abnormal, causing seizures. The patient has seizures in common with this disease, but does not have symptoms such as periods of unusual behavior or feelings, and sometimes loss of awareness.

+4. Friedreich's Ataxia:
This is a genetic disease that causes progressive damage to the nervous system. It manifests in initial symptoms of poor coordination such as gait disturbance; it can also lead to scoliosis, heart disease and diabetes. The patient has ataxia and tremor in common with this disease, but does not have symptoms such as scoliosis and heart disease.

+5. Parkinson's Disease:
This is a progressive nervous system disorder that affects movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. The patient has tremor in common with this disease, but does not have symptoms such as slowed movement, rigid muscles, impaired posture and balance, loss of automatic movements, speech changes, and writing changes.

+6. Tay-Sachs Disease:
This is a rare, inherited disorder that destroys nerve cells in the brain and spinal cord. The most common form, known as infantile Tay-Sachs disease, usually results in death by age 4. The patient has seizures and early death in common with this disease, but does not have symptoms such as loss of motor skills, red spot in the back of the eye, and muscle weakness."
['Canavan disease'],"+1. Tay-Sachs Disease: This is a rare, inherited disorder that progressively destroys nerve cells in the brain and spinal cord. Symptoms in common with the patient include 'Motor delay' and 'Death in infancy'. However, 'Abnormal circulating aspartate family amino acid concentration' is not a common symptom of this disease.

+2. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Symptoms in common with the patient include 'Motor delay' and 'Death in infancy'. 'Abnormal circulating aspartate family amino acid concentration' is not typically associated with this disease.

+3. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include 'Motor delay' and 'Death in infancy'. 'Abnormal circulating aspartate family amino acid concentration' is not a common symptom of this disease.

+4. Maple Syrup Urine Disease: This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. Symptoms in common with the patient include 'Abnormal circulating aspartate family amino acid concentration'. However, 'Motor delay' and 'Death in infancy' are not typically associated with this disease.

+5. Aspartate Aminotransferase, Serum, Elevated: This is a condition where there is an abnormal increase in the levels of aspartate aminotransferase enzyme in the blood. Symptoms in common with the patient include 'Abnormal circulating aspartate family amino acid concentration'. However, 'Motor delay' and 'Death in infancy' are not typically associated with this condition."
['Citrullinemia type I'],"+1. Citrullinemia Type 1:
This is a disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms in common with the patient include 'Hyperammonemia' and 'Elevated plasma citrulline'. However, 'Death in infancy', 'Increased total bilirubin', and 'Neonatal death' are not typically associated with this disease.

+2. Crigler-Najjar syndrome:
This is a severe condition characterized by high levels of a toxic substance called bilirubin in the blood (hyperbilirubinemia). Symptoms in common with the patient include 'Increased total bilirubin'. However, 'Death in infancy', 'Hyperammonemia', 'Neonatal death', and 'Elevated plasma citrulline' are not typically associated with this disease.

+3. Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency (NICCD):
This is a liver disorder that prevents the body from properly processing certain nutrients. Symptoms in common with the patient include 'Elevated plasma citrulline' and 'Increased total bilirubin'. However, 'Death in infancy', 'Hyperammonemia', and 'Neonatal death' are not typically associated with this disease.

+4. Argininosuccinic Aciduria:
This is a disorder that causes ammonia to accumulate in the blood. Symptoms in common with the patient include 'Hyperammonemia' and 'Elevated plasma citrulline'. However, 'Death in infancy', 'Increased total bilirubin', and 'Neonatal death' are not typically associated with this disease.

+5. Neonatal Hemochromatosis:
This is a condition in which excess iron builds up in the liver, leading to liver failure and death. Symptoms in common with the patient include 'Neonatal death'. However, 'Death in infancy', 'Hyperammonemia', 'Increased total bilirubin', and 'Elevated plasma citrulline' are not typically associated with this disease."
['3-hydroxy-3-methylglutaric aciduria'],"+1. Propionic Acidemia: This is a metabolic disorder characterized by the accumulation of propionic acid in the blood. Symptoms include lethargy, vomiting, hypoglycemia, metabolic acidosis, and hyperammonemia. However, the patient does not show signs of death in infancy or childhood, recurrent viral infections, or elevated urinary carboxylic acid.

+2. Glutaric Acidemia Type II: This is a rare metabolic disorder characterized by deficiencies of multiple enzyme systems, leading to a buildup of harmful substances in the body. Symptoms include lethargy, hypoglycemia, vomiting, diarrhea, hepatomegaly, and drowsiness. However, the patient does not show signs of death in infancy or childhood, recurrent viral infections, or elevated urinary carboxylic acid.

+3. Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This is a metabolic disorder that prevents the body from converting certain fats to energy. Symptoms include lethargy, hypoglycemia, vomiting, and metabolic acidosis. However, the patient does not show signs of death in infancy or childhood, recurrent viral infections, or elevated urinary carboxylic acid.

+4. Organic Acidemia: This is a group of metabolic disorders which disrupt normal amino acid metabolism, particularly branched-chain amino acids, leading to a buildup of acids in the body. Symptoms include lethargy, vomiting, metabolic acidosis, hyperammonemia, diarrhea, hepatomegaly, and drowsiness. However, the patient does not show signs of death in infancy or childhood, recurrent viral infections, or elevated urinary carboxylic acid.

+5. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): This is a metabolic disorder that disrupts the breakdown of certain amino acids and fats. Symptoms include lethargy, hypoglycemia, vomiting, metabolic acidosis, hyperammonemia, diarrhea, hepatomegaly, and drowsiness. However, the patient does not show signs of death in infancy or childhood, recurrent viral infections, or elevated urinary carboxylic acid."
['Cystinuria'],"+1. Epilepsy: This is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain. The patient's symptom of 'Seizure' is common in this disease. However, 'Death in infancy', 'Splenomegaly', and 'Respiratory insufficiency' are not typically associated with Epilepsy.

+2. Niemann-Pick disease: This is a group of severe metabolic disorders in which sphingomyelin accumulates in lysosomes in cells. The patient's symptoms of 'Splenomegaly' and 'Respiratory insufficiency' are common in this disease. 'Seizure' is not typically associated with Niemann-Pick disease, and 'Death in infancy' can occur in severe cases.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The patient's symptom of 'Death in infancy' is common in this disease. However, 'Seizure', 'Splenomegaly', and 'Respiratory insufficiency' are not typically associated with SIDS.

+4. Gaucher's disease: This is a genetic disorder in which a certain type of fat (lipid) accumulates in cells and certain organs. The patient's symptom of 'Splenomegaly' is common in this disease. However, 'Seizure', 'Death in infancy', and 'Respiratory insufficiency' are not typically associated with Gaucher's disease.

+5. Infantile Neuroaxonal Dystrophy (INAD): This is a rare inherited neurological disorder. It affects the nerve axons (which conduct impulses to the muscles and sensory organs) in the brain and other parts of the body, leading to a progressive loss of vision and of physical and mental skills. The patient's symptoms of 'Seizure', 'Death in infancy', and 'Respiratory insufficiency' are common in this disease. However, 'Splenomegaly' is not typically associated with INAD."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Propionic Acidemia: This is a metabolic disorder characterized by the accumulation of propionic acid in the blood. Symptoms in common with the patient include intellectual disability, motor delay, generalized hypotonia, death in infancy, hyperammonemia, vomiting, hypoproteinemia, increased blood urea nitrogen, neonatal death, death in childhood, feeding difficulties, decreased serum creatinine, and methylmalonic aciduria. Symptoms not in common with the patient are recurrent viral infections, hypervalinemia, abnormal circulating isoleucine concentration, and abnormal circulating carnitine concentration.

+2. Maple Syrup Urine Disease: This is a metabolic disorder where the body is unable to process certain protein building blocks. Symptoms in common with the patient include intellectual disability, motor delay, generalized hypotonia, vomiting, feeding difficulties, and increased blood urea nitrogen. Symptoms not in common with the patient are death in infancy, hyperammonemia, hypoproteinemia, hyperthreoninemia, neonatal death, death in childhood, recurrent viral infections, hypervalinemia, abnormal circulating isoleucine concentration, abnormal circulating carnitine concentration, decreased serum creatinine, and methylmalonic aciduria.

+3. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare metabolic condition where the body is unable to use certain fats for energy. Symptoms in common with the patient include generalized hypotonia, death in infancy, hyperammonemia, vomiting, hypoproteinemia, increased blood urea nitrogen, neonatal death, death in childhood, feeding difficulties, and abnormal circulating carnitine concentration. Symptoms not in common with the patient are intellectual disability, motor delay, hyperthreoninemia, recurrent viral infections, hypervalinemia, abnormal circulating isoleucine concentration, decreased serum creatinine, and methylmalonic aciduria.

+4. Isovaleric Acidemia: This is a disorder characterized by a distinctive odor of sweaty feet due to the accumulation of a particular acid in the body. Symptoms in common with the patient include intellectual disability, motor delay, generalized hypotonia, vomiting, feeding difficulties, and increased blood urea nitrogen. Symptoms not in common with the patient are death in infancy, hyperammonemia, hypoproteinemia, hyperthreoninemia, neonatal death, death in childhood, recurrent viral infections, hypervalinemia, abnormal circulating isoleucine concentration, abnormal circulating carnitine concentration, decreased serum creatinine, and methylmalonic aciduria."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. Symptoms not in common include 'Liver and kidney disease', 'Intellectual disability', and 'Nervous system problems'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. Symptoms not in common include 'Intellectual disability', 'Delayed development', and 'Behavioral, emotional and social problems'.

+3. Multiple Carboxylase Deficiency: This is a disorder of biotin metabolism that can lead to metabolic acidosis, skin rash, and neurological abnormalities. Symptoms in common with the patient include 'Elevated urinary carboxylic acid'. Symptoms not in common include 'Skin rash', 'Hair loss', and 'Neurological abnormalities'.

+4. Severe Combined Immunodeficiency (SCID): This is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations. Symptoms in common with the patient include 'Recurrent viral infections' and 'Death in infancy'. Symptoms not in common include 'Chronic diarrhea', 'Thrush in the mouth and throat', and 'Failure to thrive'.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include 'Death in infancy' and 'Death in childhood'. Symptoms not in common include 'Progressive loss of mental and movement abilities' and 'Lactic acidosis'."
['Phenylketonuria'],"+1. Down Syndrome: This condition is characterized by intellectual disability, which matches one of the patient's symptoms. However, the patient does not exhibit other common symptoms such as distinctive facial features, heart defects, and delayed development.

+2. Phenylketonuria (PKU): This genetic disorder is characterized by an inability to break down the amino acid phenylalanine, leading to hyperphenylalaninemia, a symptom the patient has. However, the patient does not exhibit other symptoms such as eczema or a musty odor.

+3. Tyrosinemia: This is a rare genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. The patient's symptom of hypertyrosinemia matches this condition. However, the patient does not exhibit other common symptoms such as liver and kidney disturbances, and problems affecting the nervous system.

+4. Prader-Willi Syndrome: This genetic disorder is characterized by intellectual disability and obesity, which matches two of the patient's symptoms. However, the patient does not exhibit other common symptoms such as poor muscle tone, short stature, and incomplete sexual development.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The patient's symptom of death in infancy matches this condition. However, the patient does not exhibit other common symptoms as SIDS usually has no symptoms.

+6. Congenital Malformation Syndromes: These are conditions that cause a variety of developmental abnormalities at birth. The patient's symptom of abnormality of prenatal development or birth matches this condition. However, the patient does not exhibit other common symptoms such as physical deformities or organ malfunctions.

+7. Strabismus: This condition is characterized by eyes that do not properly align with each other when looking at an object. The patient's symptom of strabismus matches this condition. However, strabismus is not typically associated with other symptoms the patient has.

+8. Early Adult Death Syndrome: This is a broad term for conditions that cause death in early adulthood. The patient's symptom of death in early adulthood matches this condition. However, the specific cause of death and other symptoms would need to be identified for a more accurate diagnosis."
['Ornithine transcarbamylase deficiency'],"+1. Hemophilia:
This is a rare disorder in which your blood doesn't clot normally because it lacks sufficient blood-clotting proteins (clotting factors). Symptoms in common with the patient: 'Abnormal bleeding', 'Abnormality of the coagulation cascade'. Symptoms not in common: 'Death in infancy', 'Hyperammonemia', 'Vomiting', 'Oroticaciduria'.

+2. Orotic Aciduria:
This is a rare metabolic disorder that is characterized by an excess of orotic acid in the urine. Symptoms in common with the patient: 'Oroticaciduria', 'Vomiting'. Symptoms not in common: 'Death in infancy', 'Abnormal bleeding', 'Hyperammonemia', 'Abnormality of the coagulation cascade'.

+3. Hyperammonemia:
This is a metabolic disturbance characterized by an excess of ammonia in the blood. It is a dangerous condition that may lead to brain damage and death. Symptoms in common with the patient: 'Hyperammonemia', 'Vomiting'. Symptoms not in common: 'Death in infancy', 'Abnormal bleeding', 'Oroticaciduria', 'Abnormality of the coagulation cascade'.

+4. Von Willebrand Disease:
This is a lifelong bleeding disorder in which your blood doesn't clot well. Symptoms in common with the patient: 'Abnormal bleeding', 'Abnormality of the coagulation cascade'. Symptoms not in common: 'Death in infancy', 'Hyperammonemia', 'Vomiting', 'Oroticaciduria'.

+5. Sudden Infant Death Syndrome (SIDS):
This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient: 'Death in infancy'. Symptoms not in common: 'Abnormal bleeding', 'Hyperammonemia', 'Vomiting', 'Oroticaciduria', 'Abnormality of the coagulation cascade'."
['L-2-hydroxyglutaric aciduria'],"+1. L-2-Hydroxyglutaric Aciduria: This is a rare inherited metabolic disorder characterized by the buildup of a certain acid (L-2-hydroxyglutaric acid) in the body. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, hyperammonemia, abnormal cerebral morphology, death in childhood, abnormal myelination, and L-2-hydroxyglutaric acidemia. The patient has all these symptoms.

+2. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and abnormal cerebral morphology. The patient has these symptoms but does not have hyperammonemia, death in childhood, abnormal myelination, and L-2-hydroxyglutaric acidemia which are also associated with this disease.

+3. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms include generalized hypotonia, hyperreflexia, and abnormal cerebral morphology. The patient has these symptoms but does not have intellectual disability, hyperammonemia, death in childhood, abnormal myelination, and L-2-hydroxyglutaric acidemia which are also associated with this disease.

+4. Ornithine Transcarbamylase Deficiency: This is a genetic disorder that causes an accumulation of ammonia in the blood (hyperammonemia). Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and hyperammonemia. The patient has these symptoms but does not have abnormal cerebral morphology, death in childhood, abnormal myelination, and L-2-hydroxyglutaric acidemia which are also associated with this disease.

+5. Alexander Disease: This is a rare disorder of the nervous system. It is characterized by intellectual disability, generalized hypotonia, hyperreflexia, and abnormal cerebral morphology. The patient has these symptoms but does not have hyperammonemia, death in childhood, abnormal myelination, and L-2-hydroxyglutaric acidemia which are also associated with this disease."
['PMM2-CDG'],"+1. Alexander Disease: This is a rare genetic disorder that primarily affects the nervous system. Symptoms include intellectual disability, ataxia, and cerebellar atrophy. However, the patient does not show symptoms of death in infancy, thromboembolism, stroke-like episode, and cerebellar agenesis.

+2. Ataxia Telangiectasia: This is a rare, neurodegenerative, autosomal recessive disease causing severe disability. Symptoms include ataxia, cerebellar atrophy, and a higher risk of thromboembolism. However, the patient does not show symptoms of intellectual disability, death in infancy, stroke-like episode, and cerebellar agenesis.

+3. Cerebellar Ataxia, Areflexia, Pes Cavus, Optic Atrophy, and Sensorineural Hearing Loss (CAPOS) Syndrome: This is a neurological disorder that becomes apparent with fever-induced episodes of muscle weakness and unsteadiness. Symptoms include ataxia and cerebellar atrophy. However, the patient does not show symptoms of intellectual disability, death in infancy, thromboembolism, stroke-like episode, and cerebellar agenesis.

+4. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL): This is a genetic cerebrovascular disease that results in stroke and dementia. Symptoms include stroke-like episodes. However, the patient does not show symptoms of intellectual disability, ataxia, cerebellar atrophy, death in infancy, thromboembolism, and cerebellar agenesis.

+5. Pontocerebellar Hypoplasia: This is a group of related conditions that affect the development of the brain. Symptoms include intellectual disability, ataxia, cerebellar atrophy, and cerebellar agenesis. However, the patient does not show symptoms of death in infancy, thromboembolism, and stroke-like episode."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. Symptoms not in common with the patient include 'Liver and kidney disease', 'Nervous system crises', and 'Poor weight gain'.

+2. Phenylketonuria (PKU): This is a rare genetic condition that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. Symptoms not in common with the patient include 'Intellectual disability', 'Delayed development', and 'Behavioral, emotional, and social problems'.

+3. Neonatal Death: This refers to the death of a baby within the first 28 days of life. Symptoms in common with the patient include 'Neonatal death'. Symptoms not in common with the patient include 'Stillbirth', 'Low birth weight', and 'Birth defects'.

+4. Premature Birth Complications: Premature birth is a birth that takes place more than three weeks before the baby's estimated due date. Symptoms in common with the patient include 'Premature birth'. Symptoms not in common with the patient include 'Breathing problems', 'Heart problems', and 'Immature organs'.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy'. Symptoms not in common with the patient include 'Brain abnormalities', 'Low birth weight', and 'Respiratory infection'."
['Propionic acidemia'],"+1. Nonketotic Hyperglycinemia: This is a metabolic disorder characterized by abnormally high levels of the amino acid glycine. Symptoms in common with the patient include lethargy, seizures, intellectual disability, motor delay, and hyperglycinemia. Symptoms not in common include hiccups and apnea.

+2. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to break down certain parts of proteins. Symptoms in common with the patient include intellectual disability, seizures, lethargy, and difficulty walking. Symptoms not in common include sweet-smelling urine and earwax.

+3. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include seizures, intellectual disability, and hypertyrosinemia. Symptoms not in common include liver and kidney disease.

+4. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy. Symptoms in common with the patient include seizures, lethargy, motor delay, and abnormal circulating carnitine concentration. Symptoms not in common include muscle weakness and pain.

+5. Propionic Acidemia: This is a disorder that affects the breakdown of proteins and fats in the body. Symptoms in common with the patient include intellectual disability, seizures, lethargy, and vomiting. Symptoms not in common include poor feeding and weak muscle tone.

+6. Urea Cycle Disorder: This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. Symptoms in common with the patient include intellectual disability, seizures, lethargy, and increased blood urea nitrogen. Symptoms not in common include confusion and coma.

+7. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include seizures, lethargy, motor delay, and increased circulating lactate concentration. Symptoms not in common include muscle weakness and problems with movement."
['Wilson disease'],"+1. Diabetes Mellitus: This is a chronic disease that affects the body's ability to use sugar for energy. It is characterized by high blood sugar levels over a prolonged period. Symptoms in common with the patient: Polydipsia. Symptoms not in common with the patient: Frequent urination, unexplained weight loss, fatigue, blurred vision.

+2. Hepatitis: This is an inflammation of the liver, usually caused by a viral infection. It may also occur as a secondary result of medications, drugs, toxins, and alcohol. Symptoms in common with the patient: Elevated circulating hepatic transaminase concentration. Symptoms not in common with the patient: Jaundice, abdominal pain, loss of appetite, nausea and vomiting.

+3. Wilson's Disease: This is a rare inherited disorder that causes copper to accumulate in your liver, brain and other vital organs. Symptoms in common with the patient: Decreased circulating ceruloplasmin concentration, Decreased circulating copper concentration. Symptoms not in common with the patient: Difficulty speaking, tremors, unsteady movement, bruising easily.

+4. Juvenile Huntington's Disease: This is a rare, inherited disease that causes the progressive breakdown (degeneration) of nerve cells in the brain. Symptoms in common with the patient: Death in adolescence. Symptoms not in common with the patient: Behavioral changes, uncontrolled movements, clumsiness, balance problems. 

Please note that these are potential diseases based on the given symptoms. Further tests and examinations are needed for a definitive diagnosis."
['Ornithine transcarbamylase deficiency'],"+1. Epilepsy: This condition is characterized by recurrent seizures. Symptoms in common with the patient include 'Seizure'. However, the patient does not exhibit symptoms such as 'Memory loss', 'Mood disorders', and 'Loss of consciousness or awareness'.

+2. Hypotonia (Floppy Baby Syndrome): This is a state of low muscle tone often involving reduced muscle strength. Symptoms in common with the patient include 'Generalized hypotonia'. The patient does not exhibit symptoms such as 'Poor reflexes', 'Difficulty feeding', and 'Breathing difficulties'.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy', 'Sleep abnormality'. The patient does not exhibit symptoms such as 'Apnea (brief cessation of breathing)'.

+4. Gastroenteritis: This is an inflammation of the digestive tract, particularly the stomach, and large and small intestines. Symptoms in common with the patient include 'Vomiting'. The patient does not exhibit symptoms such as 'Diarrhea', 'Abdominal pain', and 'Fever'.

+5. Narcolepsy: This is a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep. Symptoms in common with the patient include 'Drowsiness', 'Sleep abnormality'. The patient does not exhibit symptoms such as 'Sudden loss of muscle tone', 'Hallucinations', and 'Sleep paralysis'.

+6. Hyperammonemia: This is a metabolic disturbance characterized by an excess of ammonia in the blood. Symptoms in common with the patient include 'Hyperglutaminemia'. The patient does not exhibit symptoms such as 'Confusion', 'Coma', and 'Brain damage'.

+7. Orotic Aciduria: This is a rare metabolic disorder characterized by a deficiency of certain enzymes in the pathway of pyrimidine synthesis. Symptoms in common with the patient include 'Oroticaciduria'. The patient does not exhibit symptoms such as 'Failure to thrive', 'Developmental delay', and 'Megaloblastic anemia'.

+8. Neonatal Death: This refers to the death of a baby within the first 28 days of life. Symptoms in common with the patient include 'Neonatal death'. The patient does not exhibit symptoms as this is a condition rather than a disease with specific symptoms."
['Classic galactosemia'],"+1. Down Syndrome: This is a genetic disorder that causes lifelong intellectual disability, developmental delays, and other problems. Symptoms in common include 'Microcephaly', 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia'. Symptoms not in common include 'Abnormality of galactoside metabolism', 'Hypergalactosemia'.

+2. Galactosemia: This is a disorder that affects how the body processes a simple sugar called galactose. Symptoms in common include 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Feeding difficulties', 'Abnormality of galactoside metabolism', 'Hypergalactosemia'. Symptoms not in common include 'Obesity', 'Elevated circulating alkaline phosphatase concentration'.

+3. Iron Deficiency Anemia: This is a common type of anemia that occurs if you don't have enough iron in your body. Symptoms in common include 'Anemia', 'Decreased circulating ferritin concentration', 'Decreased serum iron'. Symptoms not in common include 'Death in infancy', 'Neonatal death', 'Death in childhood'.

+4. Hypophosphatasia: This is a rare genetic disorder characterized by the abnormal development of bones and teeth. Symptoms in common include 'Elevated circulating alkaline phosphatase concentration'. Symptoms not in common include 'Obesity', 'Death in infancy', 'Neonatal death', 'Death in childhood'.

+5. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common include 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Obesity'. Symptoms not in common include 'Abnormal circulating porphyrin concentration', 'Decreased circulating ferritin concentration', 'Decreased serum iron'.

+6. Porphyrin Metabolism Disorder: This is a group of rare disorders that affect the body's ability to change molecules called porphyrins into heme. Symptoms in common include 'Abnormal circulating porphyrin concentration'. Symptoms not in common include 'Death in infancy', 'Neonatal death', 'Death in childhood'."
['Biotinidase deficiency'],"+1. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone, feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. Common symptoms include obesity, intellectual disability, and short stature. However, this condition does not typically involve abnormal foot morphology, hyperammonemia, or death in childhood.

+2. Alkaptonuria: This is a rare genetic disorder that causes homogentisic acid to build up in your body. The most noticeable sign of alkaptonuria is that urine turns black when exposed to air. Other symptoms can include arthritis, particularly in the spine and large joints, and heart problems. However, this condition does not typically involve obesity, abnormal foot morphology, hyperammonemia, or death in childhood.

+3. Ornithine Transcarbamylase Deficiency: This is an inherited disorder that causes ammonia to accumulate in the blood. Ammonia, which is formed when proteins are broken down in the body, is toxic if the levels become too high. The nervous system is especially sensitive to the effects of excess ammonia. Common symptoms include hyperammonemia, lethargy, poor appetite, seizures, and coma. However, this condition does not typically involve obesity, abnormal foot morphology, or death in childhood.

+4. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Common symptoms include loss of appetite, vomiting, seizures, and muscle weakness. However, this condition does not typically involve obesity, abnormal foot morphology, or hyperammonemia.

+5. Charcot-Marie-Tooth Disease: This is a group of hereditary disorders that damage the nerves in your arms and legs (peripheral nerves). Charcot-Marie-Tooth is also known as hereditary motor and sensory neuropathy. Common symptoms include foot deformities such as high arches and hammertoes, difficulty lifting your foot (foot drop), and a loss of muscle tissue in the lower legs. However, this condition does not typically involve obesity, hyperammonemia, or death in childhood."
['Canavan disease'],"+1. Attention Deficit Hyperactivity Disorder (ADHD): This is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. Symptoms in common: 'Hyperactivity'. Symptoms not in common: 'Death in infancy', 'Abnormal circulating aspartate family amino acid concentration', 'Feeding difficulties', 'Abnormal myelination'.

+2. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells (neurons) in the brain to send and receive messages. Symptoms in common: 'Abnormal myelination'. Symptoms not in common: 'Hyperactivity', 'Death in infancy', 'Abnormal circulating aspartate family amino acid concentration', 'Feeding difficulties'.

+3. Maple Syrup Urine Disease (MSUD): This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. Symptoms in common: 'Abnormal circulating aspartate family amino acid concentration', 'Feeding difficulties'. Symptoms not in common: 'Hyperactivity', 'Death in infancy', 'Abnormal myelination'.

+4. Tay-Sachs Disease: This is a rare, inherited disorder that destroys nerve cells in the brain and spinal cord. Symptoms in common: 'Death in infancy', 'Abnormal myelination'. Symptoms not in common: 'Hyperactivity', 'Abnormal circulating aspartate family amino acid concentration', 'Feeding difficulties'.

+5. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common: 'Feeding difficulties'. Symptoms not in common: 'Hyperactivity', 'Death in infancy', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal myelination'."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Hyperphenylalaninemia'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this condition.

+2. Maternal Phenylketonuria: This is a condition in pregnant women with phenylketonuria (PKU) that can harm the development of the baby if not properly managed. Symptoms in common with the patient include 'Hyperphenylalaninemia' and 'Abnormality of prenatal development or birth'. 'Death in infancy' and 'Neonatal death' are not typically associated with this condition but can occur in severe cases.

+3. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder leading to the inability to break down certain amino acids. The condition is named for the sweet maple syrup smell of the urine. None of the patient's symptoms are typically associated with this condition.

+4. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hyperphenylalaninemia'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this condition.

+5. Trisomy 18 (Edwards Syndrome): This is a genetic disorder caused by the presence of all or part of an extra 18th chromosome. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. 'Hyperphenylalaninemia' is not typically associated with this condition. 

+6. Trisomy 13 (Patau Syndrome): This is a severe genetic disorder associated with the presence of an extra chromosome 13. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. 'Hyperphenylalaninemia' is not typically associated with this condition."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Hyperphenylalaninemia'. However, 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', and 'Death in early adulthood' are not typically associated with this condition.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Hypertyrosinemia'. However, 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Hyperphenylalaninemia', and 'Death in early adulthood' are not typically associated with this condition.

+3. Neonatal Death Syndrome: This is a term used to describe the death of a baby within the first 28 days of life. Symptoms in common with the patient include 'Neonatal death'. However, 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Death in childhood', 'Hyperphenylalaninemia', and 'Death in early adulthood' are not typically associated with this condition.

+4. Childhood Death Syndrome: This is a term used to describe the death of a child within the first 18 years of life. Symptoms in common with the patient include 'Death in childhood'. However, 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Hyperphenylalaninemia', and 'Death in early adulthood' are not typically associated with this condition.

+5. Early Adult Death Syndrome: This is a term used to describe the death of an adult within the first 40 years of life. Symptoms in common with the patient include 'Death in early adulthood'. However, 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', and 'Hyperphenylalaninemia' are not typically associated with this condition."
[],"+1. Alport Syndrome: This is a genetic disorder affecting the kidneys, ears, and eyes. Common symptoms include Nephritis, which the patient has. However, the patient does not have symptoms related to hearing loss or eye abnormalities, which are also common in this disease.

+2. Barth Syndrome: This is a rare genetic disorder primarily affecting males. It is characterized by cardiomyopathy, neutropenia, muscle weakness, and growth delay. The patient has Cardiomyopathy, which is a common symptom of this disease. However, the patient does not have neutropenia, muscle weakness, or growth delay, which are also common symptoms of this disease.

+3. Congenital Heart Disease: This is a general term for a range of birth defects that affect the normal workings of the heart. The patient has Ventricular septal defect and Pulmonic stenosis, which are common symptoms of this disease. However, the patient does not have symptoms like cyanosis or shortness of breath, which are also common in this disease.

+4. Pompe Disease: This is a rare genetic disorder characterized by muscle weakness and breathing difficulties. The patient has Generalized hypotonia, which is a common symptom of this disease. However, the patient does not have symptoms like muscle pain or difficulty breathing, which are also common in this disease.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. The patient has Death in infancy, which is a common symptom of this disease. However, the patient does not have symptoms like psychomotor regression or respiratory failure, which are also common in this disease."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Irritability', 'Hypertyrosinemia', 'Neonatal death', 'Death in infancy', and 'Death in childhood'. Symptoms not in common include 'Liver and kidney disease', 'Rickets', and 'Failure to thrive'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Irritability' and 'Hyperphenylalaninemia'. Symptoms not in common include 'Intellectual disability', 'Delayed development', and 'Fair skin and blue eyes'.

+3. Spastic Paraplegia: This is a group of hereditary diseases characterized by progressive stiffness and contraction (spasticity) and weakness of the legs. Symptoms in common with the patient include 'Spasticity' and 'Hyperreflexia'. Symptoms not in common include 'Difficulty walking', 'Muscle weakness', and 'Urinary bladder disturbances'.

+4. Severe Combined Immunodeficiency (SCID): This is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in differing clinical presentations. Symptoms in common with the patient include 'Recurrent viral infections', 'Neonatal death', 'Death in infancy', and 'Death in childhood'. Symptoms not in common include 'Chronic diarrhea', 'Thrush in the mouth and throat', and 'Failure to thrive'.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include 'Irritability', 'Death in infancy', and 'Death in childhood'. Symptoms not in common include 'Loss of appetite', 'Vomiting', and 'Seizures'."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine Deficiency, Systemic Primary:
This is a metabolic disorder that prevents the body from using certain fats for energy. Symptoms in common with the patient include 'Abnormal circulating carnitine concentration'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this disease.

+2. Carnitine Palmitoyltransferase II Deficiency:
This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include 'Neonatal death' and 'Abnormal circulating carnitine concentration'. 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this disease.

+3. Carnitine-Acylcarnitine Translocase Deficiency:
This is a rare metabolic condition that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Neonatal death' and 'Abnormal circulating carnitine concentration'. 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this disease.

+4. Medium-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Neonatal death' and 'Abnormal circulating carnitine concentration'. 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this disease.

+5. Zellweger Syndrome:
This is a rare, congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. However, 'Abnormal circulating carnitine concentration' is not typically associated with this disease."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Generalized hypotonia', 'Hyperphenylalaninemia', and 'Hypertyrosinemia'. Symptoms not in common include 'Musty body odor', 'Intellectual disability', and 'Seizures'.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Generalized hypotonia', 'Hypertyrosinemia', 'Neonatal death', and 'Death in infancy'. Symptoms not in common include 'Liver and kidney disease', 'Rickets', and 'Eye abnormalities'.

+3. Prenatal and Infantile Hypophosphatasia: This is a rare genetic metabolic disorder characterized by the abnormal development of bones and teeth. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Generalized hypotonia', 'Neonatal death', and 'Death in infancy'. Symptoms not in common include 'Short stature', 'Bone pain', and 'Respiratory failure'.

+4. Childhood Disintegrative Disorder: This is a condition in which children develop normally and then, usually between the ages of 2 and 10, lose many of the skills they had developed. Symptoms in common with the patient include 'Delayed speech and language development', 'Generalized hypotonia', and 'Death in childhood'. Symptoms not in common include 'Loss of social skills', 'Loss of bowel and bladder control', and 'Loss of motor skills'.

+5. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Neonatal death' and 'Death in infancy'. Symptoms not in common include 'Apnea', 'Change in sleeping position', and 'Low birth weight'."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Acidemia Type 1: This is a genetic disorder that affects the body's ability to process certain proteins. Symptoms in common include 'Seizure', 'Encephalopathy', 'Death in infancy', 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Death in childhood', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'. 

+2. Carnitine Deficiency: This is a condition that prevents the body from using fats for energy, particularly during periods without food. Symptoms in common include 'Seizure', 'Encephalopathy', 'Death in infancy', 'Death in childhood', 'Decreased plasma free carnitine'. Symptoms not in common include 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Elevated urinary carboxylic acid'.

+3. Organic Acidemia: This is a group of disorders in which the body is unable to properly break down proteins and carbohydrates. Symptoms in common include 'Seizure', 'Encephalopathy', 'Death in infancy', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Death in childhood', 'Elevated urinary carboxylic acid'. Symptoms not in common include 'Opisthotonus', 'Decreased plasma free carnitine'.

+4. Epilepsy: This is a central nervous system disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness. Symptoms in common include 'Seizure', 'Encephalopathy'. Symptoms not in common include 'Death in infancy', 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Death in childhood', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'. 

+5. Metabolic Encephalopathy: This is a potentially reversible metabolic condition that can cause cognitive impairment and changes in consciousness. Symptoms in common include 'Seizure', 'Encephalopathy', 'Death in infancy', 'Death in childhood'. Symptoms not in common include 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'."
[],"+1. Cerebral Palsy: This condition is characterized by impaired muscle coordination (spastic diplegia and spastic tetraplegia) and/or intellectual disability. The patient has these symptoms. However, the patient does not have other common symptoms such as difficulty with speech and swallowing.

+2. Menkes Disease: This is a disorder that affects copper levels in the body, leading to copper deficiency. Symptoms include fair hair and white hair, which the patient has. However, the patient does not have other common symptoms such as kinky hair and failure to thrive.

+3. Hyperkalemic Periodic Paralysis: This is a condition that causes episodes of muscle weakness or paralysis. The patient has hyperkalemia, a common symptom. However, the patient does not have other common symptoms such as muscle stiffness and difficulty with movement.

+4. Congenital Hypotonia: This is a state of low muscle tone often involving reduced muscle strength. The patient has generalized hypotonia, a common symptom. However, the patient does not have other common symptoms such as poor reflexes and difficulty feeding.

+5. Infantile Neuroaxonal Dystrophy: This is a rare neurodegenerative disorder characterized by the accumulation of iron in the brain. Symptoms include strabismus and nystagmus, which the patient has. However, the patient does not have other common symptoms such as vision loss and progressive cognitive decline.

+6. Pneumonia: This is an infection that inflames the air sacs in one or both lungs. The patient has pneumonia, a common symptom. However, the patient does not have other common symptoms such as chest pain and fatigue.

+7. Metabolic Acidosis: This is a condition that occurs when the body produces too much acid or when the kidneys are not removing enough acid from the body. The patient has metabolic acidosis, a common symptom. However, the patient does not have other common symptoms such as confusion and rapid breathing.

+8. Attention Deficit Hyperactivity Disorder (ADHD): This is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity. The patient has hyperactivity, a common symptom. However, the patient does not have other common symptoms such as impulsivity and inattention. 

+9. Epilepsy: This is a central nervous system (neurological) disorder in which brain activity becomes abnormal, causing seizures. The patient has seizures, a common symptom. However, the patient does not have other common symptoms such as temporary confusion and loss of consciousness or awareness. 

+10. Cyanotic Heart Disease: This is a heart defect that results in low oxygen levels in the blood. The patient has cyanosis, a common symptom. However, the patient does not have other common symptoms such as shortness of breath and fatigue."
['PMM2-CDG'],"+1. Down Syndrome: This is a genetic disorder that results in intellectual disability and developmental delays. Symptoms in common with the patient include intellectual disability and motor delay. However, the patient does not exhibit other common symptoms such as distinctive facial features, short stature, and heart defects.

+2. Cerebellar Ataxia: This is a failure of muscle control in the arms and legs that results in movement disorders. Symptoms in common with the patient include ataxia, cerebellar atrophy, and generalized hypotonia. However, the patient does not exhibit other common symptoms such as difficulty with coordination and balance, and speech difficulties.

+3. Alagille Syndrome: This is a genetic disorder that can affect the liver, heart, and other parts of the body. Symptoms in common with the patient include strabismus, intellectual disability, ataxia, motor delay, cirrhosis, hepatic fibrosis, and death in infancy. However, the patient does not exhibit other common symptoms such as distinctive facial features, heart problems, and kidney problems.

+4. Antithrombin III Deficiency: This is a disorder of blood clotting. Symptoms in common with the patient include thromboembolism and reduced antithrombin III activity. However, the patient does not exhibit other common symptoms such as deep vein thrombosis and pulmonary embolism.

+5. Berardinelli-Seip Congenital Lipodystrophy: This is a rare genetic disorder characterized by the near total loss of body fat. Symptoms in common with the patient include lipodystrophy. However, the patient does not exhibit other common symptoms such as insulin resistance, acanthosis nigricans, and hypertriglyceridemia.

+6. Cerebellar Agenesis: This is a rare condition in which a person is born without one or both parts of the cerebellum. Symptoms in common with the patient include cerebellar agenesis. However, the patient does not exhibit other common symptoms such as difficulty with movement and coordination, and abnormal eye movements."
['Canavan disease'],"+1. Epilepsy: This neurological disorder is characterized by recurrent seizures. Symptoms in common with the patient include 'Seizure', 'Irritability', and 'Hyperreflexia'. Symptoms not in common include 'Death in infancy', 'Opisthotonus', 'Abnormal circulating aspartate family amino acid concentration', and 'Feeding difficulties'.

+2. Infantile Neuroaxonal Dystrophy: This is a rare inherited neurological disorder. Symptoms in common with the patient include 'Seizure', 'Generalized hypotonia', 'Hyperreflexia', 'Death in infancy', and 'Feeding difficulties'. Symptoms not in common include 'Opisthotonus' and 'Abnormal circulating aspartate family amino acid concentration'.

+3. Phenylketonuria: This is a rare genetic disorder that affects a person's ability to metabolize the amino acid phenylalanine. Symptoms in common with the patient include 'Irritability', 'Seizure', 'Hyperreflexia', and 'Feeding difficulties'. Symptoms not in common include 'Death in infancy', 'Opisthotonus', and 'Abnormal circulating aspartate family amino acid concentration'.

+4. Maple Syrup Urine Disease: This is a metabolic disorder in which the body cannot break down certain parts of proteins. Symptoms in common with the patient include 'Irritability', 'Seizure', 'Generalized hypotonia', 'Hyperreflexia', 'Feeding difficulties', and 'Abnormal circulating aspartate family amino acid concentration'. Symptoms not in common include 'Death in infancy' and 'Opisthotonus'.

+5. Menkes Disease: This is a disorder that affects copper levels in the body. Symptoms in common with the patient include 'Irritability', 'Seizure', 'Generalized hypotonia', 'Hyperreflexia', and 'Feeding difficulties'. Symptoms not in common include 'Death in infancy', 'Opisthotonus', and 'Abnormal circulating aspartate family amino acid concentration'."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Neonatal death', 'Abnormality of prenatal development or birth', and 'Death in infancy'. The patient does not have 'Gastrointestinal inflammation' and 'Hyperphenylalaninemia' which are not typically associated with this disease.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Abnormality of prenatal development or birth', and 'Death in infancy'. The patient does not have 'Hypertyrosinemia', 'Neonatal death', and 'Gastrointestinal inflammation' which are not typically associated with PKU.

+3. Inflammatory Bowel Disease (IBD): This is a term for two conditions (Crohn's disease and ulcerative colitis) that are characterized by chronic inflammation of the gastrointestinal (GI) tract. Symptoms in common with the patient include 'Gastrointestinal inflammation'. The patient does not have 'Hypertyrosinemia', 'Neonatal death', 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Hyperphenylalaninemia' which are not typically associated with IBD.

+4. Neonatal Infection: This refers to an infection that a baby gets while still in the womb or during or shortly after birth. Symptoms in common with the patient include 'Neonatal death', 'Abnormality of prenatal development or birth', and 'Death in infancy'. The patient does not have 'Hypertyrosinemia', 'Gastrointestinal inflammation', and 'Hyperphenylalaninemia' which are not typically associated with neonatal infections."
['Maple syrup urine disease'],"+1. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Common symptoms include ataxia, metabolic acidosis, and cerebral edema. However, this patient does not show signs of psychomotor regression or respiratory failure.

+2. Maple Syrup Urine Disease: This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. Symptoms include coma, metabolic acidosis, and abnormal cerebral white matter morphology. However, the patient does not have the characteristic sweet-smelling urine or poor feeding.

+3. Biotinidase Deficiency: This is an inherited disorder in which the body is unable to reuse much of the vitamin biotin, leading to its deficiency. Symptoms include ataxia, alopecia, and reduced tendon reflexes. However, the patient does not show signs of skin rash or hearing loss.

+4. Alexander Disease: This is a rare disorder of the nervous system characterized by the destruction of white matter in the brain and abnormal protein deposits known as Rosenthal fibers. Symptoms include ataxia, cerebral edema, and abnormal cerebral white matter morphology. However, the patient does not show signs of seizures or developmental delay.

+5. Hyper IgM Syndrome: This is an immunodeficiency disorder characterized by a decreased ability to fight infections. Symptoms include recurrent viral infections and death in childhood. However, the patient does not show signs of pneumonia or diarrhea.

+6. Hyperleucinemia: This is a rare metabolic disorder characterized by elevated levels of the amino acid leucine in the blood. Symptoms include hyperleucinemia and death in adolescence. However, the patient does not show signs of muscle weakness or fatigue."
['Acute intermittent porphyria'],"+1. Acute Appendicitis: This condition is characterized by severe abdominal pain, often on the right side. The patient's symptom of abdominal pain aligns with this diagnosis. However, elevated urinary delta-aminolevulinic acid and death in childhood are not typical symptoms of acute appendicitis.

+2. Porphyria: This is a group of rare genetic disorders that affect the nervous system. Symptoms can include abdominal pain and elevated urinary delta-aminolevulinic acid, which aligns with the patient's symptoms. However, death in childhood is not a common symptom of porphyria.

+3. Lead Poisoning: This condition occurs from exposure to high levels of lead, often over months or years. Symptoms can include abdominal pain and elevated urinary delta-aminolevulinic acid, which are present in the patient. However, death in childhood is not a typical symptom, although it can occur in severe cases.

+4. Acute Intermittent Porphyria: This is a type of porphyria that can cause severe abdominal pain and elevated levels of delta-aminolevulinic acid in the urine. These symptoms align with the patient's. However, death in childhood is not a common symptom of this disease.

+5. Adrenoleukodystrophy: This is a rare genetic disorder that affects the adrenal glands, spinal cord, and nervous system. It can lead to death in childhood, which aligns with one of the patient's symptoms. However, abdominal pain and elevated urinary delta-aminolevulinic acid are not typical symptoms of this disease. 

+6. Tay-Sachs Disease: This is a rare and fatal genetic disorder that results in progressive destruction of the nervous system. It often leads to death in childhood, which aligns with one of the patient's symptoms. However, abdominal pain and elevated urinary delta-aminolevulinic acid are not typical symptoms of Tay-Sachs disease."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Common symptoms include seizures, metabolic acidosis, and methylmalonic aciduria. However, death in infancy and neonatal death are severe outcomes rather than symptoms. 

+2. Propionic Acidemia: This is a disorder that affects the breakdown of certain parts of proteins and lipids. Symptoms include seizures, metabolic acidosis, and death in infancy. However, the patient does not show propionic aciduria, which is a common symptom of this disease.

+3. Isovaleric Acidemia: This is a disorder characterized by a distinctive odor of sweaty feet during acute illness due to the inability to break down an amino acid leucine. The common symptoms include seizures and metabolic acidosis. However, the patient does not show signs of a distinctive odor, neonatal death, or isovaleric aciduria.

+4. Multiple Carboxylase Deficiency: This is a disorder of biotin metabolism, with both early and late-onset forms. Symptoms include seizures, metabolic acidosis, and death in infancy. However, the patient does not show signs of skin rash or alopecia, which are common symptoms of this disease.

+5. Glutaric Acidemia Type II: This is a disorder characterized by the body's inability to break down certain fats and proteins properly. Symptoms include neonatal death and metabolic acidosis. However, the patient does not show signs of hypoglycemia or hepatomegaly, which are common symptoms of this disease."
['Alkaptonuria'],"+1. Epilepsy: This condition is characterized by recurrent seizures. Symptoms in common with the patient include 'Seizure'. Symptoms not in common include 'Memory loss', 'Mood swings', and 'Loss of consciousness'.

+2. Hypotonic cerebral palsy: This is a form of cerebral palsy characterized by decreased muscle tone. Symptoms in common with the patient include 'Generalized hypotonia', 'Growth delay', and 'Seizure'. Symptoms not in common include 'Difficulty walking' and 'Speech difficulties'.

+3. Narcolepsy: This is a neurological disorder that affects the control of sleep and wakefulness. Symptoms in common with the patient include 'Drowsiness', 'Sleep abnormality', and 'Lethargy'. Symptoms not in common include 'Sudden loss of muscle tone' and 'Hallucinations'.

+4. Alkaptonuria: This is a rare inherited genetic disorder in which the body cannot process the amino acids phenylalanine and tyrosine. Symptoms in common with the patient include 'Dark urine'. Symptoms not in common include 'Arthritis', 'Heart disease', and 'Kidney stones'.

+5. Leigh syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include 'Seizure', 'Lethargy', 'Generalized hypotonia', 'Growth delay', and 'Death in childhood'. Symptoms not in common include 'Difficulty swallowing' and 'Respiratory failure'.

+6. Hypothyroidism: This is a condition in which the thyroid gland does not produce enough thyroid hormone. Symptoms in common with the patient include 'Lethargy', 'Growth delay', and 'Generalized hypotonia'. Symptoms not in common include 'Weight gain', 'Cold intolerance', and 'Constipation'."
['Maple syrup urine disease'],"+1. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder that affects the body's ability to process certain amino acids. Symptoms in common with the patient include 'Aminoaciduria', 'Abnormal circulating leucine concentration', 'Abnormal circulating isoleucine concentration', and 'Abnormal circulating valine concentration'. Symptoms not in common with the patient are 'Odor of maple syrup from body fluids', 'Poor feeding', and 'Lethargy'.

+2. Pyridoxine-Dependent Epilepsy (PDE): This is a condition that involves seizures beginning in infancy or, in some cases, before birth. Symptoms in common with the patient include 'Seizure' and 'Death in infancy'. Symptoms not in common with the patient are 'Intellectual disability', 'Developmental delay', and 'Failure to thrive'.

+3. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include 'Seizure', 'Death in infancy', and 'Neonatal death'. Symptoms not in common with the patient are 'Lactic acidosis', 'Ataxia', and 'Hypotonia'.

+4. Nonketotic Hyperglycinemia (NKH): This is a metabolic disorder characterized by abnormally high levels of a molecule called glycine. Symptoms in common with the patient include 'Seizure', 'Death in infancy', and 'Neonatal death'. Symptoms not in common with the patient are 'Hypotonia', 'Breathing difficulties', and 'Intellectual disability'.

+5. Menkes Disease: This is a disorder that affects copper levels in the body. Symptoms in common with the patient include 'Seizure' and 'Death in infancy'. Symptoms not in common with the patient are 'Kinky hair', 'Failure to thrive', and 'Developmental delay'."
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1. Glycogen Storage Disease Type IV: This is a rare genetic disorder that affects the body's ability to break down glycogen. Symptoms in common with the patient include hepatomegaly and cardiomegaly. However, the patient does not exhibit other symptoms such as muscle weakness, developmental delay, and failure to thrive.

+2. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy. Symptoms in common with the patient include hypoglycemia, cardiomegaly, hepatomegaly, and abnormal circulating carnitine concentration. However, the patient does not exhibit other symptoms such as muscle weakness and seizures.

+3. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include hypoglycemia, increased circulating lactate concentration, and tachypnea. However, the patient does not exhibit other symptoms such as developmental delay, seizures, and muscle weakness.

+4. Medium-Chain Acyl-CoA Dehydrogenase Deficiency: This is a disorder that prevents the body from converting certain fats to energy. Symptoms in common with the patient include hypoglycemia, hepatomegaly, and dicarboxylic aciduria. However, the patient does not exhibit other symptoms such as vomiting, lethargy, and poor appetite.

+5. Severe Combined Immunodeficiency: This is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells. Symptoms in common with the patient include recurrent viral infections and neonatal death. However, the patient does not exhibit other symptoms such as chronic diarrhea, thrush, and skin rash.

+6. Barth Syndrome: This is a genetic disorder characterized by cardiomyopathy, neutropenia, and 3-methylglutaconic aciduria. Symptoms in common with the patient include cardiomegaly, increased circulating lactate concentration, and neonatal death. However, the patient does not exhibit other symptoms such as muscle weakness and growth delay."
['3-hydroxy-3-methylglutaric aciduria'],"+1. Glutaric Acidemia Type I: This is a genetic disorder that affects the body's ability to break down certain proteins. Symptoms include seizures, lethargy, vomiting, drowsiness, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, and 3-Methylglutaric aciduria. The patient has all these symptoms. However, this disease does not typically cause fever, hypoglycemia, metabolic acidosis, death in infancy or childhood, recurrent viral infections, abnormal circulating glycine concentration, or elevated urinary carboxylic acid, which the patient has.

+2. Glycine Encephalopathy: This is a genetic disorder characterized by abnormally high levels of glycine, a protein building block. Symptoms include seizures, lethargy, drowsiness, and abnormal circulating glycine concentration. The patient has these symptoms. However, this disease does not typically cause fever, vomiting, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, 3-Methylglutaric aciduria, death in infancy or childhood, recurrent viral infections, or elevated urinary carboxylic acid, which the patient has.

+3. Organic Acidemia: This is a group of metabolic disorders which disrupt normal amino acid metabolism, particularly branched-chain amino acids, leading to a buildup of acids in the body. Symptoms include metabolic acidosis, vomiting, lethargy, hypoglycemia, and elevated urinary carboxylic acid. The patient has these symptoms. However, this disease does not typically cause seizures, drowsiness, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, 3-Methylglutaric aciduria, death in infancy or childhood, or recurrent viral infections, which the patient has.

+4. Severe Combined Immunodeficiency (SCID): This is a genetic disorder that results in a weak immune system that is unable to effectively fight off infections. Symptoms include recurrent viral infections and death in infancy or childhood. The patient has these symptoms. However, this disease does not typically cause seizures, lethargy, metabolic acidosis, hypoglycemia, fever, vomiting, drowsiness, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, 3-Methylglutaric aciduria, abnormal circulating glycine concentration, or elevated urinary carboxylic acid, which the patient has."
['MODY'],"+1. Diabetes Mellitus: This is a chronic disease that affects the body's ability to use sugar for energy. It is characterized by high blood sugar levels. Symptoms in common with the patient include Hypoglycemia and Glycosuria. The patient does not have the symptom of Abnormal circulating porphyrin concentration.

+2. Hypoglycemia: This is a condition characterized by an abnormally low level of sugar (glucose) in the blood. The patient has this symptom.

+3. Porphyria: This is a group of rare genetic disorders that result from a buildup of natural chemicals that produce porphyrin in your body. The patient has the symptom of Abnormal circulating porphyrin concentration, but does not have Hypoglycemia and Glycosuria.

+4. Renal Glycosuria: This is a rare condition in which the simple sugar glucose is excreted in the urine despite normal or low levels of glucose in the blood. The patient has the symptom of Glycosuria, but does not have Hypoglycemia and Abnormal circulating porphyrin concentration.

+5. Addison's Disease: This is a disorder that occurs when your body produces insufficient amounts of certain hormones produced by your adrenal glands. Symptoms can include Hypoglycemia. The patient has this symptom, but does not have Glycosuria and Abnormal circulating porphyrin concentration. 

+6. Insulinoma: This is a small tumor in your pancreas that produces an excess amount of insulin. The excess insulin leads to low blood sugar levels (hypoglycemia). The patient has the symptom of Hypoglycemia, but does not have Glycosuria and Abnormal circulating porphyrin concentration."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Hyperphenylalaninemia'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are not typically associated with this condition.

+2. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder leading to the inability to break down certain amino acids. The patient's symptoms do not directly align with this disease, but 'Death in infancy' and 'Neonatal death' could occur in severe cases. 'Abnormality of prenatal development or birth' and 'Hyperphenylalaninemia' are not common symptoms.

+3. Trisomy 18 (Edwards Syndrome): This is a genetic disorder caused by the presence of an extra 18th chromosome. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. 'Hyperphenylalaninemia' is not a typical symptom of this condition.

+4. Trisomy 13 (Patau Syndrome): This is a severe genetic disorder associated with the presence of an extra 13th chromosome. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. 'Hyperphenylalaninemia' is not a typical symptom of this condition.

+5. Zellweger Syndrome: This is a rare, congenital disorder, characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. 'Hyperphenylalaninemia' is not a typical symptom of this condition."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Acidemia Type 1: This is a genetic disorder characterized by deficiency of an enzyme that helps break down certain amino acids. Symptoms in common with the patient include Hydrocephalus, Macrocephaly, Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Vomiting, Cerebral atrophy, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Increased CSF protein concentration, Glutaric aciduria, Death in childhood. Symptoms not in common include Anemia, Fever, Opisthotonus, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence.

+2. Alexander Disease: This is a rare genetic disorder that primarily affects the nervous system. Symptoms in common with the patient include Hydrocephalus, Macrocephaly, Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Vomiting, Cerebral atrophy, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction. Symptoms not in common include Anemia, Fever, Opisthotonus, Increased CSF protein concentration, Glutaric aciduria, Death in childhood, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence.

+3. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Symptoms in common with the patient include Hydrocephalus, Macrocephaly, Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Vomiting, Cerebral atrophy, Drowsiness, Sleep abnormality, Fasciculations. Symptoms not in common include Anemia, Fever, Opisthotonus, Increased CSF protein concentration, Glutaric aciduria, Death in childhood, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence.

+4. Tay-Sachs Disease: This is a rare, inherited disorder that progressively destroys nerve cells in the brain and spinal cord. Symptoms in common with the patient include Hydrocephalus, Macrocephaly, Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Vomiting, Cerebral atrophy, Drowsiness, Sleep abnormality. Symptoms not in common include Anemia, Fever, Opisthotonus, Increased CSF protein concentration, Glutaric aciduria, Death in childhood, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence.

+5. Meningitis: This is an inflammation of the meninges, the membranes that cover the brain and spinal cord. Symptoms in common with the patient include Hydrocephalus, Seizure, Lethargy, Fever, Vomiting, Drowsiness, Sleep abnormality. Symptoms not in common include Macrocephaly, Dystonia, Hyperreflexia, Death in infancy, Anemia, Cerebral atrophy, Opisthotonus, Fasciculations, Upper airway obstruction, Increased CSF protein concentration, Glutaric aciduria, Death in childhood, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Neonatal death', 'Death in infancy', 'Death in childhood', and 'Abnormality of prenatal development or birth'. However, the patient does not show any signs of 'Liver and kidney damage', which is also a common symptom of this disease.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Death in infancy', 'Neonatal death', 'Death in childhood', and 'Abnormality of prenatal development or birth'. The patient does not show any signs of 'Intellectual disability', which is also a common symptom of this disease.

+3. Maternal Phenylketonuria: This is a condition in pregnant women who have previously diagnosed phenylketonuria (PKU) and who do not follow the PKU diet during pregnancy. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Death in infancy', 'Neonatal death', 'Death in childhood', and 'Abnormality of prenatal development or birth'. The patient does not show any signs of 'Microcephaly', which is also a common symptom of this disease.

+4. Tyrosinemia Type II: This is a genetic metabolic disorder characterized by elevated blood levels of the amino acid tyrosine. Symptoms in common with the patient include 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', 'Death in childhood', and 'Abnormality of prenatal development or birth'. The patient does not show any signs of 'Eye abnormalities', which is also a common symptom of this disease."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. Symptoms not in common include 'Liver and kidney dysfunction', 'Failure to gain weight and grow at the expected rate', and 'Nervous system crises'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. Symptoms not in common include 'Intellectual disability', 'Delayed development', 'Behavioral, emotional, and social problems', and 'Skin rashes (eczema)'.

+3. Maternal Phenylketonuria: This is a condition in pregnant women who have previously diagnosed phenylketonuria (PKU). Symptoms in common with the patient include 'Hyperphenylalaninemia' and 'Preeclampsia'. Symptoms not in common include 'Microcephaly', 'Developmental delay', 'Low birth weight', and 'Heart defects'.

+4. Preeclampsia: This is a pregnancy complication characterized by high blood pressure and signs of damage to another organ system, most often the liver and kidneys. Symptoms in common with the patient include 'Preeclampsia'. Symptoms not in common include 'Severe headaches', 'Changes in vision', 'Upper abdominal pain', and 'Shortness of breath'.

+5. Hypertensive Disorders of Pregnancy: These are a group of conditions that occur in pregnant women who have high blood pressure. Symptoms in common with the patient include 'Preeclampsia'. Symptoms not in common include 'Chronic hypertension', 'Gestational hypertension', and 'HELLP syndrome'.

+6. Progeria: This is a rare genetic disorder that results in rapid aging starting in childhood. Symptoms in common with the patient include 'Death in early adulthood'. Symptoms not in common include 'Growth failure', 'Loss of body fat and hair', 'Aged-looking skin', and 'Stiffness in joints'."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Neonatal death', 'Death in infancy', and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Cabbage-like odor', 'Renal tubular dysfunction', and 'Hepatocellular carcinoma'.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. Symptoms not in common include 'Intellectual disability', 'Delayed speech and language development', and 'Fair hair and skin'.

+3. Propionic Acidemia: This is a disorder that affects the breakdown of certain proteins and lipids in the body. Symptoms in common with the patient include 'Elevated urinary carboxylic acid', 'Death in early adulthood', 'Neonatal death', and 'Death in infancy'. Symptoms not in common include 'Poor feeding', 'Vomiting', and 'Weak muscle tone (hypotonia)'.

+4. Maple Syrup Urine Disease (MSUD): This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. Symptoms not in common include 'Poor feeding', 'Lethargy', and 'Maple syrup odor in the earwax, sweat, and urine'.

+5. Glutaric Acidemia Type I: This is a disorder characterized by deficiencies of certain enzymes that prevent the body from fully breaking down certain amino acids and lipids. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. Symptoms not in common include 'Macrocephaly', 'Movement abnormalities', and 'Enlarged liver and spleen'."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Neonatal death', 'Death in infancy', 'Death in childhood'. However, 'Abnormality of prenatal development or birth' is not a common symptom.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Death in infancy', 'Neonatal death', 'Death in childhood'. The symptom 'Abnormality of prenatal development or birth' is not typically associated with PKU.

+3. Hereditary Tyrosinemia Type II: This is a rare genetic metabolic disorder characterized by elevated blood levels of the amino acid tyrosine. Symptoms in common with the patient include 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', 'Death in childhood'. The symptom 'Abnormality of prenatal development or birth' is not typically associated with this disease.

+4. Hereditary Tyrosinemia Type III: This is a very rare genetic metabolic disorder characterized by elevated blood levels of the amino acid tyrosine. Symptoms in common with the patient include 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', 'Death in childhood'. The symptom 'Abnormality of prenatal development or birth' is not typically associated with this disease.

+5. Maternal Phenylketonuria: This is a condition in pregnant women who have previously diagnosed phenylketonuria (PKU) and are not currently being treated. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Death in infancy', 'Neonatal death', 'Death in childhood'. The symptom 'Abnormality of prenatal development or birth' is also associated with this disease."
['Hereditary orotic aciduria'],"+1. Kawasaki Disease: This is a disease that primarily affects children and is associated with fever, skin rash, and lymph node swelling. Symptoms in common with the patient include 'Skin rash', 'Fever', 'Lethargy', and 'Drowsiness'. Symptoms not in common include 'Lymph node swelling'.

+2. Measles: A highly contagious viral disease known for its distinctive skin rash. Symptoms in common with the patient include 'Skin rash', 'Fever', 'Lethargy', 'Drowsiness', and 'Pneumonia'. Symptoms not in common include 'Koplik's spots' and 'Conjunctivitis'.

+3. Non-Hodgkin Lymphoma: A type of cancer that originates in the lymphatic system. Symptoms in common with the patient include 'Fever', 'Lethargy', 'Splenomegaly', and 'Hepatomegaly'. Symptoms not in common include 'Night sweats' and 'Unintentional weight loss'.

+4. Glycine Encephalopathy: A metabolic disorder characterized by abnormally high levels of a molecule called glycine. Symptoms in common with the patient include 'Hyperglycinuria', 'Generalized hypotonia', 'Lethargy', 'Drowsiness', and 'Feeding difficulties'. Symptoms not in common include 'Seizures' and 'Intellectual disability'.

+5. Cystinuria: A condition characterized by the buildup of the amino acid cystine, a component of protein, in the kidneys and bladder. Symptoms in common with the patient include 'Cystinuria'. Symptoms not in common include 'Kidney stones' and 'Flank pain'.

+6. Orotic Aciduria: A disorder that causes an excess of orotic acid in the urine. Symptoms in common with the patient include 'Oroticaciduria'. Symptoms not in common include 'Failure to thrive' and 'Developmental delay'.

+7. Ornithine Transcarbamylase Deficiency: A genetic disorder that causes an accumulation of ammonia in the blood. Symptoms in common with the patient include 'Ornithinuria', 'Vomiting', 'Lethargy', and 'Feeding difficulties'. Symptoms not in common include 'Coma' and 'Irritability'. 

+8. Sudden Infant Death Syndrome (SIDS): The unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy', 'Sleep abnormality'. Symptoms not in common include 'Apnea'. 

+9. Erythema Multiforme: A skin disorder resulting from an allergic reaction or infection. Symptoms in common with the patient include 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule', 'Skin rash'. Symptoms not in common include 'Target lesions on the skin'. 

+10. Hyperalaninemia: A condition characterized by elevated levels of the amino acid alanine in the blood. Symptoms in common with the patient include 'Abnormal circulating alanine concentration'. Symptoms not in common include 'Seizures' and 'Developmental delay'."
['Holocarboxylase synthetase deficiency'],"+1. Propionic Acidemia: This is a disorder that affects the breakdown of certain proteins and lipids in the body. Symptoms in common with the patient include metabolic acidosis, hyperammonemia, propionyl-CoA carboxylase deficiency, neonatal death, abnormal circulating glycine concentration, abnormal circulating monocarboxylic acid concentration, and elevated urinary carboxylic acid. Symptoms not in common include cyanosis, eczematoid dermatitis, skin rash, generalized hypotonia, death in infancy, anemia, diarrhea, tachypnea, and decreased pyruvate carboxylase activity.

+2. Methylmalonic Acidemia: This is a disorder that affects the body's ability to break down certain proteins and fats. Symptoms in common with the patient include metabolic acidosis, hyperammonemia, propionyl-CoA carboxylase deficiency, neonatal death, abnormal circulating glycine concentration, abnormal circulating monocarboxylic acid concentration, and elevated urinary carboxylic acid. Symptoms not in common include cyanosis, eczematoid dermatitis, skin rash, generalized hypotonia, death in infancy, anemia, diarrhea, tachypnea, and decreased pyruvate carboxylase activity.

+3. Isovaleric Acidemia: This is a disorder characterized by a distinctive odor of sweaty feet and intellectual disability. Symptoms in common with the patient include metabolic acidosis, hyperammonemia, propionyl-CoA carboxylase deficiency, neonatal death, abnormal circulating glycine concentration, abnormal circulating monocarboxylic acid concentration, and elevated urinary carboxylic acid. Symptoms not in common include cyanosis, eczematoid dermatitis, skin rash, generalized hypotonia, death in infancy, anemia, diarrhea, tachypnea, and decreased pyruvate carboxylase activity.

+4. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to break down certain amino acids. Symptoms in common with the patient include metabolic acidosis, hyperammonemia, propionyl-CoA carboxylase deficiency, neonatal death, abnormal circulating glycine concentration, abnormal circulating monocarboxylic acid concentration, and elevated urinary carboxylic acid. Symptoms not in common include cyanosis, eczematoid dermatitis, skin rash, generalized hypotonia, death in infancy, anemia, diarrhea, tachypnea, and decreased pyruvate carboxylase activity."
['Ornithine transcarbamylase deficiency'],"+1. Alzheimer's Disease: This is a progressive disease that destroys memory and other important mental functions. Common symptoms include apathy and lethargy. However, the patient does not show symptoms such as memory loss, confusion in familiar places, difficulty with words and numbers, and changes in personality and behavior.

+2. Ataxia-Telangiectasia: This is a rare, neurodegenerative, autosomal recessive disease causing severe disability. Symptoms include ataxia, but the patient does not show other common symptoms such as telangiectasia (small dilated blood vessels), recurrent infections, and increased risk of cancer.

+3. Hyperammonemia: This is a metabolic disturbance characterized by an excess of ammonia in the blood. The patient shows symptoms of hyperammonemia, lethargy, and vomiting. However, the patient does not show other common symptoms such as confusion, tremor, and seizures.

+4. Orotic Aciduria: This is a rare metabolic disorder characterized by a deficiency of certain enzymes in the body. The patient shows symptoms of oroticaciduria, but does not show other common symptoms such as failure to thrive, developmental delay, and megaloblastic anemia.

+5. Narcolepsy: This is a neurological disorder that affects the control of sleep and wakefulness. The patient shows symptoms of drowsiness and sleep abnormality, but does not show other common symptoms such as sudden loss of muscle tone, sleep paralysis, and hallucinations.

+6. Fatal Familial Insomnia: This is a rare, and extremely severe prion disease that is invariably fatal. The patient shows symptoms of sleep abnormality and death in adolescence, but does not show other common symptoms such as insomnia, weight loss, and dementia."
[],"+1. Ethylmalonic Encephalopathy: This is a rare inherited disorder that affects several parts of the body, including the nervous system. Symptoms in common with the patient include 'Vomiting', 'Ethylmalonic aciduria', 'Death in childhood', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'. 

+2. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare genetic disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Vomiting', 'Abnormal circulating carnitine concentration', 'Death in childhood', 'Death in adolescence'. The patient does not have 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' which is not a symptom of this disease.

+3. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This is a disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Vomiting', 'Death in childhood', 'Death in adolescence'. The patient does not have 'Ethylmalonic aciduria', 'Abnormal circulating carnitine concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' which are not symptoms of this disease.

+4. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include 'Vomiting', 'Abnormal circulating carnitine concentration', 'Death in childhood', 'Death in adolescence'. The patient does not have 'Ethylmalonic aciduria', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' which are not symptoms of this disease.

+5. Carnitine Deficiency, Systemic Primary: This is a condition that prevents the body from using fats for energy, particularly during periods without food. Symptoms in common with the patient include 'Vomiting', 'Abnormal circulating carnitine concentration', 'Death in childhood', 'Death in adolescence'. The patient does not have 'Ethylmalonic aciduria', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' which are not symptoms of this disease."
['Smith-Lemli-Opitz syndrome'],"+1. Down Syndrome: This is a genetic disorder that results in intellectual disability and developmental delays. It may also lead to physical characteristics such as low-set ears, wide nasal bridge, and anteverted nares. However, the patient does not show symptoms like hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, elevated circulating 7-dehydrocholesterol concentration, and feeding difficulties which are not typically associated with Down Syndrome.

+2. Smith-Lemli-Opitz Syndrome: This is a developmental disorder characterized by intellectual disability, motor delay, generalized hypotonia, and feeding difficulties. It is also associated with elevated 8-dehydrocholesterol and elevated circulating 7-dehydrocholesterol concentration. However, the patient does not show symptoms like death in infancy and neonatal death which are not typically associated with this syndrome.

+3. Apert Syndrome: This is a genetic disorder characterized by the premature fusion of certain skull bones. This early fusion prevents the skull from growing normally and affects the shape of the head and face. Symptoms include syndactyly, intellectual disability, and motor delay. However, the patient does not show symptoms like hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, elevated circulating 7-dehydrocholesterol concentration, and feeding difficulties which are not typically associated with Apert Syndrome.

+4. Congenital Hypotonia: This is a state of low muscle tone often involving reduced muscle strength. Symptoms include generalized hypotonia and feeding difficulties. However, the patient does not show symptoms like death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, and elevated circulating 7-dehydrocholesterol concentration which are not typically associated with Congenital Hypotonia.

+5. Neonatal Death Syndrome: This is a term used for the death of a baby within the first 28 days of life. Symptoms include death in infancy and neonatal death. However, the patient does not show symptoms like low-set ears, wide nasal bridge, anteverted nares, ptosis, syndactyly, intellectual disability, motor delay, generalized hypotonia, hypocholesterolemia, elevated 8-dehydrocholesterol, and elevated circulating 7-dehydrocholesterol concentration which are not typically associated with Neonatal Death Syndrome."
['L-2-hydroxyglutaric aciduria'],"+1. L-2-Hydroxyglutaric Aciduria: This is a rare inherited metabolic disorder characterized by the buildup of a certain acid (L-2-hydroxyglutaric acid) in the body. Symptoms include intellectual disability, ataxia, tremor, and cerebral atrophy. The patient has all these symptoms. However, the patient does not have neonatal death and death in infancy, which are also potential symptoms of this disease.

+2. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within a couple of years, usually due to respiratory failure. The patient has symptoms like intellectual disability, ataxia, and cerebral atrophy in common with this disease. However, the patient does not have death in infancy, which is a common symptom of this disease.

+3. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells (neurons) in the brain to send and receive messages. This disease is characterized by symptoms like intellectual disability, ataxia, tremor, and cerebral atrophy. The patient has these symptoms. However, the patient does not have death in infancy and neonatal death, which are also potential symptoms of this disease.

+4. Infantile Neuroaxonal Dystrophy: This is a rare neurodegenerative disorder characterized by a progressive loss of vision, intellectual and motor skills. Symptoms include intellectual disability, ataxia, tremor, and death in infancy. The patient has the first three symptoms in common with this disease but does not have death in infancy.

+5. Pantothenate Kinase-Associated Neurodegeneration: This is a disease characterized by abnormal deposits of iron in certain areas of the brain. Symptoms include intellectual disability, ataxia, tremor, and abnormal basal ganglia morphology. The patient has these symptoms. However, the patient does not have death in infancy and neonatal death, which are also potential symptoms of this disease."
['3-hydroxy-3-methylglutaric aciduria'],"+1. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Common symptoms include irritability, seizures, and generalized hypotonia. However, the patient does not show symptoms like dicarboxylic aciduria and 3-Methylglutaconic aciduria which are not typically associated with this disease.

+2. Glutaric Acidemia Type 1: This is a rare genetic disorder characterized by deficiency of an enzyme that helps break down certain amino acids. Symptoms include seizures, generalized hypotonia, metabolic acidosis, and dicarboxylic aciduria. However, the patient does not show symptoms like neonatal death and death in childhood which are not typically associated with this disease.

+3. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms include irritability, seizures, metabolic acidosis, and elevated urinary carboxylic acid. However, the patient does not show symptoms like opisthotonus and 3-Methylglutaconic aciduria which are not typically associated with this disease.

+4. 3-Methylglutaconic Aciduria: This is a group of autosomal recessive disorders characterized by a variety of neurologic symptoms. Symptoms include generalized hypotonia, 3-Methylglutaconic aciduria, and neonatal death. However, the patient does not show symptoms like opisthotonus and dicarboxylic aciduria which are not typically associated with this disease.

+5. Menkes Disease: This is a disorder that affects copper levels in the body. Symptoms include seizures, generalized hypotonia, and death in infancy. However, the patient does not show symptoms like metabolic acidosis and elevated urinary carboxylic acid which are not typically associated with this disease."
['L-2-hydroxyglutaric aciduria'],"+1. Eczema: This is a condition that makes your skin red and itchy. It's common in children but can occur at any age. Eczema is long lasting and tends to flare periodically. It may be accompanied by asthma or hay fever. Symptoms in common with the patient: 'Obsolete Eczematoid dermatitis', 'Skin rash'. Symptoms not in common: 'Asthma', 'Hay fever'.

+2. Epilepsy: This is a central nervous system (neurological) disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness. Symptoms in common with the patient: 'Seizure'. Symptoms not in common: 'Unusual behavior', 'Loss of awareness'.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. SIDS is sometimes known as crib death because the infants often die in their cribs. Symptoms in common with the patient: 'Death in infancy'. Symptoms not in common: 'Unexplained death during sleep', 'Infant less than a year old'.

+4. Influenza: This is a viral infection that attacks your respiratory system — your nose, throat and lungs. Influenza is commonly called the flu, but it's not the same as stomach ""flu"" viruses that cause diarrhea and vomiting. Symptoms in common with the patient: 'Fever'. Symptoms not in common: 'Respiratory system attack', 'Diarrhea', 'Vomiting'.

+5. Rheumatoid Arthritis: This is a chronic inflammatory disorder affecting many joints, including those in the hands and feet. In rheumatoid arthritis, the body's immune system attacks its own tissue, including joints. Symptoms in common with the patient: 'Elevated circulating C-reactive protein concentration'. Symptoms not in common: 'Inflammation in joints', 'Body's immune system attacking its own tissue'.

+6. L-2-Hydroxyglutaric Aciduria: This is a rare inherited condition in which the body is unable to break down certain proteins properly. Symptoms in common with the patient: 'L-2-hydroxyglutaric aciduria'. Symptoms not in common: 'Inability to break down certain proteins properly'.

+7. Iron Deficiency Anemia: This is a common type of anemia — a condition in which blood lacks adequate healthy red blood cells. Red blood cells carry oxygen to the body's tissues. Symptoms in common with the patient: 'Decreased serum iron'. Symptoms not in common: 'Lack of adequate healthy red blood cells', 'Tissues lacking oxygen'."
['X-linked hypophosphatemia'],"+1. Chronic Kidney Disease: This disease is characterized by gradual loss of kidney function over time. Symptoms in common with the patient include 'Nephritis'. However, the patient does not show other common symptoms such as 'Fatigue', 'Swelling of feet and ankles', and 'Persistent itching'.

+2. Hypophosphatasia: This is a rare genetic disorder characterized by the abnormal development of bones and teeth. Symptoms in common with the patient include 'Hypophosphatemia', 'Abnormal limb bone morphology', and 'Elevated circulating alkaline phosphatase concentration'. The patient does not show other common symptoms such as 'Delayed crawling or walking', and 'Loss of baby teeth before age 5'.

+3. Hyperparathyroidism: This condition occurs due to excessive production of parathyroid hormone by the parathyroid glands. Symptoms in common with the patient include 'Abnormal circulating hormone concentration'. However, the patient does not show other common symptoms such as 'Osteoporosis', 'Kidney stones', and 'Abdominal pain'.

+4. Infant Mortality Syndrome: This is a broad term for death in infancy due to various causes. The patient's symptom 'Death in infancy' is in common with this condition. However, this is a post-mortem diagnosis and cannot be diagnosed in a living individual.

+5. Juvenile Mortality Syndrome: This is a broad term for death in childhood due to various causes. The patient's symptom 'Death in childhood' is in common with this condition. However, this is a post-mortem diagnosis and cannot be diagnosed in a living individual."
['Propionic acidemia'],"+1. Nonketotic Hyperglycinemia: This is a metabolic disorder characterized by abnormally high levels of the amino acid glycine in the body. Symptoms in common with the patient include 'Delayed speech and language development', 'Hyperglycinemia', 'Hyperglycinuria', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating carnitine concentration', 'Abnormal circulating serine concentration', 'Elevated urinary carboxylic acid'. Symptoms not in common include 'obsolete Eczematoid dermatitis', 'Skin rash', 'Death in infancy', 'Leukopenia', 'Hyperammonemia', 'Elevated circulating alkaline phosphatase concentration', 'Death in childhood', 'Death in adolescence'.

+2. Propionic Acidemia: This is a disorder that affects the breakdown of proteins and fats in the body. Symptoms in common with the patient include 'Delayed speech and language development', 'Hyperammonemia', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating carnitine concentration', 'Elevated urinary carboxylic acid'. Symptoms not in common include 'obsolete Eczematoid dermatitis', 'Skin rash', 'Death in infancy', 'Leukopenia', 'Hyperglycinemia', 'Hyperglycinuria', 'Elevated circulating alkaline phosphatase concentration', 'Death in childhood', 'Death in adolescence', 'Abnormal circulating serine concentration'.

+3. Severe Combined Immunodeficiency (SCID): This is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Symptoms in common with the patient include 'Delayed speech and language development', 'Leukopenia', 'Death in infancy', 'Death in childhood', 'Death in adolescence'. Symptoms not in common include 'obsolete Eczematoid dermatitis', 'Skin rash', 'Hyperammonemia', 'Hyperglycinemia', 'Hyperglycinuria', 'Elevated circulating alkaline phosphatase concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating carnitine concentration', 'Abnormal circulating serine concentration', 'Elevated urinary carboxylic acid'.

+4. Hypophosphatasia: This is a rare genetic disorder characterized by the abnormal development of bones and teeth. Symptoms in common with the patient include 'Delayed speech and language development', 'Elevated circulating alkaline phosphatase concentration'. Symptoms not in common include 'obsolete Eczematoid dermatitis', 'Skin rash', 'Death in infancy', 'Leukopenia', 'Hyperammonemia', 'Hyperglycinemia', 'Hyperglycinuria', 'Death in childhood', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Abnormal circulating serine concentration', 'Elevated urinary carboxylic acid'."
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1. Homocystinuria: This is a disorder of the metabolism where the body is unable to process the essential amino acid methionine. Symptoms in common with the patient include 'Delayed speech and language development', 'Generalized hypotonia', 'Hyperhomocystinemia', and 'Abnormal cerebral white matter morphology'. Symptoms not in common with the patient are 'Ectopia lentis', 'Thromboembolism', and 'Marfanoid habitus'.

+2. Methylmalonic Acidemia: This is a disorder that affects the body's ability to break down certain proteins and fats. Symptoms in common with the patient include 'Delayed speech and language development', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine', and 'Methylmalonic aciduria'. Symptoms not in common with the patient are 'Metabolic acidosis', 'Hyperglycinemia', and 'Ketonuria'.

+3. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Symptoms in common with the patient include 'Delayed speech and language development', 'Generalized hypotonia', and 'Abnormal cerebral white matter morphology'. Symptoms not in common with the patient are 'Macrocephaly', 'Optic atrophy', and 'Spastic tetraplegia'.

+4. Zellweger Syndrome: This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include 'Delayed speech and language development', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death', and 'Abnormal cerebral white matter morphology'. Symptoms not in common with the patient are 'Hepatomegaly', 'Jaundice', and 'Retinopathy'.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common with the patient include 'Delayed speech and language development', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death', and 'Death in childhood'. Symptoms not in common with the patient are 'Lactic acidosis', 'Ataxia', and 'Optic atrophy'."
['Biotinidase deficiency'],"+1. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Common symptoms include death in infancy and neonatal death. However, elevated urinary carboxylic acid is not a common symptom of this disease.

+2. Zellweger Syndrome: This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. It is one of the most severe forms of a group of diseases known as peroxisome biogenesis disorders (PBD). The common symptoms include neonatal death and death in infancy. Elevated urinary carboxylic acid is not a common symptom of this disease.

+3. Nonketotic Hyperglycinemia: This is a rare genetic disorder characterized by abnormally high levels of a molecule called glycine in bodily fluids and tissues. Symptoms include neonatal death and death in infancy. However, elevated urinary carboxylic acid is not a common symptom of this disease.

+4. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms include neonatal death and death in infancy. Elevated urinary carboxylic acid is a common symptom of this disease.

+5. Propionic Acidemia: This is a disorder that causes harmful amounts of organic acids to build up in the body. Symptoms include neonatal death and death in infancy. Elevated urinary carboxylic acid is a common symptom of this disease."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1. Multiple Sclerosis: This is a disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms in common with the patient include: 'Spasticity', 'Lethargy', 'Hyperreflexia', 'Drowsiness', 'Sleep abnormality'. Symptoms not in common with the patient: 'Blurred vision', 'Difficulty in coordination and balance', 'Numbness or weakness in one or more limbs'.

+2. Cerebral Palsy: This is a group of disorders that affect movement and muscle tone or posture. It's caused by damage that occurs to the immature brain as it develops. Symptoms in common with the patient include: 'Spasticity', 'Generalized hypotonia', 'Hyperreflexia', 'Feeding difficulties'. Symptoms not in common with the patient: 'Involuntary movements', 'Delays in reaching motor skills milestones', 'Difficulty walking'.

+3. Urea Cycle Disorder: This is a genetic disorder caused by a mutation that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. Symptoms in common with the patient include: 'Hyperammonemia', 'Lethargy', 'Drowsiness', 'Neonatal death', 'Death in infancy'. Symptoms not in common with the patient: 'Cognitive impairment', 'Failure to thrive', 'Liver damage'.

+4. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Symptoms in common with the patient include: 'Generalized hypotonia', 'Feeding difficulties', 'Sleep abnormality'. Symptoms not in common with the patient: 'Intellectual disability', 'Short stature', 'Inability to feel full after eating'.

+5. Narcolepsy: This is a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep. Symptoms in common with the patient include: 'Drowsiness', 'Sleep abnormality', 'Lethargy'. Symptoms not in common with the patient: 'Sudden loss of muscle tone', 'Hallucinations', 'Sleep paralysis'."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Common symptoms include metabolic acidosis and decreased methylmalonyl-CoA mutase activity. However, death in infancy and childhood, although possible, are not guaranteed symptoms.

+2. Propionic Acidemia: This is a disorder that affects the breakdown of certain parts of proteins and lipids. Symptoms include metabolic acidosis and decreased methylmalonyl-CoA mutase activity. Death in infancy and childhood can occur in severe cases, but it's not a common symptom.

+3. Isovaleric Acidemia: This is a disorder characterized by a distinctive odor of sweaty feet and is caused by the buildup of organic acids in the body. The common symptoms with the patient are metabolic acidosis and death in infancy or childhood. However, decreased methylmalonyl-CoA mutase activity is not a symptom of this disease.

+4. Multiple Carboxylase Deficiency: This is a disorder characterized by metabolic acidosis and decreased methylmalonyl-CoA mutase activity. However, death in infancy and childhood are not common symptoms of this disease.

+5. Glutaric Acidemia Type II: This is a disorder characterized by metabolic acidosis and decreased methylmalonyl-CoA mutase activity. Death in infancy and childhood can occur in severe cases, but it's not a common symptom."
[],"+1. Attention Deficit Hyperactivity Disorder (ADHD): This is a neurodevelopmental disorder characterized by inattention, impulsivity, and hyperactivity. The patient's symptom of 'Hyperactivity' aligns with this diagnosis. However, symptoms such as 'Spasticity', 'Death in infancy', 'Hemolytic anemia', 'Metabolic acidosis', 'Increased total bilirubin', 'Neonatal death', 'Recurrent viral infections', 'Abnormal circulating porphyrin concentration', 'Increased circulating lactate dehydrogenase concentration' are not typically associated with ADHD.

+2. Hereditary Spherocytosis: This is a genetic disorder that leads to anemia, jaundice, and splenomegaly. It is characterized by symptoms such as 'Hemolytic anemia' and 'Increased total bilirubin'. However, symptoms like 'Hyperactivity', 'Spasticity', 'Death in infancy', 'Metabolic acidosis', 'Neonatal death', 'Recurrent viral infections', 'Abnormal circulating porphyrin concentration', 'Increased circulating lactate dehydrogenase concentration' are not common in this condition.

+3. Pyruvate Dehydrogenase Deficiency: This is a rare genetic disorder that affects the metabolism, leading to a buildup of lactic acid and a variety of neurological problems. Symptoms such as 'Metabolic acidosis' and 'Increased circulating lactate dehydrogenase concentration' are common in this condition. However, 'Hyperactivity', 'Spasticity', 'Death in infancy', 'Hemolytic anemia', 'Increased total bilirubin', 'Neonatal death', 'Recurrent viral infections', 'Abnormal circulating porphyrin concentration' are not typically associated with this disease.

+4. Porphyrin Metabolism Disorder: This is a group of rare genetic disorders that affect the body's ability to produce heme, leading to a buildup of porphyrins. The symptom 'Abnormal circulating porphyrin concentration' aligns with this diagnosis. However, 'Hyperactivity', 'Spasticity', 'Death in infancy', 'Hemolytic anemia', 'Metabolic acidosis', 'Increased total bilirubin', 'Neonatal death', 'Recurrent viral infections', 'Increased circulating lactate dehydrogenase concentration' are not common in this condition.

+5. Severe Combined Immunodeficiency (SCID): This is a rare genetic disorder that impairs the immune system, leading to severe infections. The symptom 'Recurrent viral infections' aligns with this diagnosis. However, 'Hyperactivity', 'Spasticity', 'Death in infancy', 'Hemolytic anemia', 'Metabolic acidosis', 'Increased total bilirubin', 'Neonatal death', 'Abnormal circulating porphyrin concentration', 'Increased circulating lactate dehydrogenase concentration' are not typically associated with SCID."
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1. Citrullinemia Type I: 
This is a disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms in common with the patient include 'Hyperammonemia', 'Respiratory distress', 'Apnea', 'Neonatal death', 'Respiratory acidosis', 'Elevated plasma citrulline'. Symptoms not in common with the patient are 'Failure to thrive', 'Vomiting', 'Ataxia', 'Irritability', 'Poor appetite'.

+2. Carbamoyl phosphate synthetase I deficiency: 
This is a rare metabolic disorder in which the body is unable to remove ammonia from the blood. Symptoms in common with the patient include 'Hyperammonemia', 'Respiratory distress', 'Apnea', 'Neonatal death', 'Respiratory acidosis'. Symptoms not in common with the patient are 'Lethargy', 'Poor feeding', 'Cerebral edema', 'Coma'.

+3. Ornithine transcarbamylase deficiency: 
This is an inherited disorder that causes ammonia to accumulate in the blood. Symptoms in common with the patient include 'Hyperammonemia', 'Respiratory distress', 'Apnea', 'Neonatal death', 'Respiratory acidosis'. Symptoms not in common with the patient are 'Confusion', 'Slurred speech', 'Agitation', 'Somnolence', 'Vomiting'.

+4. Argininosuccinic aciduria: 
This is a disorder characterized by the buildup of argininosuccinic acid (a substance the body uses to make arginine) and ammonia in the blood. Symptoms in common with the patient include 'Hyperammonemia', 'Respiratory distress', 'Apnea', 'Neonatal death', 'Respiratory acidosis'. Symptoms not in common with the patient are 'Failure to thrive', 'Liver disease', 'Intellectual disability', 'Spasticity'.

+5. N-acetylglutamate synthase deficiency: 
This is a rare genetic disorder that leads to the accumulation of ammonia in the blood. Symptoms in common with the patient include 'Hyperammonemia', 'Respiratory distress', 'Apnea', 'Neonatal death', 'Respiratory acidosis'. Symptoms not in common with the patient are 'Lethargy', 'Poor feeding', 'Seizures', 'Coma'."
[],"+1. Autism Spectrum Disorder: This is a developmental disorder that affects communication and behavior. Symptoms in common with the patient include 'Autistic behavior', 'Intellectual disability', 'Seizure', 'Generalized hypotonia', 'Clumsiness', and 'Poor coordination'. Symptoms not in common include 'Social impairment' and 'Repetitive behaviors'.

+2. Hypertensive Heart Disease: This is a complication of high blood pressure that affects the heart. Symptoms in common with the patient include 'Hypertension', 'Edema', and 'Short femur'. Symptoms not in common include 'Chest pain' and 'Shortness of breath'.

+3. Acute Pancreatitis: This is a sudden inflammation of the pancreas. Symptoms in common with the patient include 'Pancreatitis', 'Leukopenia', 'Vomiting', and 'Increased circulating lactate concentration'. Symptoms not in common include 'Abdominal pain' and 'Fever'.

+4. Chronic Kidney Disease: This is a long-term condition where the kidneys do not work effectively. Symptoms in common with the patient include 'Anemia', 'Acute kidney injury', 'Hyperuricemia', 'Increased blood urea nitrogen', 'Elevated circulating creatinine concentration', and 'Chronic kidney disease'. Symptoms not in common include 'Fatigue' and 'Swelling of feet and ankles'.

+5. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common with the patient include 'Methylmalonic acidemia', 'Decreased methylmalonyl-CoA mutase activity', 'Methylmalonic aciduria', and 'Death in infancy'. Symptoms not in common include 'Failure to thrive' and 'Feeding difficulties'.

+6. Hyperammonemia: This is a metabolic disturbance characterized by an excess of ammonia in the blood. Symptoms in common with the patient include 'Hyperammonemia', 'Coma', 'Increased circulating ferritin concentration', and 'Abnormal circulating aspartate family amino acid concentration'. Symptoms not in common include 'Confusion' and 'Lethargy'.

+7. Gout: This is a common and complex form of arthritis that can affect anyone. Symptoms in common with the patient include 'Gout', 'Hyperuricemia', and 'Kyphoscoliosis'. Symptoms not in common include 'Intense joint pain' and 'Inflammation and redness'. 

+8. Atransferrinemia: This is a very rare autosomal recessive disorder which results in anemia. Symptoms in common with the patient include 'Atransferrinemia', 'Anemia', and 'Increased circulating ferritin concentration'. Symptoms not in common include 'Iron overload' and 'Liver damage'. 

+9. Hyponatremia: This is a condition that occurs when the level of sodium in your blood is abnormally low. Symptoms in common with the patient include 'Hyponatremia', 'Seizure', and 'Coma'. Symptoms not in common include 'Headache' and 'Nausea'. 

+10. Hyperglycinemia: This is a rare inherited metabolic disorder characterized by abnormally high levels of the amino acid glycine in bodily fluids and tissues. Symptoms in common with the patient include 'Hyperglycinemia', 'Seizure', and 'Coma'. Symptoms not in common include 'Hypotonia' and 'Apnea'."
['Dihydropteridine reductase deficiency'],"+1. Phenylketonuria: This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Intellectual disability', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Hyperphenylalaninemia'. Symptoms not in common include 'Musty or mouse-like odor', 'Fair skin', 'Blue eyes', 'Eczema'.

+2. Zellweger Syndrome: This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include 'Microcephaly', 'Nystagmus', 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Cerebral atrophy', 'Abnormal cerebral white matter morphology'. Symptoms not in common include 'Hepatomegaly', 'Jaundice', 'Retinal degeneration'.

+3. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Intellectual disability', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Hypertyrosinemia', 'Neonatal death'. Symptoms not in common include 'Liver and kidney disease', 'Growth failure', 'Rickets'.

+4. Hypotonia-Cystinuria Syndrome: This is a rare metabolic disorder characterized by decreased muscle tone (hypotonia), failure to thrive, developmental delay, and excessive levels of the amino acid cystine in the urine (cystinuria). Symptoms in common with the patient include 'Intellectual disability', 'Seizure', 'Motor delay', 'Generalized hypotonia'. Symptoms not in common include 'Cystinuria', 'Failure to thrive', 'Renal tubular dysfunction'.

+5. Alopecia-Intellectual Disability Syndrome: This is a rare genetic syndrome characterized by intellectual disability and hair loss (alopecia). Symptoms in common with the patient include 'Microcephaly', 'Intellectual disability', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Alopecia'. Symptoms not in common include 'Sparse eyebrows', 'Sparse eyelashes', 'Sparse body hair'. 

+6. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells (neurons) in the brain to send and receive messages. Symptoms in common with the patient include 'Microcephaly', 'Nystagmus', 'Intellectual disability', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Cerebral atrophy', 'Abnormal cerebral white matter morphology', 'Death in childhood'. Symptoms not in common include 'Feeding difficulties', 'Large head (macrocephaly)', 'Poor visual tracking'."
[],"+1. Dermatitis: This condition is characterized by inflammation of the skin, leading to symptoms such as skin rash and erythematous plaque, which the patient has. However, the patient does not have other common symptoms such as itching and dry skin.

+2. Glycosuria Disease: This is a condition where an individual has an unusually high amount of sugar in their urine. The patient has glycosuria, but does not exhibit other common symptoms such as frequent urination and excessive thirst.

+3. Ethylmalonic Encephalopathy: This is a rare inherited disorder that affects many parts of the body, particularly the nervous system. Symptoms include ethylmalonic aciduria, death in infancy, and feeding difficulties, all of which the patient has. However, the patient does not have other symptoms such as seizures and delayed development.

+4. Cytochrome C Oxidase Deficiency: This is a condition that can cause a variety of symptoms affecting the neuromuscular and hematologic systems. The patient has cytochrome C oxidase-negative muscle fibers, but does not have other common symptoms such as muscle weakness and anemia.

+5. Hyperglycinemia: This is a metabolic disorder characterized by an excess of glycine in the body. The patient has an abnormal circulating glycine concentration, but does not have other common symptoms such as seizures and intellectual disability.

+6. Gastrointestinal Dysfunction: This refers to a range of conditions that affect the gastrointestinal tract. The patient has a functional abnormality of the gastrointestinal tract and feeding difficulties, but does not have other common symptoms such as abdominal pain and diarrhea.

+7. Erythema Multiforme: This is a skin condition characterized by the appearance of erythematous macules, papules, and sometimes plaques. The patient has erythematous macule and erythematous papule, but does not have other common symptoms such as fever and itching."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1. Argininosuccinic Aciduria: This is a rare genetic disorder characterized by a deficiency of the enzyme that helps break down certain proteins. Common symptoms include hyperammonemia, low plasma citrulline, and hypoargininemia. The patient has these symptoms. However, the patient also has symptoms like cyanosis, seizure, death in infancy, cerebral edema, fasciculations, oroticaciduria, and neonatal death which are not typically associated with this disease.

+2. Orotic Aciduria: This is a rare metabolic disorder characterized by an excess of orotic acid in the urine. The patient's symptom of oroticaciduria matches this disease. However, the patient also has symptoms like cyanosis, seizure, death in infancy, hyperammonemia, cerebral edema, fasciculations, low plasma citrulline, neonatal death, and hypoargininemia which are not typically associated with this disease.

+3. Citrullinemia: This is a condition that causes ammonia and other toxic substances to accumulate in the blood. Two types of this condition are recognized, and they are distinguished by their signs and symptoms, particularly the age at which symptoms first appear. Common symptoms include hyperammonemia, low plasma citrulline, and hypoargininemia. The patient has these symptoms. However, the patient also has symptoms like cyanosis, seizure, death in infancy, cerebral edema, fasciculations, oroticaciduria, and neonatal death which are not typically associated with this disease.

+4. Neonatal Death Syndrome: This is a general term for conditions that cause the death of an infant within the first 28 days of life. The patient's symptom of neonatal death matches this condition. However, the patient also has symptoms like cyanosis, seizure, death in infancy, hyperammonemia, cerebral edema, fasciculations, oroticaciduria, low plasma citrulline, and hypoargininemia which are not typically associated with this condition.

+5. Cerebral Edema: This is a condition where there is excess accumulation of fluid in the intracellular or extracellular spaces of the brain. The patient's symptom of cerebral edema matches this condition. However, the patient also has symptoms like cyanosis, seizure, death in infancy, hyperammonemia, fasciculations, oroticaciduria, low plasma citrulline, neonatal death, and hypoargininemia which are not typically associated with this condition."
['Canavan disease'],"+1. Urea Cycle Disorder: This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. The common symptoms with the patient are 'Hyperammonemia', 'Seizure', and 'Neonatal death'. The patient does not have 'Abnormal hair quantity', 'Abnormality of the nail', or 'Abnormality of the voice'.

+2. Glycine Encephalopathy: Also known as non-ketotic hyperglycinemia, is a rare autosomal recessive disorder of glycine metabolism. Patients with this disorder have an increased amount of glycine in their body fluids. The common symptoms with the patient are 'Seizure', 'Neonatal death', and 'Abnormal circulating glycine concentration'. The patient does not have 'Hypertonia', 'Myoclonus', or 'Apnea'.

+3. Argininosuccinic Aciduria: This is a rare genetic disorder characterized by a deficiency of the enzyme argininosuccinate lyase. This leads to an accumulation of argininosuccinic acid in the body. The common symptoms with the patient are 'Hyperammonemia', 'Seizure', and 'Neonatal death'. The patient does not have 'Trichorrhexis nodosa', 'Hepatomegaly', or 'Cirrhosis'.

+4. Citrullinemia: This is a condition that causes ammonia and other toxic substances to accumulate in the blood. Two forms of citrullinemia are recognized. The common symptoms with the patient are 'Hyperammonemia', 'Seizure', and 'Neonatal death'. The patient does not have 'Failure to thrive', 'Vomiting', or 'Ataxia'.

+5. Dermatitis Herpetiformis: This is a chronic blistering skin condition, characterised by blisters filled with a watery fluid. Despite its name, it is not related to the herpes virus. The common symptoms with the patient are 'Skin rash', 'Erythematous plaque', 'Erythematous macule', and 'Erythematous papule'. The patient does not have 'Pruritus', 'Alopecia', or 'Abnormal blistering of the skin'."
['Maple syrup urine disease'],"+1. Epilepsy: This condition is characterized by recurrent seizures. The patient's symptom of 'Seizure' matches with this disease. However, 'Death in infancy', 'Respiratory insufficiency', 'Opisthotonus', 'Neonatal death', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Feeding difficulties', 'Sepsis' are not typically associated with Epilepsy.

+2. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder leading to the accumulation of certain amino acids ('Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia') which can cause neurological damage and 'Seizure'. 'Feeding difficulties' and 'Neonatal death' are also common in MSUD. However, 'Death in infancy', 'Respiratory insufficiency', 'Opisthotonus', 'Sepsis' are not typically associated with MSUD.

+3. Neonatal Sepsis: This is a severe infection in an infant less than 28 days old. The symptoms 'Sepsis', 'Neonatal death', 'Feeding difficulties', and 'Respiratory insufficiency' match with this disease. However, 'Seizure', 'Death in infancy', 'Opisthotonus', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia' are not typically associated with Neonatal Sepsis.

+4. Infantile Spasms (West Syndrome): This is a rare epileptic disorder in infancy. The symptom 'Seizure' matches with this disease. 'Death in infancy' can also occur in severe cases. However, 'Respiratory insufficiency', 'Opisthotonus', 'Neonatal death', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Feeding difficulties', 'Sepsis' are not typically associated with Infantile Spasms.

+5. Tetanus: This is a serious bacterial infection that causes muscle stiffness and spasms ('Opisthotonus'). 'Seizure' can also occur in severe cases. However, 'Death in infancy', 'Respiratory insufficiency', 'Neonatal death', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Feeding difficulties', 'Sepsis' are not typically associated with Tetanus."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare genetic disorder that prevents the body from converting certain fats into energy. Symptoms in common include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'. The symptom 'Obesity' is not common in this disease.

+2. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This is a disorder that prevents the body from converting certain fats into energy. Symptoms in common include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'. The symptoms 'Obesity' and 'Abnormal circulating carnitine concentration' are not common in this disease.

+3. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common include 'Abnormality of prenatal development or birth', 'Obesity'. The symptoms 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' are not common in this disease.

+4. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy. Symptoms in common include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration'. The symptoms 'Obesity' and 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' are not common in this disease.

+5. Carnitine Deficiency, Systemic Primary: This is a condition that prevents the body from using fats for energy. Symptoms in common include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration'. The symptoms 'Obesity' and 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' are not common in this disease."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Intellectual disability', 'Seizure', 'Motor delay', 'Death in infancy', 'Death in childhood', 'Hyperphenylalaninemia', 'Death in early adulthood'. Symptoms not in common include 'Abnormal cerebral white matter morphology', 'Hypertyrosinemia', 'Dyskinesia'.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Intellectual disability', 'Seizure', 'Motor delay', 'Death in infancy', 'Hypertyrosinemia', 'Death in childhood', 'Death in early adulthood'. Symptoms not in common include 'Abnormal cerebral white matter morphology', 'Hyperphenylalaninemia', 'Dyskinesia'.

+3. Cerebral Palsy: This is a group of disorders that affect movement and muscle tone or posture. It's caused by damage that occurs to the immature brain as it develops, most often before birth. Symptoms in common with the patient include 'Intellectual disability', 'Seizure', 'Motor delay', 'Dyskinesia'. Symptoms not in common include 'Death in infancy', 'Abnormal cerebral white matter morphology', 'Hypertyrosinemia', 'Death in childhood', 'Hyperphenylalaninemia', 'Death in early adulthood'.

+4. Leukodystrophy: This is a group of disorders characterized by progressive degeneration of the white matter of the brain due to imperfect growth or development of the myelin sheath, the fatty covering that acts as an insulator around nerve fiber. Symptoms in common with the patient include 'Intellectual disability', 'Seizure', 'Motor delay', 'Death in infancy', 'Abnormal cerebral white matter morphology', 'Death in childhood', 'Death in early adulthood'. Symptoms not in common include 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Dyskinesia'."
['Wilson disease'],"+1. Wilson's Disease: This is a genetic disorder that prevents the body from getting rid of extra copper. A small amount of copper from the food we eat is necessary for health, but too much copper is poisonous. In Wilson's disease, copper builds up in the liver, brain, and other vital organs. Symptoms in common with the patient include hepatomegaly, elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, decreased circulating copper concentration, and copper accumulation in liver. The patient does not have generalized hypotonia, splenomegaly, death in childhood, and death in adolescence.

+2. Niemann-Pick Disease: This is a group of severe inherited metabolic disorders, in which harmful quantities of a fatty substance accumulate in the spleen, liver, lungs, bone marrow, and brain. Symptoms in common with the patient include hepatomegaly, splenomegaly, and death in childhood. The patient does not have generalized hypotonia, elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, death in adolescence, decreased circulating copper concentration, and copper accumulation in liver.

+3. Hepatolenticular Degeneration: This is another name for Wilson's disease. Symptoms in common with the patient include hepatomegaly, elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, decreased circulating copper concentration, and copper accumulation in liver. The patient does not have generalized hypotonia, splenomegaly, death in childhood, and death in adolescence. 

+4. Glycogen Storage Disease Type IV: This is a rare genetic metabolic disorder characterized by a deficiency of the enzyme required for the metabolism of glycogen, resulting in the accumulation of abnormal amounts or types of glycogen in tissues. Symptoms in common with the patient include hepatomegaly, death in childhood, and death in adolescence. The patient does not have generalized hypotonia, splenomegaly, elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, decreased circulating copper concentration, and copper accumulation in liver."
['PMM2-CDG'],"+1. Joubert Syndrome: This is a rare genetic disorder that affects the area of the brain that controls balance and coordination. Common symptoms include abnormal eye movements (strabismus), intellectual disability, ataxia, and abnormal facial shape. However, the patient does not show signs of cerebellar agenesis, abnormal calvaria morphology, and death in infancy which are not typically associated with this condition.

+2. Dandy-Walker Syndrome: This is a congenital brain malformation involving the cerebellum and the fluid filled spaces around it. Symptoms often include intellectual disability, ataxia, and cerebellar agenesis. However, the patient does not have generalized hypotonia and death in infancy, which are not common symptoms of this disease.

+3. Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome (CAMRQ): This is a rare genetic disorder characterized by nonprogressive cerebellar ataxia, mental retardation, and cerebellar hypoplasia. The patient's symptoms of intellectual disability, ataxia, cerebellar atrophy, and abnormal facial shape align with this condition. However, strabismus, generalized hypotonia, death in infancy, and abnormal calvaria morphology are not typically associated with CAMRQ.

+4. Pontocerebellar Hypoplasia: This is a group of related conditions that affect the development of the brain. Symptoms can include intellectual disability, ataxia, cerebellar atrophy, generalized hypotonia, and abnormal facial shape. However, the patient does not show signs of strabismus, death in infancy, abnormal calvaria morphology, and cerebellar agenesis which are not common symptoms of this condition.

+5. Poretti-Boltshauser Syndrome: This is a rare condition characterized by cerebellar atrophy, ataxia, intellectual disability, and abnormal facial shape. However, the patient does not have strabismus, generalized hypotonia, death in infancy, abnormal calvaria morphology, and cerebellar agenesis, which are not typically associated with this syndrome."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Hyperphenylalaninemia', and 'Death in adolescence' are not typically associated with this condition.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', and 'Death in adolescence' are not typically associated with this condition.

+3. Neonatal Death Syndrome: This is a term used to describe the death of a newborn within the first 28 days of life. Symptoms in common with the patient include 'Neonatal death'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Hyperphenylalaninemia', and 'Death in adolescence' are not typically associated with this condition.

+4. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy'. However, 'Abnormality of prenatal development or birth', 'Hypertyrosinemia', 'Neonatal death', 'Hyperphenylalaninemia', and 'Death in adolescence' are not typically associated with this condition.

+5. Congenital Abnormalities: These are physical defects present in a baby at birth that can be either structural or functional anomalies. Symptoms in common with the patient include 'Abnormality of prenatal development or birth'. However, 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Hyperphenylalaninemia', and 'Death in adolescence' are not typically associated with this condition.

+6. Adolescent Mortality: This refers to deaths that occur during adolescence. Symptoms in common with the patient include 'Death in adolescence'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', and 'Hyperphenylalaninemia' are not typically associated with this condition."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Common symptoms include macrocephaly and generalized hypotonia. However, this disease does not typically present with death in infancy, abnormal cerebral morphology, increased circulating lactate concentration, hypercalcemia, glutaric aciduria, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration.

+2. Glutaric Acidemia Type 1: This is a genetic disorder characterized by deficiencies in the enzyme needed to break down certain amino acids. Symptoms include macrocephaly, generalized hypotonia, and glutaric aciduria. However, it does not typically present with death in infancy, abnormal cerebral morphology, increased circulating lactate concentration, hypercalcemia, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration.

+3. Hyper IgM Syndrome: This is a rare primary immunodeficiency disorder that affects the immune system. It does not typically present with any of the listed symptoms.

+4. Leigh Syndrome: This is a severe neurological disorder that typically becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities. Symptoms include generalized hypotonia, death in infancy, abnormal cerebral morphology, and increased circulating lactate concentration. However, it does not typically present with macrocephaly, hypercalcemia, glutaric aciduria, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration.

+5. Primary Hyperoxaluria: This is a rare condition characterized by the overproduction of a substance called oxalate. It does not typically present with any of the listed symptoms.

+6. Carnitine Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms include generalized hypotonia and abnormal circulating carnitine concentration. However, it does not typically present with macrocephaly, death in infancy, abnormal cerebral morphology, increased circulating lactate concentration, hypercalcemia, glutaric aciduria, or abnormal circulating lysine concentration. 

+7. Hypercalcemia: This is a condition in which the calcium level in your blood is above normal. The patient's symptom of hypercalcemia aligns with this condition. However, it does not typically present with macrocephaly, generalized hypotonia, death in infancy, abnormal cerebral morphology, increased circulating lactate concentration, glutaric aciduria, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia' and 'Neonatal death'. However, 'Abnormality of prenatal development or birth' and 'Death in infancy' are not typically associated with this condition.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. The patient's symptom of 'Hyperphenylalaninemia' is a key indicator of this disease. However, 'Death in infancy', 'Neonatal death', and 'Death in childhood' are not common symptoms unless the disease is left untreated.

+3. Maple Syrup Urine Disease: This is a metabolic disorder in which the body cannot break down certain parts of proteins. Symptoms can be severe and may lead to 'Death in infancy' and 'Neonatal death'. However, the patient's symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not typically associated with this condition.

+4. Alkaptonuria: This is a rare genetic disorder that causes homogentisic acid to build up in the body. The symptoms of 'Abnormality of prenatal development or birth' and 'Death in infancy' could potentially be associated with this disease. However, the patient's symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not typically seen in this condition.

+5. Citrullinemia: This is a condition that causes ammonia and other toxic substances to accumulate in the blood. Two forms of citrullinemia are known; they are distinguished by age of onset, severity, and pattern of symptoms. The patient's symptoms of 'Death in infancy', 'Neonatal death', and 'Death in childhood' could potentially be associated with this disease. However, 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not typically seen in this condition."
['Phenylketonuria'],"+1. Microcephalic Osteodysplastic Primordial Dwarfism Type II (MOPD II): This is a rare genetic disorder characterized by extremely small stature and microcephaly. Symptoms in common with the patient include 'Microcephaly', 'Small for gestational age', 'Severe short stature', and 'Death in infancy'. Symptoms not in common include skeletal abnormalities and intellectual disability.

+2. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', and 'Feeding difficulties'. Symptoms not in common include liver and kidney dysfunction, and problems affecting the nervous system.

+3. Phenylketonuria (PKU): This is a rare genetic disorder that affects a person's ability to metabolize the amino acid phenylalanine. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Microcephaly', 'Small for gestational age', and 'Feeding difficulties'. Symptoms not in common include intellectual disability, seizures, and behavioral problems.

+4. Hydrops fetalis: This is a severe, life-threatening problem of severe edema (swelling) in the fetus and newborn. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Pericardial effusion', 'Pleural effusion', and 'Neonatal death'. Symptoms not in common include anemia, jaundice, and heart failure.

+5. Severe Combined Immunodeficiency (SCID): This is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations. Symptoms in common with the patient include 'Death in infancy', 'Death in childhood', and 'Feeding difficulties'. Symptoms not in common include recurrent severe infections, diarrhea, and skin rashes."
['Ornithine transcarbamylase deficiency'],"+1. Ornithine Transcarbamylase Deficiency:
This is a genetic disorder that results in the accumulation of ammonia in the blood. Symptoms in common with the patient include Hyperammonemia, Vomiting, and Death in childhood. The patient does not exhibit the common symptom of decreased appetite.

+2. Urea Cycle Disorder:
This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. The patient's symptoms of Hyperammonemia, Vomiting, and Death in childhood are common in this disorder. The patient does not exhibit the common symptoms of fatigue and confusion.

+3. Orotic Aciduria:
This is a rare metabolic disorder characterized by an excess of orotic acid in the urine. The patient's symptoms of Hyperammonemia, Oroticaciduria, and Death in childhood are common in this disorder. The patient does not exhibit the common symptoms of failure to thrive and developmental delay.

+4. Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome:
This is a rare metabolic disorder characterized by an excess of ammonia and other substances in the blood. The patient's symptoms of Hyperammonemia, Vomiting, and Death in childhood are common in this disorder. The patient does not exhibit the common symptoms of seizures and intellectual disability.

+5. Citrullinemia:
This is a condition that causes ammonia and other toxic substances to accumulate in the blood. The symptoms in common with the patient include Hyperammonemia, Vomiting, and Death in childhood. The patient does not exhibit the common symptoms of poor growth and hair loss. 

+6. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder characterized by the inability to synthesize carbamoyl phosphate, which leads to an accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Vomiting, and Death in childhood are common in this disorder. The patient does not exhibit the common symptoms of lethargy and poor feeding."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', and 'Elevated urinary carboxylic acid'. Symptoms not in common include 'Intellectual disability', 'Delayed speech and language development', and 'Seizures'.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Abnormal circulating tyrosine concentration', 'Elevated urinary carboxylic acid', and 'Death in infancy'. Symptoms not in common include 'Liver and kidney disease', 'Problems affecting the nervous system', and 'Increased risk of liver cancer'.

+3. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. Symptoms in common with the patient include 'Obesity' and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Intellectual impairment', 'Short stature', and 'Hypogonadism'.

+4. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy' and 'Neonatal death'. Symptoms not in common include 'Apnea' and 'Alterations in serotonin in the brainstem'.

+5. Alkaptonuria: This is a rare inherited genetic disorder in which the body cannot process the amino acids phenylalanine and tyrosine. Symptoms in common with the patient include 'Elevated urinary carboxylic acid' and 'Abnormal circulating tyrosine concentration'. Symptoms not in common include 'Darkening of the urine', 'Arthritis', and 'Heart disease'.

+6. Progeria: This is a rare genetic disorder characterized by rapid aging in children. Symptoms in common with the patient include 'Death in early adulthood'. Symptoms not in common include 'Growth failure', 'Loss of body fat and hair', and 'Aged-looking skin'."
['Pearson syndrome'],"+1. Polycystic Kidney Disease: This is a genetic disorder characterized by the growth of numerous cysts in the kidneys. Symptoms in common with the patient include 'Enlarged kidney', 'Lethargy', 'Congestive heart failure', 'Acute kidney injury', 'Chronic kidney disease'. Symptoms not in common include 'Pain in the sides and back', 'High blood pressure', 'Blood in urine'.

+2. Fanconi Syndrome: This is a disorder of the kidney's proximal tubules in which certain substances normally absorbed into the bloodstream by the kidneys are released into the urine instead. Symptoms in common with the patient include 'Generalized hypotonia', 'Renal Fanconi syndrome', 'Vomiting', 'Feeding difficulties'. Symptoms not in common include 'Excessive thirst', 'Excessive urination', 'Growth failure'.

+3. Congestive Heart Failure: This is a chronic progressive condition that affects the pumping power of your heart muscles. Symptoms in common with the patient include 'Lethargy', 'Congestive heart failure', 'Short stature'. Symptoms not in common include 'Shortness of breath', 'Rapid or irregular heartbeat', 'Persistent cough or wheezing'.

+4. Thrombocytopenia: This is a condition characterized by abnormally low levels of platelets, also known as thrombocytes, in the blood. Symptoms in common with the patient include 'Thrombocytopenia', 'Anemia', 'Neutropenia'. Symptoms not in common include 'Easy or excessive bruising', 'Superficial bleeding into the skin', 'Prolonged bleeding from cuts'.

+5. Hypoglycemia: This is a condition characterized by an abnormally low level of blood sugar (glucose), your body's main energy source. Symptoms in common with the patient include 'Lethargy', 'Coma', 'Hypoglycemia', 'Drowsiness'. Symptoms not in common include 'Shakiness', 'Nervousness or anxiety', 'Sweating, chills and clamminess'.

+6. Exocrine Pancreatic Insufficiency (EPI): This is a condition characterized by deficiency of the exocrine pancreatic enzymes, resulting in the inability to digest food properly, or malabsorption. Symptoms in common with the patient include 'Exocrine pancreatic insufficiency', 'Vomiting', 'Feeding difficulties'. Symptoms not in common include 'Diarrhea', 'Weight loss', 'Steatorrhea (foul-smelling, greasy stools)'.

+7. Chronic Kidney Disease: This is a long-term condition where the kidneys do not work effectively. Symptoms in common with the patient include 'Enlarged kidney', 'Lethargy', 'Acute kidney injury', 'Chronic kidney disease'. Symptoms not in common include 'Swelling of feet and ankles', 'Persistent itching', 'Chest pain'."
['Smith-Lemli-Opitz syndrome'],"+1. Smith-Lemli-Opitz Syndrome: This is a genetic disorder characterized by distinctive facial features, small head size, intellectual disability, and multiple congenital malformations. Symptoms in common with the patient include 'Broad philtrum', 'Long philtrum', 'Anteverted nares', 'Syndactyly', 'Generalized hypotonia', 'Death in infancy', 'Deep philtrum', 'Hypocholesterolemia', 'Elevated 8-dehydrocholesterol', 'Neonatal death', 'Elevated circulating 7-dehydrocholesterol concentration', 'Feeding difficulties'.

+2. Apert Syndrome: This is a genetic disorder characterized by the premature fusion of certain skull bones. This early fusion prevents the skull from growing normally and affects the shape of the head and face. Symptoms in common with the patient include 'Syndactyly', 'Generalized hypotonia'. Symptoms not in common include 'Broad philtrum', 'Long philtrum', 'Anteverted nares', 'Death in infancy', 'Deep philtrum', 'Hypocholesterolemia', 'Elevated 8-dehydrocholesterol', 'Neonatal death', 'Elevated circulating 7-dehydrocholesterol concentration', 'Feeding difficulties'.

+3. Prader-Willi Syndrome: This is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone, feeding difficulties, poor growth, and delayed development. Symptoms in common with the patient include 'Generalized hypotonia', 'Feeding difficulties'. Symptoms not in common include 'Broad philtrum', 'Long philtrum', 'Anteverted nares', 'Syndactyly', 'Death in infancy', 'Deep philtrum', 'Hypocholesterolemia', 'Elevated 8-dehydrocholesterol', 'Neonatal death', 'Elevated circulating 7-dehydrocholesterol concentration'.

+4. Zellweger Syndrome: This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include 'Generalized hypotonia', 'Neonatal death'. Symptoms not in common include 'Broad philtrum', 'Long philtrum', 'Anteverted nares', 'Syndactyly', 'Death in infancy', 'Deep philtrum', 'Hypocholesterolemia', 'Elevated 8-dehydrocholesterol', 'Elevated circulating 7-dehydrocholesterol concentration', 'Feeding difficulties'."
['Acute intermittent porphyria'],"+1. Gastroenteritis: This is an inflammation of the gastrointestinal tract, primarily the stomach and intestines. Symptoms in common: 'Vomiting', 'Abdominal pain'. Symptoms not in common: 'Death in childhood', 'Recurrent viral infections'.

+2. Appendicitis: This is an inflammation of the appendix, a small tube that branches off the large intestine. Symptoms in common: 'Vomiting', 'Abdominal pain'. Symptoms not in common: 'Death in childhood', 'Recurrent viral infections'.

+3. Food Poisoning: This is an illness caused by consuming contaminated food. Symptoms in common: 'Vomiting', 'Abdominal pain'. Symptoms not in common: 'Death in childhood', 'Recurrent viral infections'.

+4. Severe Combined Immunodeficiency (SCID): This is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in differing clinical presentations. Symptoms in common: 'Recurrent viral infections'. Symptoms not in common: 'Vomiting', 'Abdominal pain', 'Death in childhood'.

+5. Gaucher Disease Type 2: This is a rare genetic disorder that affects many of the body's organs and tissues. The disease is characterized by a deficiency of the enzyme glucocerebrosidase. Symptoms in common: 'Death in childhood'. Symptoms not in common: 'Vomiting', 'Abdominal pain', 'Recurrent viral infections'. 

+6. Norovirus: This is a highly contagious virus that causes vomiting and diarrhea. Symptoms in common: 'Vomiting', 'Abdominal pain'. Symptoms not in common: 'Death in childhood', 'Recurrent viral infections'. 

+7. Peptic Ulcer: This is a sore that develops on the lining of the stomach, upper small intestine or esophagus. Symptoms in common: 'Vomiting', 'Abdominal pain'. Symptoms not in common: 'Death in childhood', 'Recurrent viral infections'. 

+8. Influenza: This is a viral infection that attacks your respiratory system. Symptoms in common: 'Vomiting'. Symptoms not in common: 'Abdominal pain', 'Death in childhood', 'Recurrent viral infections'. 

+9. HIV/AIDS: This is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). Symptoms in common: 'Recurrent viral infections'. Symptoms not in common: 'Vomiting', 'Abdominal pain', 'Death in childhood'. 

+10. Hepatitis A: This is a highly contagious liver infection caused by the hepatitis A virus. Symptoms in common: 'Vomiting', 'Abdominal pain'. Symptoms not in common: 'Death in childhood', 'Recurrent viral infections'."
['Citrullinemia type I'],"+1. Citrullinemia Type 1: This is a disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms in common include 'Hyperammonemia', 'Elevated plasma citrulline', 'Neonatal death', and 'Metabolic acidosis'. Symptoms not in common are 'Death in infancy', 'Hyperglycinuria', 'Hyperglutaminemia', and 'Argininuria'.

+2. Argininosuccinic Aciduria: This is a condition that causes harmful amounts of ammonia to accumulate in the blood. Symptoms in common include 'Hyperammonemia', 'Neonatal death', and 'Metabolic acidosis'. Symptoms not in common are 'Death in infancy', 'Hyperglycinuria', 'Hyperglutaminemia', 'Argininuria', and 'Elevated plasma citrulline'.

+3. Hyperargininemia: This is a rare genetic disorder characterized by elevated blood levels of the amino acid arginine. Symptoms in common include 'Hyperammonemia', 'Abnormal circulating arginine concentration', and 'Argininuria'. Symptoms not in common are 'Death in infancy', 'Metabolic acidosis', 'Hyperglycinuria', 'Hyperglutaminemia', 'Neonatal death', and 'Elevated plasma citrulline'.

+4. Carbamoyl Phosphate Synthetase I Deficiency: This is a disorder that causes ammonia to accumulate in the blood. Symptoms in common include 'Hyperammonemia', 'Neonatal death', and 'Metabolic acidosis'. Symptoms not in common are 'Death in infancy', 'Hyperglycinuria', 'Hyperglutaminemia', 'Argininuria', 'Abnormal circulating arginine concentration', and 'Elevated plasma citrulline'.

+5. Ornithine Transcarbamylase Deficiency: This is an inherited disorder that causes ammonia to accumulate in the blood. Symptoms in common include 'Hyperammonemia', 'Neonatal death', and 'Metabolic acidosis'. Symptoms not in common are 'Death in infancy', 'Hyperglycinuria', 'Hyperglutaminemia', 'Argininuria', 'Abnormal circulating arginine concentration', and 'Elevated plasma citrulline'."
[],"+1. Methylmalonic Acidemia: This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common with the patient include 'Delayed speech and language development', 'Lethargy', 'Generalized hypotonia', 'Dehydration', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Methylmalonic acidemia', 'Decreased plasma free carnitine', and 'Methylmalonic aciduria'. The symptom 'Death in infancy' is not in common as the patient is still alive.

+2. Hyperammonemia: This is a metabolic disturbance characterized by an excess of ammonia in the blood. Symptoms in common with the patient include 'Lethargy', 'Generalized hypotonia', 'Dehydration', 'Hyperammonemia', 'Drowsiness', and 'Sleep abnormality'. Symptoms not in common include 'Delayed speech and language development', 'Death in infancy', 'Hyperhomocystinemia', 'Methylmalonic acidemia', 'Decreased plasma free carnitine', and 'Methylmalonic aciduria'.

+3. Hyperhomocystinemia: This is a disorder characterized by an excess of homocysteine in the blood. The only symptom in common with the patient is 'Hyperhomocystinemia'. Symptoms not in common include 'Delayed speech and language development', 'Lethargy', 'Generalized hypotonia', 'Death in infancy', 'Dehydration', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Methylmalonic acidemia', 'Decreased plasma free carnitine', and 'Methylmalonic aciduria'.

+4. Carnitine Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include 'Delayed speech and language development', 'Lethargy', 'Generalized hypotonia', 'Dehydration', 'Drowsiness', 'Sleep abnormality', and 'Decreased plasma free carnitine'. Symptoms not in common include 'Death in infancy', 'Hyperammonemia', 'Hyperhomocystinemia', 'Methylmalonic acidemia', and 'Methylmalonic aciduria'."
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine Palmitoyltransferase II Deficiency: This is a metabolic disorder characterized by an enzyme deficiency, which can lead to a variety of symptoms. Common symptoms include hypotonia, hyperammonemia, and decreased plasma free carnitine. The patient's symptoms of hyperactivity, premature birth, neonatal death, death in infancy, death in childhood, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, and abnormal circulating creatine kinase concentration are not typically associated with this disease.

+2. Ornithine Transcarbamylase Deficiency: This is a genetic disorder that causes an accumulation of ammonia in the blood (hyperammonemia). Other common symptoms include hyperactivity and generalized hypotonia. The patient's symptoms of premature birth, neonatal death, death in infancy, death in childhood, decreased plasma free carnitine, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, and abnormal circulating creatine kinase concentration are not typically associated with this disease.

+3. Citrullinemia: This is a disorder that causes an accumulation of ammonia in the blood (hyperammonemia). Other common symptoms include hyperactivity and generalized hypotonia. The patient's symptoms of premature birth, neonatal death, death in infancy, death in childhood, decreased plasma free carnitine, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, and abnormal circulating creatine kinase concentration are not typically associated with this disease.

+4. Argininosuccinic Aciduria: This is a genetic disorder characterized by a buildup of argininosuccinic acid and ammonia in the blood (hyperammonemia). Other common symptoms include hyperactivity and generalized hypotonia. The patient's symptoms of premature birth, neonatal death, death in infancy, death in childhood, decreased plasma free carnitine, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, and abnormal circulating creatine kinase concentration are not typically associated with this disease. 

+5. Creatine Kinase Deficiency: This is a rare genetic disorder that affects the muscles and brain. It is characterized by an abnormal circulating creatine kinase concentration. The patient's symptoms of hyperactivity, generalized hypotonia, death in infancy, premature birth, hyperammonemia, neonatal death, death in childhood, decreased plasma free carnitine, abnormal circulating aspartate family amino acid concentration, and abnormal circulating alanine concentration are not typically associated with this disease."
['Phenylketonuria'],"+1. Cystic Fibrosis: This is a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys, and intestine. Symptoms in common with the patient include 'Chronic pulmonary obstruction' and 'Upper airway obstruction'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', and 'Hyperphenylalaninemia' are not typically associated with this disease.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Neonatal death', and 'Death in infancy'. However, 'Abnormality of prenatal development or birth', 'Upper airway obstruction', and 'Chronic pulmonary obstruction' are not typically associated with this disease.

+3. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Neonatal death', and 'Death in infancy'. However, 'Abnormality of prenatal development or birth', 'Upper airway obstruction', and 'Chronic pulmonary obstruction' are not typically associated with this disease.

+4. Congenital Diaphragmatic Hernia: This is a birth defect of the diaphragm. The most common type of CDH is a Bochdalek hernia; other types include Morgagni hernia, diaphragm eventration and central tendon defects of the diaphragm. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Upper airway obstruction', and 'Chronic pulmonary obstruction'. However, 'Hypertyrosinemia', 'Neonatal death', 'Hyperphenylalaninemia', and 'Death in infancy' are not typically associated with this disease. 

+5. Tracheomalacia: This is a condition or incident where the cartilage that keeps the airway (trachea) open is soft such that the trachea partly collapses especially during increased airflow. Symptoms in common with the patient include 'Upper airway obstruction' and 'Chronic pulmonary obstruction'. However, 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', and 'Hyperphenylalaninemia' are not typically associated with this disease."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Cerebral Palsy: This is a group of disorders that affect movement and muscle tone or posture. It's caused by damage that occurs to the immature brain as it develops, most often before birth. Symptoms in common with the patient include 'Spasticity' and 'Premature birth'. Symptoms not in common include 'Seizures', 'Impaired vision', and 'Abnormal touch or pain perceptions'.

+2. Carnitine Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include 'Decreased plasma free carnitine', 'Neonatal death', and 'Death in infancy'. Symptoms not in common include 'Muscle weakness', 'Confusion', and 'Vomiting'.

+3. Iron Deficiency Anemia: This is a common type of anemia — a condition in which blood lacks adequate healthy red blood cells. Symptoms in common with the patient include 'Decreased circulating ferritin concentration'. Symptoms not in common include 'Fatigue', 'Pale skin', and 'Shortness of breath'.

+4. Vitamin B12 Deficiency: This occurs when the body does not have enough of the vitamin B12. Symptoms in common with the patient include 'Abnormal circulating vitamin B12 concentration'. Symptoms not in common include 'Fatigue', 'Weakness', and 'Constipation'.

+5. Hypoxemia: This is a below-normal level of oxygen in your blood, specifically in the arteries. Symptoms in common with the patient include 'Hypoxemia'. Symptoms not in common include 'Shortness of breath', 'Headache', and 'Rapid breathing'.

+6. Peritonitis: This is inflammation of the peritoneum, the thin layer of tissue that lines the inside of the abdomen. Symptoms in common with the patient include 'Peritoneal effusion' and 'Ileus'. Symptoms not in common include 'Abdominal pain or tenderness', 'Bloating or a feeling of fullness in your abdomen', and 'Nausea and vomiting'.

+7. Mitochondrial Trifunctional Protein Deficiency: This is a condition that prevents the body from converting certain fats to energy, particularly during periods without food. Symptoms in common with the patient include 'Decreased 3-hydroxyacyl-CoA dehydrogenase level', 'Neonatal death', and 'Death in infancy'. Symptoms not in common include 'Weakness', 'Fatigue', and 'Hypoglycemia'."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia'. However, 'Death in infancy', 'Death in childhood', 'Recurrent viral infections', 'Hyperphenylalaninemia', and 'Death in adolescence' are not typically associated with this condition.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia'. However, 'Death in infancy', 'Hypertyrosinemia', 'Death in childhood', 'Recurrent viral infections', and 'Death in adolescence' are not typically associated with this condition.

+3. Severe Combined Immunodeficiency (SCID): This is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Symptoms in common with the patient include 'Recurrent viral infections'. However, 'Death in infancy', 'Hypertyrosinemia', 'Death in childhood', 'Hyperphenylalaninemia', and 'Death in adolescence' are not typically associated with this condition.

+4. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy'. However, 'Hypertyrosinemia', 'Death in childhood', 'Recurrent viral infections', 'Hyperphenylalaninemia', and 'Death in adolescence' are not typically associated with this condition.

+5. Juvenile Huntington's disease: This is a rare form of Huntington's disease that begins in childhood or adolescence. It is a progressive disorder that causes the breakdown of brain cells in certain areas of the brain. Symptoms in common with the patient include 'Death in adolescence'. However, 'Death in infancy', 'Hypertyrosinemia', 'Death in childhood', 'Recurrent viral infections', and 'Hyperphenylalaninemia' are not typically associated with this condition."
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1. Nonketotic Hyperglycinemia (NKH): This is a rare genetic disorder characterized by an excess of glycine on the body. Symptoms in common with the patient include 'Abnormal circulating glycine concentration' and 'Elevated urinary carboxylic acid'. However, 'Death in infancy' and 'Aminoaciduria' are not typically associated with this condition.

+2. Glycine Encephalopathy (GE): Also known as Nonketotic Hyperglycinemia, this is a metabolic disorder characterized by abnormally high levels of the amino acid glycine. Symptoms in common with the patient include 'Abnormal circulating glycine concentration'. However, 'Death in infancy', 'Aminoaciduria', and 'Elevated urinary carboxylic acid' are not typically associated with this condition.

+3. Propionic Acidemia (PA): This is a rare genetic disorder that affects the breakdown of certain proteins and lipids in the body. Symptoms in common with the patient include 'Death in infancy' and 'Elevated urinary carboxylic acid'. However, 'Aminoaciduria' and 'Abnormal circulating glycine concentration' are not typically associated with this condition.

+4. Methylmalonic Acidemia (MMA): This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms in common with the patient include 'Death in infancy' and 'Elevated urinary carboxylic acid'. However, 'Aminoaciduria' and 'Abnormal circulating glycine concentration' are not typically associated with this condition.

+5. Isovaleric Acidemia (IVA): This is a rare genetic disorder characterized by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient include 'Death in infancy' and 'Elevated urinary carboxylic acid'. However, 'Aminoaciduria' and 'Abnormal circulating glycine concentration' are not typically associated with this condition."
['Succinic semialdehyde dehydrogenase deficiency'],"+1. Autism Spectrum Disorder: This disorder is characterized by difficulties with social interaction and communication, and by restricted and repetitive behavior. Symptoms in common with the patient include 'Delayed speech and language development' and 'Hyperactivity'. Symptoms not in common include 'Seizure', 'Ataxia', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+2. Epilepsy: This is a central nervous system disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness. Symptoms in common with the patient include 'Seizure'. Symptoms not in common include 'Delayed speech and language development', 'Hyperactivity', 'Ataxia', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+3. Ataxia Telangiectasia: This is a rare, neurodegenerative, autosomal recessive disease causing severe disability. Symptoms in common with the patient include 'Ataxia', 'Delayed speech and language development', 'Motor delay'. Symptoms not in common include 'Hyperactivity', 'Seizure', 'Generalized hypotonia', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+4. Cerebral Palsy: This is a group of disorders that affect movement and muscle tone or posture. Symptoms in common with the patient include 'Motor delay', 'Generalized hypotonia', 'Seizure'. Symptoms not in common include 'Delayed speech and language development', 'Hyperactivity', 'Ataxia', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+5. Infantile Neuroaxonal Dystrophy: This is a rare inherited neurological disorder. Symptoms in common with the patient include 'Delayed speech and language development', 'Hyperactivity', 'Seizure', 'Ataxia', 'Motor delay', 'Generalized hypotonia', 'Death in infancy'. Symptoms not in common include 'Death in childhood', 'Elevated urinary carboxylic acid'.

+6. Methylmalonic Acidemia: This is a disorder in which the body cannot break down certain proteins and fats. Symptoms in common with the patient include 'Delayed speech and language development', 'Hyperactivity', 'Seizure', 'Ataxia', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'."
['Argininosuccinic aciduria'],"+1. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Common symptoms include vomiting, metabolic acidosis, and death in infancy. However, symptoms such as tachycardia, hepatomegaly, and tachypnea are not typically associated with this condition.

+2. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms can include tachycardia, metabolic acidosis, vomiting, hepatomegaly, and neonatal death. However, death in infancy and tachypnea are not typically associated with this condition.

+3. Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This is a disorder that prevents the body from converting certain fats to energy, particularly during periods of fasting. Common symptoms include vomiting, metabolic acidosis, and hepatomegaly. However, symptoms such as tachycardia, tachypnea, death in infancy, and neonatal death are not typically associated with this condition.

+4. Reye Syndrome: This is a rare but serious condition that causes swelling in the liver and brain. Reye's syndrome most often affects children and teenagers recovering from a viral infection and can lead to a sudden death. Symptoms can include vomiting, hepatomegaly, and tachypnea. However, symptoms such as tachycardia, metabolic acidosis, death in infancy, and neonatal death are not typically associated with this condition.

+5. Zellweger Syndrome: This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms can include hepatomegaly, neonatal death, and death in infancy. However, symptoms such as tachycardia, metabolic acidosis, vomiting, and tachypnea are not typically associated with this condition."
['Gyrate atrophy of choroid and retina'],"+1. Retinitis Pigmentosa: This is a group of rare genetic disorders that involve a breakdown and loss of cells in the retina. Common symptoms include blindness and difficulty seeing at night. The patient has blindness, but does not have difficulty seeing at night.

+2. Iron Deficiency Anemia: This is a common type of anemia that occurs if you don't have enough iron in your body. Symptoms include anemia, headache, and feeding difficulties. The patient has all these symptoms.

+3. Hyperammonemia: This is a metabolic disturbance characterized by an excess of ammonia in the blood. Symptoms include hyperammonemia, headache, and feeding difficulties. The patient has all these symptoms.

+4. Celiac Disease: This is an immune reaction to eating gluten, a protein found in wheat, barley, and rye. Symptoms include malabsorption, anemia, and headache. The patient has all these symptoms.

+5. Nonketotic Hyperglycinemia: This is a rare genetic disorder characterized by abnormally high levels of a molecule called glycine in the body. Symptoms include hyperglycinemia, severe short stature, and feeding difficulties. The patient has all these symptoms.

+6. Migraine: This is a type of headache characterized by recurrent headaches that are moderate to severe. Symptoms include headache, anemia, and blindness. The patient has headache and anemia, but not severe headaches.

+7. Laron Syndrome: This is a rare form of short stature that results from the body's inability to use growth hormone. Symptoms include severe short stature, feeding difficulties, and anemia. The patient has all these symptoms.

+8. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms include death in childhood and feeding difficulties. The patient has both symptoms.

+9. Arginase Deficiency: This is a rare inherited disorder that affects the liver's ability to process and remove ammonia from the body. Symptoms include hypoargininemia, hyperammonemia, and feeding difficulties. The patient has all these symptoms.

+10. Ornithine Transcarbamylase Deficiency: This is a genetic disorder that causes an accumulation of ammonia in the blood. Symptoms include hyperornithinemia, hyperammonemia, and feeding difficulties. The patient has all these symptoms.

+11. Serine Deficiency: This is a rare genetic disorder that affects the body's ability to produce the amino acid serine. Symptoms include abnormal circulating serine concentration, hyperglycinemia, and feeding difficulties. The patient has all these symptoms. 

+12. Huntington's Disease: This is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain. Symptoms include death in early adulthood, feeding difficulties, and headache. The patient has death in early adulthood and feeding difficulties, but not the progressive breakdown of nerve cells in the brain."
['Phenylketonuria'],"+1. Tyrosinemia Type I: This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient include 'Hypertyrosinemia', 'Neonatal death', 'Death in infancy', 'Abnormality of prenatal development or birth'. However, 'Death in childhood' and 'Hyperphenylalaninemia' are not common symptoms of this disease.

+2. Phenylketonuria (PKU): This is a rare genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Death in infancy', 'Neonatal death', 'Abnormality of prenatal development or birth'. However, 'Hypertyrosinemia' and 'Death in childhood' are not common symptoms of this disease.

+3. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder in which the body cannot break down certain parts of proteins. Symptoms in common with the patient include 'Death in infancy', 'Neonatal death', 'Abnormality of prenatal development or birth'. However, 'Hypertyrosinemia', 'Hyperphenylalaninemia', and 'Death in childhood' are not common symptoms of this disease.

+4. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy', 'Neonatal death'. However, 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Abnormality of prenatal development or birth', and 'Death in childhood' are not common symptoms of this disease.

+5. Alkaptonuria: This is a rare genetic disorder that causes homogentisic acid to build up in your body. Symptoms in common with the patient include 'Abnormality of prenatal development or birth'. However, 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in infancy', 'Neonatal death', and 'Death in childhood' are not common symptoms of this disease."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1. Neonatal Hyperammonemia:
This is a condition characterized by an excess of ammonia in the newborn's blood. Common symptoms include generalized hypotonia (low muscle tone), feeding difficulties, and hyperammonemia. The patient's symptoms align with this condition. However, the patient does not exhibit neonatal death, which is a potential outcome of this disease.

+2. Urea Cycle Disorder:
This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. The patient's symptoms of hyperammonemia, generalized hypotonia, and feeding difficulties are common in this disorder. However, the patient does not exhibit neonatal death, which can occur in severe cases.

+3. Maple Syrup Urine Disease:
This is a metabolic disorder in which the body is unable to process certain protein building blocks (amino acids) properly. The most common symptoms are feeding difficulties, apathy, and generalized hypotonia. However, the patient does not exhibit the characteristic sweet-smelling urine or maple syrup odor of the ear wax, which are common symptoms of this disease.

+4. OTC Deficiency:
Ornithine transcarbamylase (OTC) deficiency is an inherited disorder that causes an excess of ammonia in the blood (hyperammonemia). Symptoms include feeding difficulties, generalized hypotonia, and cerebral edema. However, the patient does not exhibit neonatal death, which can occur in severe cases.

+5. Carnitine Palmitoyltransferase II Deficiency:
This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms include generalized hypotonia, feeding difficulties, and neonatal death. However, the patient does not exhibit symptoms of low blood sugar (hypoglycemia), which is common in this condition.

+6. Citrullinemia:
This is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms include hyperammonemia, generalized hypotonia, and feeding difficulties. However, the patient does not exhibit symptoms of citrulline accumulation in the blood, which is a key feature of this condition."
['Canavan disease'],"+1. Leber's Hereditary Optic Neuropathy (LHON): This is a condition that primarily affects the eyes, leading to vision loss. Symptoms in common with the patient include 'Blindness'. Symptoms not in common include 'Cardiac conduction defect', 'Dysarthria', and 'Dystonia'.

+2. Infantile Neuroaxonal Dystrophy (INAD): This is a rare inherited neurological disorder. It affects the nerve axons which are responsible for conducting messages in the brain. Symptoms in common with the patient include 'Nystagmus', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Abnormal myelination'. Symptoms not in common include 'Dystonia', 'Ataxia', and 'Progressive visual loss'.

+3. Canavan Disease: This is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Symptoms in common with the patient include 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death', 'Abnormal myelination'. Symptoms not in common include 'Macrocephaly', 'Feeding difficulties', and 'Progressive neurologic deterioration'.

+4. Alpers Syndrome: This is a progressive neurological disorder that leads to a loss of mental and movement abilities. Symptoms in common with the patient include 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Opisthotonus', 'Neonatal death'. Symptoms not in common include 'Hepatic failure', 'Spasticity', and 'Cerebral atrophy'.

+5. Zellweger Syndrome: This is a rare congenital disorder characterized by the reduction or absence of functional peroxisomes in the cells of an individual. Symptoms in common with the patient include 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death', 'Abnormal circulating aspartate family amino acid concentration'. Symptoms not in common include 'Hepatomegaly', 'Jaundice', and 'Renal cyst'.

+6. Usher Syndrome: This is a condition characterized by partial or total hearing loss and vision loss that worsens over time. Symptoms in common with the patient include 'Blindness', 'Nystagmus', 'Severe hearing impairment'. Symptoms not in common include 'Vestibular dysfunction', 'Retinitis pigmentosa', and 'Progressive night blindness'."
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1. Hydrocephalus: This is a condition that occurs when fluid builds up in the skull and causes the brain to swell. The patient has this symptom.

+2. Microcephaly: This is a medical condition in which the circumference of the head is smaller than normal because the brain has not developed properly or has stopped growing. The patient has this symptom.

+3. Strabismus: This is a condition in which the eyes do not properly align with each other when looking at an object. The patient has this symptom.

+4. Nystagmus: This is a condition of involuntary eye movement, acquired in infancy or later in life, that may result in reduced or limited vision. The patient has this symptom.

+5. Intellectual Disability: This is a disability characterized by significant limitations in both intellectual functioning and in adaptive behavior, which covers many everyday social and practical skills. The patient has this symptom.

+6. Death in Infancy: This is a term used to describe the death of an infant before their first birthday. The patient has this symptom.

+7. Premature Birth: This is a birth that takes place more than three weeks before the baby's estimated due date. The patient has this symptom.

+8. Respiratory Insufficiency: This is a condition in which the body's organs and tissues do not get enough oxygen. The patient has this symptom.

+9. Hyperhomocystinemia: This is a medical condition characterized by an abnormally high level of homocysteine in the blood. The patient has this symptom.

+10. Neonatal Death: This is the death of a baby within the first 28 days of life. The patient has this symptom.

+11. Death in Childhood: This is a term used to describe the death of a child before the age of 18. The patient has this symptom.

+12. Abnormal Circulating Carnitine Concentration: This is a condition characterized by abnormal levels of carnitine in the blood. The patient has this symptom.

+13. Methylmalonic Aciduria: This is a disorder in which the body is unable to process certain proteins and fats properly. The patient has this symptom.

+14. Dyskinesia: This is a disorder that results in involuntary, erratic, writhing movements of the face, arms, legs, or trunk. The patient has this symptom."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare genetic disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Abnormal circulating carnitine concentration'. Symptoms not in common include 'Muscle weakness', 'Hypoglycemia', 'Enlarged liver'.

+2. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This is a disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Vomiting', 'Death in infancy', 'Neonatal death', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'. Symptoms not in common include 'Lethargy', 'Seizures', 'Coma'.

+3. Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCADD): This is a fatty acid oxidation disorder that prevents the body from converting certain fats into energy. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'. Symptoms not in common include 'Hypotonia', 'Cardiomyopathy', 'Hepatomegaly'.

+4. Gastroenteritis: This is an inflammation of the gastrointestinal tract that involves both the stomach and the small intestine. Symptoms in common with the patient include 'Vomiting', 'Gastrointestinal inflammation'. Symptoms not in common include 'Diarrhea', 'Abdominal pain', 'Fever'.

+5. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Abnormal circulating carnitine concentration'. Symptoms not in common include 'Respiratory distress', 'Seizures', 'Hypoketotic hypoglycemia'."
['Biotinidase deficiency'],"+1. Leigh Syndrome: This is a severe neurological disorder that typically arises in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Common symptoms include generalized hypotonia, metabolic acidosis, and death in infancy. However, this condition does not typically present with leukopenia, hyperammonemia, or neonatal death.

+2. Carnitine-Acylcarnitine Translocase Deficiency: This is a rare metabolic condition that prevents the body from converting certain fats into energy, particularly during periods without food. Symptoms include generalized hypotonia, metabolic acidosis, hyperammonemia, and neonatal death. However, this condition does not typically present with death in infancy or leukopenia.

+3. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to break down certain parts of proteins. The condition gets its name from the distinctive sweet odor of affected infants' urine. Symptoms include generalized hypotonia and metabolic acidosis. However, this condition does not typically present with death in infancy, leukopenia, hyperammonemia, or neonatal death.

+4. OTC Deficiency: This is a genetic disorder that causes an enzyme deficiency, leading to the accumulation of ammonia in the blood. Symptoms include generalized hypotonia, metabolic acidosis, hyperammonemia, and neonatal death. However, this condition does not typically present with death in infancy or leukopenia.

+5. Severe Combined Immunodeficiency (SCID): This is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Symptoms include leukopenia. However, this condition does not typically present with generalized hypotonia, death in infancy, metabolic acidosis, hyperammonemia, or neonatal death."
['Tyrosinemia type 2'],"+1. Keratoconjunctivitis:
This is an inflammation of the cornea and conjunctiva. The patient's symptoms of Keratitis and Conjunctivitis are consistent with this disease. However, the patient does not exhibit the common symptom of eye discharge.

+2. Tyrosinemia Type II:
This is a rare metabolic disorder characterized by elevated blood levels of the amino acid tyrosine. The patient's symptoms of Keratitis, Intellectual disability, and Hypertyrosinemia are consistent with this disease. However, the patient does not exhibit the common symptoms of painful skin lesions and corneal ulcers.

+3. Refsum Disease:
This is a genetic disorder that affects the metabolism of the fatty acid phytanic acid. The patient's symptoms of Intellectual disability and Seizure are consistent with this disease. However, the patient does not exhibit the common symptoms of peripheral neuropathy and ataxia.

+4. Xeroderma Pigmentosum:
This is a rare genetic disorder that affects the body's ability to repair DNA damage. The patient's symptoms of Photophobia and Hyperkeratosis are consistent with this disease. However, the patient does not exhibit the common symptoms of skin cancer and premature skin aging.

+5. Batten Disease:
This is a fatal, inherited disorder of the nervous system. The patient's symptoms of Seizure, Intellectual disability, and Death in childhood are consistent with this disease. However, the patient does not exhibit the common symptoms of vision loss and motor skills deterioration.

+6. Sjogren's Syndrome:
This is an autoimmune disease that affects the glands that produce tears and saliva. The patient's symptoms of Keratitis, Conjunctivitis, and Epiphora are consistent with this disease. However, the patient does not exhibit the common symptoms of dry mouth and joint pain."
['Phenylketonuria'],"+1. Phenylketonuria (PKU): This is a genetic disorder that increases the levels of a substance called phenylalanine in the blood. Symptoms in common with the patient include 'Hyperphenylalaninemia' and 'Abnormal circulating tyrosine concentration'. Symptoms not in common include 'Intellectual disability', 'Delayed speech and language development', and 'Motor delay'.

+2. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. Symptoms in common with the patient include 'Abnormal circulating tyrosine concentration', 'Death in infancy', 'Neonatal death', and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Liver and kidney failure', 'Rickets', and 'Failure to thrive'.

+3. Maternal Phenylketonuria: This is a condition in pregnant women who have previously diagnosed phenylketonuria (PKU). Symptoms in common with the patient include 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', and 'Abnormality of prenatal development or birth'. Symptoms not in common include 'Microcephaly', 'Heart defects', and 'Growth retardation'.

+4. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with the patient include 'Death in infancy' and 'Neonatal death'. Symptoms not in common include 'Apnea' and 'Changes in heart rate'.

+5. Early Adult Death Syndrome: This is a condition where an individual dies unexpectedly as an adult. Symptoms in common with the patient include 'Death in early adulthood'. Symptoms not in common include 'Cardiac arrest' and 'Unexplained death'."
[],"+1. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder characterized by the body's inability to remove ammonia from the blood. Common symptoms include hyperammonemia, neonatal death, and death in infancy. The patient's symptoms of cyanosis, seizure, and 3-hydroxydicarboxylic aciduria are not typically associated with this condition.

+2. Citrullinemia Type I:
This is a disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms include hyperammonemia, neonatal death, and death in infancy. The patient's symptoms of cyanosis, seizure, and 3-hydroxydicarboxylic aciduria are not typically associated with this condition.

+3. OTC Deficiency:
Ornithine transcarbamylase deficiency is an inherited disorder that causes ammonia to accumulate in the blood. Symptoms include hyperammonemia, neonatal death, and death in infancy. The patient's symptoms of cyanosis, seizure, and 3-hydroxydicarboxylic aciduria are not typically associated with this condition.

+4. Argininosuccinic Aciduria:
This is a genetic disorder that causes ammonia to build up in the body. Symptoms include hyperammonemia, neonatal death, and death in infancy. The patient's symptoms of cyanosis, seizure, and 3-hydroxydicarboxylic aciduria are not typically associated with this condition.

+5. Methylmalonic Acidemia:
This is a disorder in which the body is unable to process certain proteins and fats properly. Symptoms can include seizures and death in infancy. The patient's symptoms of cyanosis, hyperammonemia, neonatal death, and 3-hydroxydicarboxylic aciduria are not typically associated with this condition. 

+6. Propionic Acidemia:
This is a disorder that affects the breakdown of proteins and fats in the body. Symptoms can include seizures and death in infancy. The patient's symptoms of cyanosis, hyperammonemia, neonatal death, and 3-hydroxydicarboxylic aciduria are not typically associated with this condition. 

+7. Isovaleric Acidemia:
This is a disorder that affects the breakdown of certain amino acids in the body. Symptoms can include seizures and death in infancy. The patient's symptoms of cyanosis, hyperammonemia, neonatal death, and 3-hydroxydicarboxylic aciduria are not typically associated with this condition."
['Alkaptonuria'],"+1. Alkaptonuria: This is a rare genetic disorder that affects the body's ability to process certain amino acids, leading to a buildup of a substance called homogentisic acid in the body. Symptoms include dark urine. However, death in infancy and vomiting are not typically associated with this condition.

+2. Acute Hepatitis: This is an inflammation of the liver that results in symptoms such as dark urine and vomiting. However, it does not typically result in death in infancy.

+3. Maple Syrup Urine Disease: This is a rare genetic disorder that affects the body's ability to process certain amino acids. Symptoms can include vomiting and, in severe cases, can lead to death in infancy. However, the urine typically has a sweet or burnt sugar smell, not a dark color.

+4. Hemolytic Uremic Syndrome: This is a condition that results from the destruction of red blood cells and can lead to kidney injury. Symptoms can include vomiting and dark urine. However, it does not typically result in death in infancy.

+5. Wilson's Disease: This is a rare inherited disorder that causes copper to accumulate in your liver, brain and other vital organs. Symptoms can include vomiting and dark urine. However, it does not typically result in death in infancy. 

+6. Tyrosinemia: This is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. Symptoms can include vomiting and dark urine. In severe cases, it can lead to death in infancy."
['Maple syrup urine disease'],"+1. Maple Syrup Urine Disease (MSUD): This is a metabolic disorder that affects the body's ability to process certain amino acids. Symptoms in common include 'Seizure', 'Lethargy', 'Growth delay', 'Metabolic acidosis', 'Drowsiness', 'Sleep abnormality', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Feeding difficulties', and 'Elevated urinary carboxylic acid'. Symptoms not in common include 'Death in infancy', 'Hyperammonemia', 'Hypervalinemia', and 'Severe hearing impairment'.

+2. Propionic Acidemia: This is a disorder that affects the breakdown of proteins and fats in the body. Symptoms in common include 'Seizure', 'Lethargy', 'Growth delay', 'Metabolic acidosis', 'Drowsiness', 'Feeding difficulties', and 'Elevated urinary carboxylic acid'. Symptoms not in common include 'Death in infancy', 'Hyperammonemia', 'Sleep abnormality', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', and 'Severe hearing impairment'.

+3. Isovaleric Acidemia: This is a genetic disorder which disrupts the process of breaking down certain proteins. Symptoms in common include 'Seizure', 'Lethargy', 'Growth delay', 'Metabolic acidosis', 'Drowsiness', 'Feeding difficulties', and 'Elevated urinary carboxylic acid'. Symptoms not in common include 'Death in infancy', 'Hyperammonemia', 'Sleep abnormality', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', and 'Severe hearing impairment'.

+4. Urea Cycle Disorder: This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. Symptoms in common include 'Seizure', 'Lethargy', 'Growth delay', 'Hyperammonemia', 'Drowsiness', 'Feeding difficulties'. Symptoms not in common include 'Death in infancy', 'Metabolic acidosis', 'Sleep abnormality', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Severe hearing impairment', and 'Elevated urinary carboxylic acid'.

+5. Leigh Syndrome: This is a severe neurological disorder that usually becomes apparent in the first year of life. Symptoms in common include 'Seizure', 'Lethargy', 'Growth delay', 'Drowsiness', 'Feeding difficulties'. Symptoms not in common include 'Death in infancy', 'Metabolic acidosis', 'Hyperammonemia', 'Sleep abnormality', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Severe hearing impairment', and 'Elevated urinary carboxylic acid'."
['Ornithine transcarbamylase deficiency'],"+1. Urea Cycle Disorder: This is a genetic disorder that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. The Urea Cycle Disorder can cause hyperammonemia, oroticaciduria, elevated plasma citrulline, and abnormal circulating arginine concentration. However, the patient does not show symptoms of abnormal circulating proline concentration which is also common in this disorder.

+2. Carnitine Palmitoyltransferase II Deficiency: This is a condition that prevents the body from using certain fats for energy, particularly during periods without food. Symptoms can include hypoglycemia, generalized hypotonia, and death in infancy or childhood. However, the patient does not show symptoms of recurrent viral infections which is also common in this disorder.

+3. Propionic Acidemia: This is a disorder that affects the breakdown of proteins and lipids in the body. It can cause symptoms such as skin rash, vomiting, hypotonia, and hyperammonemia. However, the patient does not show symptoms of gastrointestinal inflammation which is also common in this disorder.

+4. Citrullinemia: This is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms can include hyperammonemia, elevated plasma citrulline, and neonatal death. However, the patient does not show symptoms of myocarditis which is also common in this disorder.

+5. Maple Syrup Urine Disease: This is a metabolic disorder in which the body is unable to process certain protein building blocks. Symptoms can include coma, hypotonia, and death in infancy. However, the patient does not show symptoms of abnormal circulating creatine kinase concentration which is also common in this disorder.

+6. Orotic Aciduria: This is a disorder that causes an excess of orotic acid in the body. Symptoms can include oroticaciduria, hypotonia, and hyperammonemia. However, the patient does not show symptoms of eczematoid dermatitis which is also common in this disorder. 

+7. Hyper IgM Syndrome: This is an immunodeficiency disorder that can cause recurrent viral infections, fever, and death in adolescence. However, the patient does not show symptoms of eczematoid dermatitis which is also common in this disorder. 

+8. Dermatomyositis: This is an inflammatory disease known for causing muscle weakness and a skin rash. Symptoms can include skin rash, fever, and myocarditis. However, the patient does not show symptoms of gastrointestinal inflammation which is also common in this disorder."
